TWI828910B - Liquid-crystalline medium - Google Patents

Liquid-crystalline medium Download PDF

Info

Publication number
TWI828910B
TWI828910B TW109116296A TW109116296A TWI828910B TW I828910 B TWI828910 B TW I828910B TW 109116296 A TW109116296 A TW 109116296A TW 109116296 A TW109116296 A TW 109116296A TW I828910 B TWI828910 B TW I828910B
Authority
TW
Taiwan
Prior art keywords
mixture
khz
formula
group
compounds
Prior art date
Application number
TW109116296A
Other languages
Chinese (zh)
Other versions
TW202104555A (en
Inventor
哈拉德 賀奇曼
瑪提娜 威得侯斯特
Original Assignee
德商馬克專利公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 德商馬克專利公司 filed Critical 德商馬克專利公司
Publication of TW202104555A publication Critical patent/TW202104555A/en
Application granted granted Critical
Publication of TWI828910B publication Critical patent/TWI828910B/en

Links

Abstract

The invention relates to a liquid-crystalline medium which comprises the compound of the formula I,

Description

液晶介質liquid crystal medium

本發明係關於一種包含式I化合物之液晶介質, 此類介質可尤其用於基於ECB效應之具有主動矩陣定址之電光顯示器及IPS (共平面切換型)顯示器或FFS (邊緣場切換型)顯示器。The present invention relates to a liquid crystal medium containing a compound of formula I, Such media can be used in particular for electro-optical displays with active matrix addressing based on the ECB effect and IPS (In-Plane Switching) displays or FFS (Fringe Field Switching) displays.

電控雙折射(ECB)效應或此外配向相之變形(DAP)效應之原理首次描述於1971年(M.F. Schieckel及K. Fahrenschon, 「Deformation of nematic liquid crystals with vertical orientation in electrical fields」, Appl. Phys. Lett. 19 (1971), 3912)。隨後描述於J.F.Kahn (Appl. Phys. Lett. 20 (1972), 1193)及G. Labrunie及J. Robert (J. Appl. Phys. 44 (1973), 4869)之論文中。 J. Robert及F. Clerc (SID 80 Digest Techn. Papers (1980), 30)、J. Duchene (Displays 7 (1986), 3)及H. Schad (SID 82 Digest Techn. Papers (1982), 244)之論文展示液晶相必須具有彈性常數K3 /K1 之高比值、高光學各向異性Δn值及介電各向異性值Δε≤-0.5以適用於基於ECB效應之高資訊顯示元件。基於ECB效應之電光顯示元件具有垂直邊緣配向(VA技術=豎直配向)。介電負性液晶介質亦可用於使用所謂IPS或FFS效應之顯示器。 除共平面轉換型(IPS)顯示器(例如:Yeo, S.D., 論文15.3: 「An LC Display for the TV Application」, SID 2004 International Symposium, Digest of Technical Papers, XXXV, 第II冊, 第758及759頁)及很早已知的扭轉向列型(TN)顯示器之外,使用ECB效應之顯示器,如所謂豎直配向向列型(VAN)顯示器,例如利用多域豎直配向(MVA,例如:Yoshide, H.等人, 論文3.1: 「MVA LCD for Notebook or Mobile PCs ...」, SID 2004 International Symposium, Digest of Technical Papers, XXXV, 第I冊, 第6至9頁, 及Liu, C.T.等人, 論文15.1: 「A 46-inch TFT-LCD HDTV Technology ...」, SID 2004 International Symposium, Digest of Technical Papers, XXXV, 第II冊, 第750至753頁)、圖案化豎直配向(PVA,例如:Kim, Sang Soo, 文件15.4: 「Super PVA Sets New State-of-the-Art for LCD-TV」, SID 2004 International Symposium, Digest of Technical Papers, XXXV, 第II冊, 第760至763頁)、先進的超級視圖(ASV,例如:Shigeta, Mitzuhiro及Fukuoka, Hirofumi, 文件15.2: 「Development of High Quality LCDTV」, SID 2004 International Symposium, Digest of Technical Papers, XXXV, 第II冊, 第754至757頁)模式之顯示器,本身已確立為當前最重要的三種較新型液晶顯示器(尤其用於電視應用)之一。該等技術在例如Souk, Jun, SID Seminar 2004, 研討會M-6: 「Recent Advances in LCD Technology」, Seminar Lecture Notes, M-6/1至M-6/26及Miller, Ian, SID Seminar 2004, 研討會M-7: 「LCD-Television」, Seminar Lecture Notes, M-7/1至M-7/32中以一般形式進行比較。儘管現代ECB顯示器之反應時間已藉由使用超速驅動之定址方法顯著改良,例如:Kim, Hyeon Kyeong等人, 論文9.1: 「A 57-in. Wide UXGA TFT-LCD for HDTV Application」, SID 2004 International Symposium, Digest of Technical Papers, XXXV, 第I冊, 第106頁至第109頁,但視訊相容性反應時間之達成,尤其關於灰度轉換仍為尚未得到圓滿解決之問題。 此效應在電光顯示元件中之工業應用需要LC相,其必須滿足多種要求。在本文中,對濕氣、空氣之化學抗性及物理影響(諸如熱、紅外、可見光及紫外輻射以及直流及交流電場)尤其重要。 此外,工業上可使用之LC相為在適合之溫度範圍內及低黏度下具有液晶中間相所必需。 迄今揭示之具有液晶中間相之一系列化合物均不包括符合所有此等要求之單一化合物。因此一般製備兩種至25種、較佳三種至18種化合物之混合物以獲得可用作LC相之物質。然而,以此方式不可能容易地製備最佳相,因為迄今尚未獲得具有顯著負介電各向異性及足夠長期穩定性之液晶材料。 已知矩陣液晶顯示器(MLC顯示器)。可用於個別像素之個別轉換的非線性元件為例如主動元件(亦即電晶體)。隨後使用術語「主動矩陣」,其中可在兩種類型之間進行區分: 1.矽晶圓上之金屬氧化物半導體(MOS)電晶體作為基板 2.玻璃板上之薄膜電晶體(TFT)作為基板。 在類型1之情形下,所用電光效應通常為動態散射或客體-主體效應。使用單晶矽作為基板材料限制了顯示器尺寸,因為即使模組組裝各種部分顯示器亦會在接合點處產生問題。 在更有前景之類型2 (其為較佳)之情形下,使用電光效應通常為TN效應。 在兩種技術之間進行區分:包含化合物半導體(諸如CdSe)之TFT或基於多晶或非晶矽之TFT。後一技術在全世界廣泛使用。 將TFT矩陣塗覆於顯示器之一個玻璃板的內部,而另一玻璃板在其內部攜有透明相對電極。相較於像素電極之尺寸,TFT極小且對影像實際上無不良影響。此技術亦可沿用至全色能顯示器,其中以某種方式配置紅光、綠光及藍光濾光器之嵌合體以使得濾光器元件與各可切換像素相對。 本文之術語MLC顯示器涵蓋具有整合之非線性元件的任何矩陣顯示器,亦即除主動矩陣以外,顯示器亦具有被動元件,諸如變阻器或二極體(MIM=金屬-絕緣體-金屬)。 此類型之MLC顯示器尤其適用於TV應用(例如口袋型TV)或汽車或飛機構造中之高資訊顯示器。除關於對比度及反應時間之角度依賴性的問題以外,MLC顯示器中亦由於液晶混合物之不夠高之比電阻而產生困難[TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E., SORIMACHI, K., TAJIMA, E., WATANABE, H., SHIMIZU, H., Proc. Eurodisplay 84, 1984年9月: A 210-288 Matrix LCD Controlled by Double Stage Diode Rings, 第141頁及以下, Paris;STROMER, M., Proc. Eurodisplay 84, 1984年9月: Design of Thin Film Transistors for Matrix Addressing of Television Liquid Crystal Displays, 第145頁及以下, Paris]。隨著電阻減小,MLC顯示器之對比度劣化。由於液晶混合物之比電阻一般由於與顯示器內表面相互作用而隨MLC顯示器之壽命下降,故對於必須在長操作時間段具有可接受之電阻值的顯示器,高(初始)電阻極其重要。 因此,仍非常需要在大工作溫度範圍及低臨限電壓之同時具有快速反應時間的MLC顯示器,從而可產生各種灰度。 常使用之MLC-TN顯示器的缺點係由於其相對較低的對比度、相對較高的視角依賴性及在此等顯示器中產生灰度之困難。 VA顯示器具有顯著較佳視角依賴性。因此主要用於電視及監視器。然而,此處仍需要改良反應時間,尤其考慮到用於圖框速率(影像變化頻率/刷新速率)大於60 Hz之電視。然而,同時必須不減弱諸如低溫穩定性之特性。The principle of the electrically controlled birefringence (ECB) effect or the deformation of additional alignment phase (DAP) effect was first described in 1971 (MF Schieckel and K. Fahrenschon, "Deformation of nematic liquid crystals with vertical orientation in electrical fields", Appl. Phys . Lett. 19 (1971), 3912). It was subsequently described in papers by JF Kahn (Appl. Phys. Lett. 20 (1972), 1193) and G. Labrunie and J. Robert (J. Appl. Phys. 44 (1973), 4869). J. Robert and F. Clerc (SID 80 Digest Techn. Papers (1980), 30), J. Duchene (Displays 7 (1986), 3), and H. Schad (SID 82 Digest Techn. Papers (1982), 244) The paper shows that the liquid crystal phase must have a high ratio of elastic constant K 3 /K 1 , high optical anisotropy Δn value and dielectric anisotropy value Δε≤-0.5 to be suitable for high information display elements based on the ECB effect. Electro-optical display elements based on the ECB effect have vertical edge alignment (VA technology = vertical alignment). Dielectric negative liquid crystal media can also be used in displays using the so-called IPS or FFS effect. Except for in-plane switching (IPS) displays (for example: Yeo, SD, Paper 15.3: "An LC Display for the TV Application", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Volume II, pages 758 and 759 ) and the early known twisted nematic (TN) displays, displays using the ECB effect, such as so-called vertical alignment nematic (VAN) displays, such as multi-domain vertical alignment (MVA), such as Yoshide, H. et al., Paper 3.1: "MVA LCD for Notebook or Mobile PCs...", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Volume I, pages 6 to 9, and Liu, CT et al., Paper 15.1: "A 46-inch TFT-LCD HDTV Technology ...", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Volume II, pages 750 to 753), Patterned Vertical Alignment (PVA, e.g. : Kim, Sang Soo, Document 15.4: "Super PVA Sets New State-of-the-Art for LCD-TV", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Volume II, pages 760 to 763), Advanced Super View (ASV, for example: Shigeta, Mitzuhiro and Fukuoka, Hirofumi, Document 15.2: "Development of High Quality LCDTV", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Volume II, pages 754 to 757) The LCD display itself has established itself as one of the three most important newer LCD displays (especially for television applications). Such technologies are discussed in, for example, Souk, Jun, SID Seminar 2004, Seminar M-6: "Recent Advances in LCD Technology", Seminar Lecture Notes, M-6/1 to M-6/26 and Miller, Ian, SID Seminar 2004 , Seminar M-7: "LCD-Television", Seminar Lecture Notes, M-7/1 to M-7/32 for comparison in general form. Although the response time of modern ECB displays has been significantly improved by using overdrive addressing methods, for example: Kim, Hyeon Kyeong et al., Paper 9.1: "A 57-in. Wide UXGA TFT-LCD for HDTV Application", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Volume I, pages 106 to 109. However, the achievement of video compatibility response time, especially regarding grayscale conversion, is still an issue that has not yet been satisfactorily solved. The industrial application of this effect in electro-optical display components requires an LC phase, which must meet various requirements. In this context, chemical resistance to moisture, air, and physical influences such as heat, infrared, visible and ultraviolet radiation, and DC and AC electric fields are of particular importance. In addition, an industrially usable LC phase is necessary to have a liquid crystalline mesophase within a suitable temperature range and at low viscosity. The series of compounds with liquid crystalline mesophases disclosed so far do not include a single compound that meets all of these requirements. Therefore generally mixtures of two to 25, preferably three to 18 compounds are prepared to obtain materials that can be used as LC phases. However, it is not possible to easily prepare optimal phases in this way, since liquid crystal materials with significant negative dielectric anisotropy and sufficient long-term stability have not yet been obtained. Matrix liquid crystal displays (MLC displays) are known. Nonlinear elements that can be used for individual switching of individual pixels are, for example, active elements (ie transistors). The term "active matrix" is subsequently used, where a distinction can be made between two types: 1. Metal Oxide Semiconductor (MOS) transistors on silicon wafers as substrate 2. Thin Film Transistors (TFTs) on glass plates as substrate. In the case of type 1, the electro-optical effects used are usually dynamic scattering or guest-host effects. The use of monocrystalline silicon as the substrate material limits display size because even modules that assemble various parts of the display can cause problems at the joints. In the case of the more promising type 2 (which is better), the electro-optical effect is used, usually the TN effect. A distinction is made between two technologies: TFTs containing compound semiconductors such as CdSe or TFTs based on polycrystalline or amorphous silicon. The latter technique is widely used around the world. A TFT matrix is coated on the inside of one glass plate of the display, while the other glass plate carries a transparent counter electrode on its inside. Compared with the size of the pixel electrode, TFT is extremely small and has virtually no adverse effect on the image. This technology could also be carried over to full-color energy displays, where a chimera of red, green, and blue filters is arranged in such a way that the filter element is opposite each switchable pixel. The term MLC display herein covers any matrix display with integrated non-linear elements, that is, in addition to the active matrix, the display also has passive elements, such as varistors or diodes (MIM = Metal-Insulator-Metal). This type of MLC display is particularly suitable for TV applications (such as pocket TVs) or high-information displays in automobile or aircraft structures. In addition to problems regarding the angular dependence of contrast and response time, difficulties arise in MLC displays due to the insufficiently high specific resistance of the liquid crystal mixture [TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E. , SORIMACHI, K., TAJIMA, E., WATANABE, H., SHIMIZU, H., Proc. Eurodisplay 84, September 1984: A 210-288 Matrix LCD Controlled by Double Stage Diode Rings, pp. 141 et seq., Paris; STROMER, M., Proc. Eurodisplay 84, September 1984: Design of Thin Film Transistors for Matrix Addressing of Television Liquid Crystal Displays, pp. 145 et seq., Paris]. As the resistance decreases, the contrast ratio of the MLC display deteriorates. Since the specific resistance of the liquid crystal mixture generally decreases with the life of the MLC display due to interaction with the inner surface of the display, high (initial) resistance is extremely important for displays that must have acceptable resistance values over long periods of operation. Therefore, there is still a strong need for MLC displays with fast response times along with a wide operating temperature range and low threshold voltage, so that various gray scales can be produced. Disadvantages of commonly used MLC-TN displays are due to their relatively low contrast ratio, relatively high viewing angle dependence and the difficulty of generating grayscale in such displays. VA displays have significantly better viewing angle dependence. Therefore it is mainly used in TVs and monitors. However, there is still a need to improve the response time here, especially when considering the use of TVs with frame rates (image change frequency/refresh rate) greater than 60 Hz. However, at the same time properties such as low temperature stability must not be compromised.

本發明係基於提供尤其用於監視器及TV應用,基於ECB效應或基於IPS或FFS效應之液晶混合物之目標,該等液晶混合物無上文指示之缺點,或僅具有降低程度之上文指示之缺點。詳言之,必須確保監視器及電視在極高及極低溫度下亦工作,且同時具有極短反應時間且同時具有改良之可靠性行為,尤其在長操作時間之後不展現影像殘留或展現顯著降低之影像殘留。 意外地,若將式I化合物用於液晶混合物,尤其具有負介電各向異性之LC混合物,較佳用於VA、IPS及FFS顯示器,進一步用於PM (被動矩陣)-VA顯示器,則可降低旋轉黏度γ1與彈性常數K33之比率(γ1/K33),因此改良反應時間。 意外地,式I化合物同時具有極低旋轉黏度及介電各向異性之高絕對值。因此可能製備具有極短反應時間,同時具有優良相特性及優良低溫行為之液晶化合物,較佳VA、IPS及FFS混合物。 因此,本發明係關於如技術方案1之液晶介質,其包含式I化合物。 本發明之混合物較佳展現極寬向列相範圍,且清澈點≥68℃,較佳≥70℃,展現極有利之電容臨限值,相對高之保持率值,且同時在-20℃及-30℃下極優良之低溫穩定性以及低旋轉黏度及短反應時間。此外,除旋轉黏度γ1 改良之外,本發明之混合物藉由可觀察到用於改良反應時間之相對高的彈性常數K33 值而區分。 本發明混合物之一些較佳實施例如下所指示。 以混合物作為整體計,式I化合物較佳以≥1重量%、較佳≥3重量%之量用於液晶介質中。尤其較佳為包含5至30重量%、極尤其較佳5至15重量%式I化合物之液晶介質。 本發明之液晶介質之較佳實施例如下所指示: a)另外包含一或多種選自式IIA、IIB及IIC之化合物之群的化合物的液晶介質, IIA       IIB       IIC       其中 R2A 、R2B 及R2C 各彼此獨立地表示H;具有至多15個C原子之烷基或烯基,其未經取代、經CN或CF3 單取代或至少經鹵素單取代,其中,另外,此等基團中之一或多個CH2 基團可以使得O原子不直接彼此鍵聯之方式經-O-、-S-、、-C≡C-、-CF2 O-、-OCF2 -、-OC-O-或-O-CO-置換;或具有3至6個C原子之環烷基環, L1-4 各獨立地表示F、Cl、CF3 或CHF2 , Z2 及Z2' 各獨立地表示單鍵、-CH2 CH2 -、-CH=CH-、-CF2 O-、-OCF2 -、-CH2 O-、-OCH2 -、-COO-、-OCO-、-C2 F4 -、-CF=CF-、-CH=CHCH2 O-, p表示1或2, q表示0或1,且 v表示1至6。 在式IIA及IIB之化合物中,Z2 可具有相同或不同含義。在式IIB化合物中,Z2 及Z2 ' 可具有相同或不同含義。 在式IIA、IIB及IIC之化合物中,R2A 、R2B 及R2C 各較佳表示具有1至6個C原子之烷基,尤其CH3 、C2 H5 、n-C3 H7 、n-C4 H9 、n-C5 H11 。 在式IIA及IIB之化合物中,L1 、L2 、L3 及L4 較佳表示L1 = L2 = F,且L3 = L4 = F,此外L1 = F,且L2 = Cl,L1 = Cl,且L2 = F,L3 = F,且L4 = Cl,L3 = Cl,且L4 = F。式IIA及IIB中之Z2 及Z2 '較佳各彼此獨立地表示單鍵,此外表示-C2 H4 -或-CH2 O-橋。 若在式IIB中,Z2 =-C2 H4 -或-CH2 O-,則Z2 ' 較佳為單鍵,或若Z2 ' =-C2 H4 -或-CH2 O-,則Z2 較佳為單鍵。在式IIA及IIB之化合物中,(O)Cv H2v + 1 較佳表示OCv H2v + 1 ,此外Cv H2v + 1 。在式IIC化合物中,(O)Cv H2v + 1 較佳表示Cv H2v + 1 。在式IIC化合物中,L3 及L4 較佳各表示F。 較佳之式IIA、IIB及IIC之化合物如下所指示: , 其中烷基及烷基*各彼此獨立地表示具有1至6個C原子之直鏈烷基。 本發明之尤其較佳混合物包含一或多種式IIA-2、IIA-8、IIA-14、IIA-26、IIA-28、IIA-33、IIA-39、IIA-45、IIA-46、IIA-47、IIB-2、IIB-11、IIB-16及IIC-1之化合物。 式IIA及/或IIB之化合物在整個混合物中之比例較佳為至少20重量%。 本發明之尤其較佳介質包含至少一種式IIC-1之化合物,, 其中烷基及烷基*具有上文所指示之含義,其量較佳為>3重量%,尤其>5重量%且尤其較佳5至25重量%。 b)另外包含一或多種式III化合物之液晶介質,III 其中 R31 及R32 各獨立地表示有至多12個C原子之直鏈烷基、烷氧基烷基或烷氧基,且表示 Z3 表示單鍵、-CH2 CH2 -、-CH=CH-、-CF2 O-、-OCF2 -、-CH2 O-、-OCH2 -、-COO-、-OCO-、-C2 F4 -、-C4 H8 -、-CF=CF-。 較佳式III化合物如下所指示: 其中 烷基及烷基*各彼此獨立地表示具有1至6個C原子之直鏈烷基。 本發明之介質較佳包含至少一種式IIIa及/或式IIIb之化合物。 式III化合物在整體混合物中之比例較佳為至少5重量%。 c)另外包含一或多種下式之四環化合物的液晶介質:V-1V-2V-3V-4V-5V-6V-7V-8V-9 其中 R7-10 各彼此獨立地具有技術方案2中對於R2A 所指示之含義之一,且 w及x各獨立地表示1至6。 尤其較佳為包含至少一種式V-9化合物之混合物。 d)另外包含一或多種式Y-1至Y-6之化合物的液晶介質,Y-1Y-2Y-3Y-4Y-5Y-6 其中R14 -R19 各獨立地表示具有1至6個C原子之烷基或烷氧基;z及m各獨立地表示1至6;x表示0、1、2或3。 本發明之介質尤其較佳包含一或多種式Y-1至Y-6之化合物,其量較佳為≥5重量%。 e)另外包含一或多種式T-1至T-21之氟化聯三苯的液晶介質,T-1T-2T-3T-4T-5T-6T-7T-8T-9T-10T-11T-12T-13T-14T-15T-16T-17T-18T-19T-20T-21 其中 R表示具有1至7個C原子之直鏈烷基或烷氧基或具有2至7個C原子之烯基, 且m = 0、1、2、3、4、5或6,且n表示0、1、2、3或4。 R較佳表示甲基、乙基、丙基、丁基、戊基、己基、甲氧基、乙氧基、丙氧基、丁氧基、戊氧基。 本發明之介質較佳包含式T-1至T-21之聯三苯,其量為2至30重量%,尤其5至20重量%。 尤其較佳為式T-1、T-2、T-20及T-21之化合物。在此等化合物中,R較佳表示烷基,此外烷氧基,其各具有1至5個C原子。在式T-20化合物中,R較佳表示烷基或烯基,尤其烷基。在式T-21化合物中,R較佳表示烷基。 若混合物之Δn值欲為≥0.1,則聯三苯較佳用於本發明之混合物中。較佳混合物包含2至20重量%的一或多種選自化合物T-1至T-21之群的聯三苯化合物。 f)另外包含一或多種式B-1至B-4之聯苯的液晶介質, 其中 烷基及烷基*各彼此獨立地表示具有1至6個C原子之直鏈烷基, 烯基及烯基*各彼此獨立地表示具有2至6個C原子之直鏈烯基,且 烷氧基表示具有1至6個C原子之直鏈烷氧基。 式B-1至B-4之聯苯在整體混合物中之比例較佳為至少3重量%,尤其≥5重量%。 在式B-1至B-4之化合物中哦和那個,式B-2化合物為尤其較佳。 尤其較佳聯苯為, 其中烷基*表示具有1至6個C原子之烷基。本發明之介質尤其較佳包含一或多種式B-1a及/或B-2c之化合物。 g)包含至少一種式Z-1至Z-7之化合物的液晶介質, 其中 R表示具有1至7個C原子之直鏈烷基或烷氧基或具有2至7個C原子之烯基, 烷基表示具有1至6個C原子之烷基,且 (O)烷基表示烷基或O烷基。 h)包含至少一種式O-1至O-17之化合物的液晶介質, O-1 O-2 O-3 O-4 O-5 O-6 O-7 O-8 O-9 O-10 O-11 O-12 O-13 O-14 O-15 O-16 O-17 其中R1 及R2 具有對於R2A 所指示之含義,且式O-17化合物與式I化合物不相同。R1 及R2 較佳各獨立地表示具有1至6個C原子之直鏈烷基,或R1 表示具有1至6個C原子之直鏈烷基,且R2 表示具有2至6個C原子之烯基。 較佳介質包含一或多種式O-1、O-3、O-4、O-5、O-9、O-12、O-14、O-15、O-16及/或O-17之化合物。 本發明之混合物極尤其較佳包含式O-9、O-12、O-16及/或O-17之化合物,其量尤其為5至30%。 較佳之式O-9及O-17之化合物如下所指示: O-9a       O-9b       O-17a       O-17b       O-17c       O-17d 本發明之介質尤其較佳包含式O-9a及/或式O-9b之三環化合物以及一或多種式O-17a至O-17d之雙環化合物。式O-9a及/或O-9b之化合物以及一或多種選自式O-17a至O-17d之雙環化合物的化合物之總比例較佳為5至40%,極尤其較佳為15至35%。 極尤其較佳混合物包含化合物O-9a及O-17a: O-9a       O-17a。 以混合物作為整體計,化合物O-9a及O-17a較佳以15至35%、尤其較佳15至25%且特別較佳18至22%之濃度存在於混合物中。 極尤其較佳混合物包含化合物O-9b及O-17a: O-9b O-17a。 以混合物作為整體計,化合物O-9b及O-17a較佳以15至35%、尤其較佳15至25%且尤其較佳18至22%之濃度存在於混合物中。 極尤其較佳混合物包含以下三種化合物: O-9a       O-9b       O-17a。 以混合物作為整體計,化合物O-9a、O-9b及O-17a較佳以15至35%、尤其較佳15至25%且尤其較佳18至22%之濃度存在於混合物中。 此外,較佳式O-17化合物為選自下式之化合物的群的化合物 O-17e             O-17f             O-17g             O-17h             O-17i             , O-17j    在各情形下,其量較佳為≥3重量%,尤其≥10重量%。 i)包含一或多種式BA化合物之液晶介質 其中 烯基及烯基*各彼此獨立地表示具有2至12個C原子之直鏈烯基,表示, Z3 表示單鍵、-CH2 CH2 -、-CH=CH-、-CF2 O-、-OCF2 -、-CH2 O-、-OCH2 -、-COO-、-OCO-、-C2 F4 -、-C4 H8 -、-CF=CF-。 較佳式BA化合物如下所指示:       BA-1                BA-2                BA-3                BA-4                BA-5。 較佳混合物包含5至60重量%、較佳10至55重量%、尤其20至50重量%式O-17e化合物    O-17e。 此外,較佳為包含化合物O-17e 及化合物O-17i 之液晶混合物,其總量較佳為3至60重量%。 j)本發明之較佳液晶介質包含一或多種含有四氫萘基或萘基單元之物質,諸如式N-1至N-5之化合物, N-1 N-2 N-3 N-4 N-5 其中R1N 及R2N 各彼此獨立地具有對於R2A 所指示之含義,較佳表示直鏈烷基、直鏈烷氧基或直鏈烯基,且 Z1 及Z2 各獨立地表示-C2 H4 -、-CH=CH-、-(CH2 )4 -、-(CH2 )3 O-、-O(CH2 )3 -、-CH=CHCH2 CH2 -、-CH2 CH2 CH=CH-、-CH2 O-、-OCH2 -、‌-COO-、-OCO-、-C2 F4 -、-CF=CF-、-CF=CH-、-CH=CF-、-CF2 O-、-OCF2 -、-CH2 -或單鍵。 k)較佳混合物包含一或多種選自以下之群的化合物:式BC之二氟二苯并烷化合物、式CR之烷、式PH-1及PH-2之氟化菲、式BF-1及BF-2之氟化二苯并呋喃以及式BS-1及BS-2之氟化二苯并噻吩,BCCRPH-1PH-2BF-1BF-2BS-1BS-2 其中 RB1 、RB2 、RCR1 、RCR2 、R1 、R2 各彼此獨立地具有R2A 之含義。c為0、1或2。d為1或2。R1 及R2 分別較佳彼此獨立地表示具有1至6或2至6個C原子之烷基、烷氧基、烯基或烯氧基。 本發明之混合物較佳以3至20重量%之量、尤其以3至15重量%之量包含式BC、CR、PH-1、PH-2、BF-1、BF-2、BS-1及/或BS-2之化合物。 尤其較佳之式BC、CR、BF及BS之化合物為化合物BC-1至BC-7及CR-1至CR-5, 其中 烷基及烷基*各彼此獨立地表示具有1至6個C原子之直鏈烷基,且 烯基及烯基*各彼此獨立地表示具有2至6個C原子之直鏈烯基,且 烯氧基表示具有2至6個C原子之直鏈烯氧基。 極尤其較佳為包含一種、兩種或三種式BC-2及/或BF-1a之化合物的混合物。 l)較佳混合物包含一或多種式In之茚滿化合物,In 其中 R11 、R12 、R13 各分別獨立地表示具有1至6個C原子或2至6個C原子之直鏈烷基、烷氧基、烷氧基烷基或烯基, R12 及R13 另外表示鹵素,較佳F,表示, i表示0、1或2。 較佳式In化合物為如下所指示之式In-1至In-16之化合物:In-1In-2In-3In-4In-5In-6In-7In-8In-9In-10In-11In-12In-13In-14In-15In-16 尤其較佳為式In-1、In-2、In-3及In-4之化合物。 式In及次式In-1至In-16之化合物較佳以≥5重量%、尤其5至30重量%且極尤其較佳5至25重量%之濃度用於本發明之混合物。 m)較佳混合物另外包含一或多種式L-1至L-11之化合物, 其中 R、R1 及R2 各彼此獨立地具有技術方案2中對於R2A 所指示之含義,且烷基表示具有1至6個C原子之烷基。s表示1或2。 尤其較佳為式L-1及L-4、尤其L-4之化合物。 式L-1至L-11之化合物較佳以5至50重量%、尤其5至40重量%及極尤其較佳10至40重量%之濃度使用。 n)介質另外包含一或多種式EY化合物 EY 其中 R1 及R1 * 各彼此獨立地具有技術方案2中對於R2A 所指示之含義,且 L1 及L2 各獨立地表示F、Cl、CF3 或CHF2 。 在式EY化合物中,R1 及R1 * 較佳表示具有≥2個C原子之烷氧基,且L1 =L2 =F。尤其較佳為下式之化合物 EY-1       EY-2       EY-3       EY-4       EY-5       EY-6       EY-7       EY-8       EY-9       EY-10       EY-11       EY-12       EY-13       EY-14       EY-15       EY-16       EY-17       EY-18       EY-19       EY-20       EY-21       EY-22       EY-23       EY-24       EY-25       EY-26。 o)介質另外包含一或多種選自下式之化合物: Q-1       Q-2       Q-3       Q-4       Q-5       Q-6       Q-7       Q-8       Q-9。 在式Q-1至Q-9之化合物中,RQ 及XQ 各彼此獨立地具有技術方案2中R2A 之含義。RQ 及XQ 較佳表示具有1至6個C原子、尤其具有2至5個C原子之直鏈烷基。 尤其較佳混合物概念如下所指示:(所用首字母縮寫詞於表1-3及表A中說明。本文之n及m各彼此獨立地表示1至6)。 本發明之混合物較佳包含 -式I化合物以及一或多種式O-17化合物,較佳以及化合物CCH-23, 及/或 -式I化合物以及CCH-25、CCH-34及/或CCH-35, 及/或 -CPY-n-Om,尤其CPY-2-O2、CPY-3-O2及/或CPY-5-O2,以混合物作為整體計,其濃度較佳為>5%,尤其10至30% , 及/或 -B-nO-Om,其濃度較佳為1至15, 及/或 -CY-n-Om,較佳CY-3-O2、CY-3-O4、CY-5-O2及/或CY-5-O4,以混合物作為整體計,其濃度較佳為> 5%、尤其15-50%, 及/或 -CCY-n-Om,較佳CCY-4-O2、CCY-3-O2、CCY-3-O3、CCY-3-O1及/或CCY-5-O2,以混合物作為整體計,其濃度較佳為> 5%、尤其10至30%, 及/或 -CLY-n-Om,較佳CLY-2-O4、CLY-3-O2及/或CLY-3-O3,以混合物作為整體計,其濃度較佳為> 5%、尤其10至30%, 及/或 -  CK-n-F,較佳CK-3-F、CK-4-F及/或CK-5-F,以混合物作為整體計,較佳> 5%、尤其5至25%。 此外,較佳為包含以下混合物概念之本發明混合物: (n及m各獨立地表示1至6。) -  CPY-n-Om及CY-n-Om,以混合物作為整體計,其濃度較佳為10至80%, 及/或 -  CPY-n-Om及CK-n-F,以混合物作為整體計,其濃度較佳為10至70%, 及/或 -CPY-n-Om及PY-n-Om,較佳CPY-2-O2及/或CPY-3-O2及PY-3-O2,以混合物作為整體計,其濃度較佳為10至40%, 及/或 -  CPY-n-Om及CLY-n-Om,以混合物作為整體計,其濃度較佳為10至80%, 及/或 -CC-3-V1,其量較佳為3至15% 及/或 CC-V-V,其量較佳為5至60% 及/或 CC-3-V,其量較佳為5至60% 及/或 PGIY-n-Om,其量較佳為3至15%, 及/或 CC-n-2V1,其量較佳為3至20%。 此外,本發明係關於一種基於ECB、VA、PS-VA、PVA、PM-VA、SS-VA、IPS、PS-IPS、FFS或PS-FFS效應、尤其UB-FFS之具有主動矩陣定址的電光顯示器,其特徵在於其含有如技術方案1至14中之一或多者的液晶介質作為介電質。 本發明之液晶介質較佳在≤-20℃至≥70℃、尤其較佳≤-30℃至≥80℃、極尤其較佳≤-40℃至≥90℃下具有向列相。The present invention is based on the object of providing liquid crystal mixtures based on the ECB effect or based on the IPS or FFS effect, especially for monitor and TV applications, which liquid crystal mixtures do not have the disadvantages indicated above, or only have them to a reduced extent. shortcoming. Specifically, it is necessary to ensure that monitors and televisions operate at extremely high and extremely low temperatures, have extremely short response times, and at the same time have improved reliability behavior, especially without displaying image retention or showing significant degradation after long periods of operation. The image remains. Unexpectedly, if the compound of formula I is used in a liquid crystal mixture, especially an LC mixture with negative dielectric anisotropy, preferably for VA, IPS and FFS displays, and further for PM (passive matrix)-VA displays, it can Reduce the ratio of rotational viscosity γ1 to elastic constant K33 (γ1/K33), thus improving the reaction time. Unexpectedly, the compound of formula I possesses both extremely low rotational viscosity and high absolute value of dielectric anisotropy. Therefore, it is possible to prepare liquid crystal compounds with extremely short reaction times, excellent phase characteristics and excellent low-temperature behavior, preferably VA, IPS and FFS mixtures. Therefore, the present invention relates to a liquid crystal medium as in technical scheme 1, which contains a compound of formula I. The mixture of the present invention preferably exhibits an extremely wide nematic phase range, and has a clear point ≥ 68°C, preferably ≥ 70°C, exhibits a very favorable capacitance threshold value, a relatively high retention rate value, and simultaneously operates at -20°C and Excellent low temperature stability at -30℃, low rotational viscosity and short reaction time. Furthermore, in addition to an improvement in the rotational viscosity γ 1 , the mixtures of the invention are distinguished by the observable relatively high values of the elastic constant K 33 for improved reaction times. Some preferred embodiments of the mixtures of the invention are indicated below. Based on the mixture as a whole, the compound of formula I is preferably used in the liquid crystal medium in an amount of ≥1% by weight, preferably ≥3% by weight. Particularly preferred are liquid-crystalline media containing 5 to 30% by weight, very particularly preferably 5 to 15% by weight, of a compound of formula I. Preferred embodiments of the liquid crystal medium of the invention are indicated below: a) a liquid crystal medium additionally comprising one or more compounds selected from the group of compounds of formulas IIA, IIB and IIC, IIA IIB IC wherein R 2A , R 2B and R 2C each independently represent H; an alkyl or alkenyl group having up to 15 C atoms, which is unsubstituted, monosubstituted with CN or CF 3 or at least monosubstituted with halogen, wherein, In addition, one or more of the CH 2 groups in these groups may be passed through -O-, -S-, , -C≡C-, -CF 2 O-, -OCF 2 -, -OC-O- or -O-CO- substitution; or a cycloalkyl ring with 3 to 6 C atoms, L 1-4 each Independently represents F, Cl, CF 3 or CHF 2 , Z 2 and Z 2' each independently represents a single bond, -CH 2 CH 2 -, -CH=CH-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, -C 2 F 4 -, -CF=CF-, -CH=CHCH 2 O-, p represents 1 or 2, q represents 0 or 1, and v represents 1 to 6. In the compounds of formula IIA and IIB, Z2 may have the same or different meanings. In compounds of formula IIB, Z 2 and Z 2 ' may have the same or different meanings. In the compounds of formulas IIA, IIB and IIC, each of R 2A , R 2B and R 2C preferably represents an alkyl group having 1 to 6 C atoms, especially CH 3 , C 2 H 5 , nC 3 H 7 , nC 4 H 9 , nC 5 H 11 . In the compounds of formulas IIA and IIB, L 1 , L 2 , L 3 and L 4 preferably represent L 1 = L 2 = F, and L 3 = L 4 = F, in addition L 1 = F, and L 2 = Cl, L 1 = Cl, and L 2 = F, L 3 = F, and L 4 = Cl, L 3 = Cl, and L 4 = F. Z 2 and Z 2 ' in formulas IIA and IIB preferably each independently represent a single bond, and furthermore represent a -C 2 H 4 - or -CH 2 O- bridge. If in formula IIB, Z 2 =-C 2 H 4 - or -CH 2 O-, then Z 2 ' is preferably a single bond, or if Z 2 ' = -C 2 H 4 - or -CH 2 O- , then Z 2 is preferably a single bond. In the compounds of formula IIA and IIB, (O)C v H 2v + 1 preferably represents OC v H 2v + 1 , in addition C v H 2v + 1 . In the compounds of formula IIC, (O)C v H 2v + 1 preferably represents C v H 2v + 1 . In the compound of formula IIC, L 3 and L 4 preferably each represent F. Preferred compounds of formula IIA, IIB and IIC are indicated below: , where alkyl and alkyl* each independently represent a straight-chain alkyl group having 1 to 6 C atoms. Particularly preferred mixtures of the invention comprise one or more of the formulas IIA-2, IIA-8, IIA-14, IIA-26, IIA-28, IIA-33, IIA-39, IIA-45, IIA-46, IIA- 47. Compounds of IIB-2, IIB-11, IIB-16 and IIC-1. The proportion of compounds of formula IIA and/or IIB in the entire mixture is preferably at least 20% by weight. Particularly preferred media of the present invention comprise at least one compound of formula IIC-1, , wherein alkyl and alkyl* have the meanings indicated above, and their amount is preferably >3% by weight, especially >5% by weight and especially preferably 5 to 25% by weight. b) a liquid crystal medium further comprising one or more compounds of formula III, III wherein R 31 and R 32 each independently represent a straight-chain alkyl, alkoxyalkyl or alkoxy group having up to 12 C atoms, and express , , , or Z 3 represents a single bond, -CH 2 CH 2 -, -CH=CH-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, - C 2 F 4 -, -C 4 H 8 -, -CF=CF-. Preferred compounds of formula III are indicated below: Where alkyl and alkyl* each independently represent a straight-chain alkyl group having 1 to 6 C atoms. The medium of the invention preferably contains at least one compound of formula IIIa and/or formula IIIb. The proportion of the compound of formula III in the overall mixture is preferably at least 5% by weight. c) Liquid crystalline media additionally containing one or more tetracyclic compounds of the formula: V-1 V-2 V-3 V-4 V-5 V-6 V-7 V-8 V-9 wherein R 7-10 each independently has one of the meanings indicated for R 2A in technical solution 2, and w and x each independently represent 1 to 6. Particularly preferred are mixtures containing at least one compound of formula V-9. d) Liquid crystal media further comprising one or more compounds of the formulas Y-1 to Y-6, Y-1 Y-2 Y-3 Y-4 Y-5 Y-6 wherein R 14 to R 19 each independently represents an alkyl group or alkoxy group having 1 to 6 C atoms; z and m each independently represent 1 to 6; x represents 0, 1, 2 or 3. The medium of the present invention particularly preferably contains one or more compounds of formulas Y-1 to Y-6, preferably in an amount of ≥5% by weight. e) a liquid crystal medium further comprising one or more fluorinated terphenyls of the formulas T-1 to T-21, T-1 T-2 T-3 T-4 T-5 T-6 T-7 T-8 T-9 T-10 T-11 T-12 T-13 T-14 T-15 T-16 T-17 T-18 T-19 T-20 T-21 where R represents a linear alkyl or alkoxy group having 1 to 7 C atoms or an alkenyl group having 2 to 7 C atoms, and m = 0, 1, 2, 3, 4, 5 or 6 , and n represents 0, 1, 2, 3 or 4. R preferably represents methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, and pentyloxy. The medium of the present invention preferably contains terphenyl of the formulas T-1 to T-21 in an amount of 2 to 30% by weight, especially 5 to 20% by weight. Particularly preferred are compounds of formulas T-1, T-2, T-20 and T-21. In these compounds, R preferably represents an alkyl group and, moreover, an alkoxy group, each of which has from 1 to 5 C atoms. In the compounds of formula T-20, R preferably represents an alkyl or alkenyl group, especially an alkyl group. In the compound of formula T-21, R preferably represents an alkyl group. If the Δn value of the mixture is to be ≥0.1, then terphenyl is preferably used in the mixture of the present invention. Preferred mixtures contain 2 to 20% by weight of one or more terphenyl compounds selected from the group of compounds T-1 to T-21. f) a liquid crystal medium further comprising one or more biphenyls of the formulas B-1 to B-4, wherein alkyl and alkyl* each independently represent a straight-chain alkyl group having 1 to 6 C atoms, and alkenyl and alkenyl* each independently represent a straight-chain alkenyl group having 2 to 6 C atoms, and Alkoxy represents a straight-chain alkoxy group having 1 to 6 C atoms. The proportion of biphenyl of the formulas B-1 to B-4 in the overall mixture is preferably at least 3% by weight, especially ≥5% by weight. Among the compounds of formulas B-1 to B-4, the compound of formula B-2 is particularly preferred. Particularly preferred biphenyl is , where alkyl* represents an alkyl group having 1 to 6 C atoms. The medium of the present invention particularly preferably contains one or more compounds of formula B-1a and/or B-2c. g) a liquid crystal medium containing at least one compound of the formulas Z-1 to Z-7, wherein R represents a straight-chain alkyl or alkoxy group having 1 to 7 C atoms or an alkenyl group having 2 to 7 C atoms, alkyl represents an alkyl group having 1 to 6 C atoms, and (O) alkyl The group represents an alkyl or O-alkyl group. h) a liquid crystal medium containing at least one compound of the formulas O-1 to O-17, O-1 O-2 O-3 O-4 O-5 O-6 O-7 O-8 O-9 O-10 O-11 O-12 O-13 O-14 O-15 O-16 O-17 wherein R 1 and R 2 have the meaning indicated for R 2A , and the compound of formula O-17 is not the same as the compound of formula I. Preferably, R 1 and R 2 each independently represent a linear alkyl group having 1 to 6 C atoms, or R 1 represents a linear alkyl group having 1 to 6 C atoms, and R 2 represents a linear alkyl group having 2 to 6 C atoms. Alkenyl group of C atom. Preferred media include one or more of the formulas O-1, O-3, O-4, O-5, O-9, O-12, O-14, O-15, O-16 and/or O-17 compound. The mixtures according to the invention very particularly preferably comprise compounds of the formulas O-9, O-12, O-16 and/or O-17, in particular in amounts from 5 to 30%. Preferred compounds of formula O-9 and O-17 are as follows: O-9a O-9b O-17a O-17b O-17c O-17d The medium of the present invention particularly preferably contains tricyclic compounds of formula O-9a and/or formula O-9b and one or more bicyclic compounds of formulas O-17a to O-17d. The total proportion of compounds of formula O-9a and/or O-9b and one or more bicyclic compounds selected from formulas O-17a to O-17d is preferably 5 to 40%, most preferably 15 to 35 %. Very particularly preferred mixtures include compounds O-9a and O-17a: O-9a O-17a. Compounds O-9a and O-17a are preferably present in the mixture at a concentration of 15 to 35%, particularly preferably 15 to 25%, and particularly preferably 18 to 22% based on the mixture as a whole. Very particularly preferred mixtures include compounds O-9b and O-17a: O-9b O-17a. Compounds O-9b and O-17a are preferably present in the mixture at a concentration of 15 to 35%, particularly preferably 15 to 25%, and particularly preferably 18 to 22% based on the mixture as a whole. Very particularly preferred mixtures contain the following three compounds: O-9a O-9b O-17a. Compounds O-9a, O-9b and O-17a are preferably present in the mixture at a concentration of 15 to 35%, particularly preferably 15 to 25% and particularly preferably 18 to 22%, based on the mixture as a whole. In addition, a preferred compound of formula O-17 is a compound selected from the group of compounds of the following formula O-17e O-17f O-17g O-17h O-17i , O-17j In each case, the amount is preferably ≥3% by weight, especially ≥10% by weight. i) Liquid crystalline media containing one or more compounds of the formula BA wherein alkenyl and alkenyl* each independently represent a straight-chain alkenyl group having 2 to 12 C atoms, express , or , Z 3 represents a single bond, -CH 2 CH 2 -, -CH=CH-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, -C 2 F 4 -, -C 4 H 8 -, -CF=CF-. Preferred compounds of formula BA are indicated below: BA-1 BA-2 BA-3 BA-4 BA-5. Preferred mixtures contain 5 to 60% by weight, preferably 10 to 55% by weight, especially 20 to 50% by weight of the compound of formula O-17e O-17e. In addition, it is preferable to include compound O-17e and compound O-17i The total amount of the liquid crystal mixture is preferably 3 to 60% by weight. j) Preferred liquid crystal media of the present invention comprise one or more substances containing tetrahydronaphthyl or naphthyl units, such as compounds of formulas N-1 to N-5, N-1 N-2 N-3 N-4 N-5 Wherein R 1N and R 2N each independently have the meaning indicated for R 2A , preferably linear alkyl, linear alkoxy or linear alkenyl, and Z 1 and Z 2 each independently represent -C 2 H 4 -, -CH=CH-, -(CH 2 ) 4 -, -(CH 2 ) 3 O-, -O(CH 2 ) 3 -, -CH=CHCH 2 CH 2 -, -CH 2 CH 2 CH=CH-, -CH 2 O-, -OCH 2 -, ‌-COO-, -OCO-, -C 2 F 4 -, -CF=CF-, -CF=CH-, -CH=CF- , -CF 2 O-, -OCF 2 -, -CH 2 - or single bond. k) Preferred mixtures contain one or more compounds selected from the group consisting of: difluorodibenzo of formula BC Alkane compound, formula CR Alkanes, fluorinated phenanthrenes of formulas PH-1 and PH-2, fluorinated dibenzofurans of formulas BF-1 and BF-2, and fluorinated dibenzothiophenes of formulas BS-1 and BS-2, B.C. CR PH-1 PH-2 BF-1 BF-2 BS-1 BS-2 wherein R B1 , R B2 , R CR1 , R CR2 , R 1 and R 2 each independently have the meaning of R 2A . c is 0, 1 or 2. d is 1 or 2. R 1 and R 2 each preferably independently represent an alkyl, alkoxy, alkenyl or alkenyloxy group having 1 to 6 or 2 to 6 C atoms. The mixture of the present invention preferably contains the formulas BC, CR, PH-1, PH-2, BF-1, BF-2, BS-1 and /or BS-2 compounds. Particularly preferred compounds of formulas BC, CR, BF and BS are compounds BC-1 to BC-7 and CR-1 to CR-5, wherein alkyl and alkyl* each independently represent a straight-chain alkyl group having 1 to 6 C atoms, and alkenyl and alkenyl* each independently represent a straight-chain alkenyl group having 2 to 6 C atoms, And the alkenyloxy group represents a straight-chain alkenyloxy group having 2 to 6 C atoms. Very particularly preferred are mixtures containing one, two or three compounds of the formula BC-2 and/or BF-1a. l) Preferably the mixture contains one or more indan compounds of formula In, In wherein R 11 , R 12 and R 13 each independently represent a straight-chain alkyl group, alkoxy group, alkoxyalkyl group or alkenyl group having 1 to 6 C atoms or 2 to 6 C atoms, R 12 and R 13 additionally represents halogen, preferably F, express , , i represents 0, 1 or 2. Preferred compounds of formula In are compounds of formulas In-1 to In-16 as indicated below: In-1 In-2 In-3 In-4 In-5 In-6 In-7 In-8 In-9 In-10 In-11 In-12 In-13 In-14 In-15 In-16 Particularly preferred are compounds of the formulas In-1, In-2, In-3 and In-4. The compounds of the formula In and sub-formulas In-1 to In-16 are preferably used in the mixtures of the invention at a concentration of ≥5% by weight, especially from 5 to 30% by weight and very particularly preferably from 5 to 25% by weight. m) Preferred mixtures additionally comprise one or more compounds of the formulas L-1 to L-11, Wherein R, R 1 and R 2 each independently have the meaning indicated for R 2A in technical scheme 2, and the alkyl group represents an alkyl group having 1 to 6 C atoms. s means 1 or 2. Particularly preferred are compounds of formulas L-1 and L-4, especially L-4. The compounds of the formulas L-1 to L-11 are preferably used in a concentration of 5 to 50% by weight, especially 5 to 40% by weight and very particularly preferably 10 to 40% by weight. n) The medium additionally contains one or more compounds of the formula EY EY Wherein R 1 and R 1 * each independently have the meaning indicated for R 2A in technical solution 2, and L 1 and L 2 each independently represent F, Cl, CF 3 or CHF 2 . In the compound of formula EY, R 1 and R 1 * preferably represent an alkoxy group having ≥2 C atoms, and L 1 =L 2 =F. Particularly preferred are compounds of the following formula EY-1 EY-2 EY-3 EY-4 EY-5 EY-6 EY-7 EY-8 EY-9 EY-10 EY-11 EY-12 EY-13 EY-14 EY-15 EY-16 EY-17 EY-18 EY-19 EY-20 EY-21 EY-22 EY-23 EY-24 EY-25 EY-26. o) The medium additionally contains one or more compounds selected from the following formula: Q-1 Q-2 Q-3 Q-4 Q-5 Q-6 Q-7 Q-8 Q-9. In the compounds of formulas Q-1 to Q-9, R Q and X Q each independently have the meaning of R 2A in technical scheme 2. R Q and X Q preferably represent straight-chain alkyl groups having 1 to 6 C atoms, especially 2 to 5 C atoms. Particularly preferred mixture concepts are indicated as follows: (The acronyms used are described in Tables 1-3 and Table A. n and m herein each independently represent 1 to 6). The mixture according to the invention preferably contains a compound of formula I and one or more compounds of formula O-17, preferably also a compound of formula CCH-23, and/or a compound of formula I and CCH-25, CCH-34 and/or CCH-35 , and/or -CPY-n-Om, especially CPY-2-O2, CPY-3-O2 and/or CPY-5-O2, based on the mixture as a whole, the concentration is preferably >5%, especially 10 to 30%, and/or -B-nO-Om, the concentration is preferably 1 to 15, and/or -CY-n-Om, preferably CY-3-O2, CY-3-O4, CY-5- O2 and/or CY-5-O4, based on the mixture as a whole, its concentration is preferably >5%, especially 15-50%, and/or -CCY-n-Om, preferably CCY-4-O2, CCY -3-O2, CCY-3-O3, CCY-3-O1 and/or CCY-5-O2, based on the mixture as a whole, the concentration is preferably > 5%, especially 10 to 30%, and/or - CLY-n-Om, preferably CLY-2-O4, CLY-3-O2 and/or CLY-3-O3, based on the mixture as a whole, its concentration is preferably > 5%, especially 10 to 30%, and / or - CK-nF, preferably CK-3-F, CK-4-F and/or CK-5-F, based on the mixture as a whole, preferably > 5%, especially 5 to 25%. In addition, the preferred mixture of the present invention includes the following mixture concepts: (n and m each independently represent 1 to 6.) - CPY-n-Om and CY-n-Om, based on the mixture as a whole, their concentrations are preferred It is 10 to 80%, and/or -CPY-n-Om and CK-nF. Taking the mixture as a whole, its concentration is preferably 10 to 70%, and/or -CPY-n-Om and PY-n- Om, preferably CPY-2-O2 and/or CPY-3-O2 and PY-3-O2, based on the mixture as a whole, its concentration is preferably 10 to 40%, and/or - CPY-n-Om and CLY-n-Om, based on the mixture as a whole, its concentration is preferably 10 to 80%, and/or -CC-3-V1, its amount is preferably 3 to 15% and/or CC-VV, its amount Preferably it is 5 to 60% and/or CC-3-V, its amount is preferably 5 to 60% and/or PGIY-n-Om, its amount is preferably 3 to 15%, and/or CC-n -2V1, the amount is preferably 3 to 20%. In addition, the present invention relates to an electro-optical device with active matrix addressing based on ECB, VA, PS-VA, PVA, PM-VA, SS-VA, IPS, PS-IPS, FFS or PS-FFS effect, especially UB-FFS. A display is characterized in that it contains one or more of the liquid crystal medium as in technical solutions 1 to 14 as a dielectric. The liquid crystal medium of the present invention preferably has a nematic phase at ≤-20°C to ≥70°C, particularly preferably ≤-30°C to ≥80°C, and most preferably ≤-40°C to ≥90°C.

表述「具有向列相」在本文中意謂:一方面,在相應溫度下在低溫下未觀察到近晶相及結晶,且另一方面,在加熱時自向列相不會出現清澈現象。低溫下之研究在相應溫度下於流動黏度計中進行,且藉由儲存於層厚度對應於電光用途之測試單元中至少100小時來檢驗。若在-20℃之溫度下於相應測試單元中儲存穩定性為1000小時或1000小時以上,則介質稱為在此溫度下穩定。在-30℃及-40℃之溫度下,相應時間分別為500小時及250小時。在高溫下,藉由習知方法在毛細管中量測清澈點。 液晶混合物較佳具有至少60 K之向列相範圍及在20℃下至多30 mm2 ∙s- 1 之流動黏度ν20 。 在液晶混合物中雙折射值Δn一般為0.07至0.16,較佳0.08至0.13。 本發明之液晶混合物的∆ε為-0.5至-8.0,尤其-2.5至-6.0,其中∆ε表示介電各向異性。在20℃下之旋轉黏度γ1 較佳為≤150 mPa∙s,尤其為≤130 mPa∙s。 本發明之液晶介質具有相對小之臨限電壓(V0 )值。其較佳在1.7 V至3.0 V範圍內,尤其較佳≤2.5 V且極尤其較佳≤2.3 V。 對於本發明,除非另外明確指示,否則術語「臨限電壓」係關於電容臨限值(V0 ),亦稱為弗雷德里克臨限值(Freedericks threshold)。 另外,本發明之液晶介質在液晶單元中具有高電壓保持率值。 一般而言,相較於具有較高定址電壓或臨限電壓之液晶介質,具有低定址電壓或臨限電壓之液晶介質展現較低電壓保持率,且反之亦然。 對於本發明,術語「介電正性化合物」表示∆ε>1.5之化合物,術語「介電中性化合物」表示-1.5≤∆ε≤1.5之化合物,且術語「介電負性化合物」表示∆ε<-1.5之化合物。在本文中,化合物之介電各向異性藉由以下步驟測定:將10%化合物溶解於液晶主體中,且測定至少一個測試單元中所得混合物之電容,在各情形下該測試單元之層厚度為20 µm,且在1 kHz下具有垂直及均質表面配向。量測電壓通常為0.5 V至1.0 V,但總低於所研究之各別液晶混合物之電容臨限值。 對於本發明所指示之所有溫度值以℃為單位。 本發明之混合物適用於所有VA-TFT應用,諸如VAN、MVA、(S)-PVA、ASV、PSA (聚合物支撐型VA)、SS(表面穩定之)-VA及PS-VA (聚合物穩定型VA)。此外,其適用於具有負Δε之IPS (共平面切換型)及FFS (邊緣場切換型),尤其UB-FFS。 本發明之顯示器中的向列型液晶混合物一般包含兩種組分A及B,其自身由一或多種個別化合物組成。 組分A具有顯著負性介電各向異性且賦予向列相≤-0.5之介電各向異性。除一或多種式I化合物以外,其較佳包含式IIA、IIB及/或IIC之化合物,此外式III化合物。 組分A之比例較佳為45至100%,尤其60至100%。 對於組分A,較佳選擇一種(或多種)Δε值≤-0.8之個別化合物。必定是,此值愈負,整體混合物中A之比例愈小。 組分B具有明顯向列原基,且在20℃下,流動黏度不大於30 mm2 ∙s- 1 ,較佳不大於25 mm2 ∙s- 1 。 多種適合材料為熟習此項技術者由文獻已知。尤其較佳為式III化合物。 組分B中之尤其較佳個別化合物為在20℃下流動黏度不大於18 mm2 ∙ s- 1 ,較佳不大於12 mm2 ∙ s- 1 的極低黏度向列型液晶。 組分B為單變性或互變性向列型,無近晶相且能夠在降至極低溫度時阻止液晶混合物中出現近晶相。舉例而言,若各種高向列原基材料在各情形下添加至近晶液晶混合物中,則此等材料之向列原基可經由達成之近晶相抑制程度比較。 混合物亦可視情況包含組分C,其包含具有≥1.5之介電各向異性Δε之化合物。以負性介電各向異性之混合物作為整體計,此等所謂正性化合物一般以≤20重量%之量存在於該混合物中。 若本發明之混合物包含一或多種介電各向異性∆ε≥1.5之化合物,則其較佳為一或多種式P-1及/或P-2之化合物, P-1       P-2 其中 R表示直鏈烷基、烷氧基或烯基,其各分別具有1或2至6個C原子,且 X表示F、Cl、CF3 、OCF3 、OCHFCF3 或CCF2 CHFCF3 ,較佳F或OCF3 。 式P-1及/或P-2之化合物較佳以0.5至10重量%、尤其0.5至8重量%之濃度用於本發明之混合物中。 尤其較佳為下式之化合物, 其較佳以0.5至3重量%之量使用。 另外,此等液晶相亦可包含超過18種組分,較佳18至25種組分。 除一或多種式I化合物以外,該等相較佳包含4至15種、尤其5至12種且尤其較佳<10種式IIA、IIB及/或IIC及視情況存在之III之化合物。 除式I化合物及式IIA、IIB及/或IIC及視情況存在之III之化合物以外,其他成分亦可例如以整體混合物的至多45%、但較佳至多35%、尤其至多10%之量存在。 其他成分較佳選自向列型或向列原基物質,尤其以下之類別的已知物質:氧偶氮苯、苯亞甲基苯胺、聯苯、聯三苯、苯甲酸苯酯或苯甲酸環己酯、環己烷甲酸苯酯或環己烷甲酸環己酯、苯基環己烷、環己基聯苯、環己基環己烷、環己基萘、1,4-雙環己基聯苯或環己基嘧啶、苯基-或環己基二噁烷、視情況經鹵化之芪、苯甲基苯基醚、二苯乙炔及經取代之肉桂酸酯。 適合作為此類型液晶相之成分的最重要化合物可由式IV表徵, R20 -L-G-E-R21 IV 其中L及E各表示來自由1,4-二取代之苯及環己烷環、4,4'-二取代之聯苯、苯基環己烷及環己基環己烷系統、2,5-二取代之嘧啶及1,3-二噁烷環、2,6-二取代之萘、二氫萘及四氫萘、喹唑啉及四氫喹唑啉形成之群的碳環或雜環系統。 G表示      -CH=CH-                -N(O)=N- -CH=CQ-                -CH=N(O)- -C≡C-                     -CH2 -CH2 - -CO-O-                   -CH2 -O- -CO-S-                    -CH2 -S- -CH=N-                  -COO-Phe-COO- -CF2 O-                    -CF=CF- -OCF2 -                    -OCH2 - -(CH2 )4 -                  -(CH2 )3 O- 或C-C單鍵,Q表示鹵素,較佳氯或-CN,且R20 及R21 各表示具有至多18個、較佳至多8個碳原子之烷基、烯基、烷氧基、烷氧基烷基或烷氧基羰氧基,或者此等基團中之一者表示CN、NC、NO2 、NCS、CF3 、SF5 、OCF3 、F、Cl或Br。 在大多數此等化合物中,R20 及R21 彼此不同,此等基團中之一者通常為烷基或烷氧基。所提出之取代基的其他變體亦為常見的。多種此類物質或其混合物亦可購得。所有此等物質可藉由自文獻已知之方法製備。 對於熟習此項技術者不言而喻,本發明之VA、IPS或FFS混合物亦可包含如下化合物,其中例如H、N、O、Cl及F已經相應同位素置換。 此外,以本發明之混合物計,可將可聚合化合物(所謂反應性液晶原基(RM),例如U.S. 6,861,107中所揭示)以較佳0.01至5重量%、尤其較佳0.2至2重量%之濃度添加至該混合物中。此等混合物可視情況亦包含引發劑,如例如U.S. 6,781,665所述。較佳將引發劑(例如來自BASF之Irganox-1076)以0至1%之量添加至包含可聚合化合物之混合物中。此類型之混合物可用於所謂聚合物穩定型VA模式(PS-VA)或PSA (聚合物支撐型VA),其中意欲在液晶混合物中進行反應性液晶原基之聚合。其前提條件為液晶混合物自身不包含亦在式M化合物聚合之條件下聚合的可聚合組分。 聚合較佳在以下條件下進行:使用具有規定強度之UV-A燈規定時段使可聚合組分在單元中聚合且施加電壓(通常10至30 V交流電壓,頻率在60 Hz至1 kHz範圍內)。所用UV-A光源通常為強度為50 mW/cm2 之金屬-鹵化物蒸氣燈或高壓汞燈。其為例如含有烯基或烯氧基側鏈之液晶化合物,諸如下式之化合物 其中n = 2、3、4、5或6, 不聚合之條件。 在本發明之一較佳實施例中,可聚合化合物係選自式M化合物 RMa -AM1 -(ZM1 -AM2 )m1 -RMb M 其中個別基團具有以下含義: RMa 及RMb 各獨立地表示P、P-Sp-、H、鹵素、SF5 、NO2 、烷基、烯基或炔基,其中基團RMa 及RMb 中之至少一者較佳表示或含有基團P或P-Sp-, P表示可聚合基團, Sp表示間隔基或單鍵, AM1 及AM2 各獨立地表示芳族基、雜芳族基、脂環族基或雜環基,其較佳具有4至25個環原子,較佳C原子,其亦包括或可含有環化環且其可視情況經L單取代或多取代, L表示P;P-Sp-;OH;CH2 OH;F;Cl;Br;I;-CN;-NO2 ;-NCO;-NCS;-OCN;-SCN;-C(=O)N(Rx )2 ;-C(=O)Y1 ;-C(=O)Rx ;-N(Rx )2 ;視情況經取代之矽烷基;視情況經取代之具有6至20個C原子之芳基;或具有1至25個C原子之直鏈或分支鏈烷基、烷氧基、烷基羰基、烷氧基羰基、烷基羰氧基或烷氧基羰氧基,其中,另外,一或多個H原子可經以下置換:F、Cl、P或P-Sp-,較佳P、P-Sp-、H、OH、CH2 OH、鹵素、SF5 、NO2 、烷基、烯基或炔基, Y1 表示鹵素, ZM1 表示-O-、-S-、-CO-、-CO-O-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O-、-SCH2 -、-CH2 S-、-CF2 O-、-OCF2 -、-CF2 S-、-SCF2 -、-(CH2 )n1 -、-CF2 CH2 -、-CH2 CF2 -、-(CF2 )n1 -、-CH=CH-、-CF=CF-、-C≡C-、-CH=CH-、-COO-、-OCO-CH=CH-、CR0 R00 或單鍵, R0 及R00 各獨立地表示H或具有1至12個C原子之烷基, Rx 表示P;P-Sp-;H;鹵素;具有1至25個C原子之直鏈、分支鏈或環狀烷基,其中,另外,一或多個不相鄰CH2 基團可以使得O及/或S原子不彼此直接鍵聯之方式經-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-置換,且其中,另外,一或多個H原子可經F、Cl、P或P-Sp-置換;、視情況經取代之具有6至40個C原子之芳基或芳氧基;或視情況經取代之具有2至40個C原子之雜芳基或雜芳氧基, m1表示0、1、2、3或4,且 n1表示1、2、3或4, 其中所存在之基團RMa 、RMb 及取代基L中之至少一者、較佳一者、兩者或三者、尤其較佳一或兩者表示基團P或P-Sp-或含有至少一個基團P或P-Sp-。 尤其較佳之式M化合物為如下化合物,其中 RMa 及RMb 各獨立地表示P;P-Sp-;H;F;Cl;Br;I;-CN;-NO2 ;-NCO;-NCS;-OCN;-SCN;SF5 ;或具有1至25個C原子之直鏈或分支鏈烷基,其中,另外,一或多個不相鄰CH2 基團可各彼此獨立地以使得O及/或S原子不彼此直接鍵聯之方式經以下置換:-C(R0 )=C(R00 )-、-C≡C-、-N(R00 )-、-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-,且其中,另外,一或多個H原子可經F、Cl、Br、I、CN、P或P-Sp-置換,其中基團RMa 及RMb 中之至少一者較佳表示或含有基團P或P-Sp-, AM1 及AM2 各獨立地表示1,4-伸苯基;萘-1,4-二基;萘-2,6-二基;菲-2,7-二基;蒽-2,7-二基;茀-2,7-二基;香豆素;黃酮,其中,另外,此等基團中之一或多個CH基團可經N置換;環己烷-1,4-二基,其中,另外,一或多個不相鄰CH2 基團可經O及/或S置換;1,4-伸環己烯基;雙環[1.1.1]戊烷-1,3-二基;雙環[2.2.2]辛烷-1,4-二基;螺[3.3]庚烷-2,6-二基;哌啶-1,4-二基;十氫萘-2,6-二基;1,2,3,4-四氫萘-2,6-二基;茚滿-2,5-二基;或八氫-4,7-亞甲基茚滿-2,5-二基,其中所有此等基團可未經取代或經L單取代或多取代, L表示P;P-Sp-;OH;CH2 OH;F;Cl;Br;I;-CN;-NO2 ;-NCO;-NCS;-OCN;-SCN;-C(=O)N(Rx )2 ;-C(=O)Y1 ;-C(=O)Rx ;-N(Rx )2 ;視情況經取代之矽烷基;視情況經取代之具有6至20個C原子之芳基;或具有1至25個C原子之直鏈或分支鏈烷基、烷氧基、烷基羰基、烷氧基羰基、烷基羰氧基或烷氧基羰氧基,其中,另外,一或多個H原子可經F、Cl、P或P-Sp-置換, p表示可聚合基團, Y1 表示鹵素, Rx 表示P;P-Sp-;H;鹵素;具有1至25個C原子之直鏈、分支鏈或環狀烷基,其中,另外,一或多個不相鄰CH2 基團可以使得O及/或S原子不彼此直接鍵聯之方式經-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-置換,且其中,另外,一或多個H原子可經F、Cl、P或P-Sp-置換;視情況經取代之具有6至40個C原子之芳基或芳氧基;或視情況經取代之具有2至40個C原子之雜芳基或雜芳氧基。 極尤其較佳為RMa 及RMb 中之一者或兩者表示P或P-Sp-之式M化合物。 用於本發明之液晶介質及PS-VA顯示器或PSA顯示器之適合及較佳RM例如選自下式: M1       M2       M3       M4       M5       M6       M7       M8       M9       M10       M11         M12         M13       M14       M15       M16       M17       M18       M19       M20       M21       M22       M23 M24       M25       M26       M27       M28       M29 其中個別基團具有以下含義: P1 及P2 各彼此獨立地表示可聚合基團,其較佳具有上文及下文對於P所指示之含義中之一者,尤佳為丙烯酸酯、甲基丙烯酸酯、氟丙烯酸酯、氧雜環丁烷、乙烯氧基或環氧基, Sp1 及Sp2 各獨立地表示單鍵或間隔基,其較佳具有上文及下文對於Sp所指示之含義中之一者,且尤其較佳為-(CH2 )p1 -、-(CH2 )p1 -O-、-(CH2 )p1 -CO-O-或-(CH2 )p1 -O-CO-O-,其中p1為1至12之整數,且其中在最後提及之基團中鍵聯至相鄰環經由O原子進行,其中基團P1 -Sp1 -及P2 -Sp2 -中之一者 亦可表示Raa , Raa 表示H;F;Cl;CN;或具有1至25個C原子之直鏈或分支鏈烷基,其中,另外,一或多個不相鄰CH2 基團可各彼此獨立地經-C(R0 )=C(R00 )-、-C≡C-、-N(R0 )-、-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-以使得O及/或S原子不彼此直接鍵聯之方式置換,且其中,另外,一或多個H原子可經F、Cl、CN或P1 -Sp1 -置換,尤其較佳為直鏈或分支鏈、視情況經單或多氟化之具有1至12個C原子烷基、烷氧基、烯基、炔基、烷基羰基、烷氧基羰基或烷基羰氧基(其中烯基及炔基具有至少兩個C原子,且分支鏈基團具有至少三個C原子), R0 、R00 各彼此獨立地且在每次出現時相同或不同地表示H或具有1至12個C原子之烷基, Ry 及Rz 各彼此獨立地表示H、F、CH3 或CF3 , ZM1 表示-O-、-CO-、-C(Ry Rz )-或-CF2 CF2 -, ZM2 及ZM3 各獨立地表示-CO-O-、-O-CO-、-CH2 O-、-OCH2 -、-CF2 O-、-OCF2 -或-(CH2 )n -,其中n為2、3或4, L在每次出現時相同或不同地表示F、Cl、CN或直鏈或分支鏈、視情況經單或多氟化之具有1至12個C原子之烷基、烷氧基、烯基、炔基、烷基羰基、烷氧基羰基或烷基羰氧基,較佳F, L'及L''各彼此獨立地表示H、F或Cl, r表示0、1、2、3或4, s表示0、1、2或3, t表示0、1或2,且 x表示0或1。 適合可聚合化合物列於例如表D中。 本申請案之液晶介質較佳總共包含0.1至10%、較佳0.2至4.0%、尤其較佳0.2至2.0%之可聚合化合物。 尤其較佳為式M及式RM-1至RM-102之可聚合化合物。 此外,本發明之混合物可包含習知添加劑,諸如穩定劑、抗氧化劑、UV吸收劑、奈米粒子、微米粒子等。 本發明之液晶顯示器之結構對應於如在例如EP-A 0 240 379中所述之常見幾何結構。 以下實例意欲解釋本發明,而不對其進行限制。在上文及下文中,百分比資料表示重量百分比;所有溫度以攝氏度表示。 在整個專利申請案中,1,4-伸環己基環及1,4-伸苯基環描繪如下: 伸環己基環為反-1,4-伸環己基環。 在整個專利申請案中及實施例中,液晶化合物之結構藉助於首字母縮寫詞指示。除非另外指示,否則根據表1-3進行向化學式之轉化。所有基團Cn H2n + 1 、Cm H2m + 1 及Cm ' H2m '+ 1 或Cn H2n 及Cm H2m 均為直鏈烷基或伸烷基,在各情形下分別具有n、m、m'或z個C原子。n、m、m'及z各獨立地表示1、2、3、4、5、6、7、8、9、10、11或12,較佳1、2、3、4、5或6。在表1中,將各別化合物之環要素編碼,在表2中,列出橋接成員,且在表3中,指示化合物之左側或右側側鏈之符號的含義。 1 :環要素    A    AI             B    B(S)                C                   D    DI       F    FI             G    GI                K                   L    LI                M    MI             N    NI                P                      S                   U    UI                Y                   Y(F,Cl)    Y(Cl,F) 2 :橋接成員 E -CH2 CH2 -       V -CH=CH-       T -C≡C-       W -CF2 CF2 -       Z -COO- ZI -OCO- O -CH2 O- OI -OCH2 - Q -CF2 O- QI -OCF2 - 3 :側鏈 左側側鏈 右側側鏈 n- Cn H2n+1 - -n -Cn H2n+1 nO- Cn H2n+1 -O- -On -O-Cn H2n+1 V- CH2 =CH- -V -CH=CH2 nV- Cn H2n+1 -CH=CH- -nV -Cn H2n -CH=CH2 Vn- CH2 =CH-Cn H2n - -Vn -CH=CH-Cn H2n+1 nVm- Cn H2n+1 -CH=CH-Cm H2m - -nVm -Cn H2n -CH=CH-Cm H2m+1 N- N≡C- -N -C≡N F- F- -F -F Cl- Cl- -Cl -Cl M- CFH2 - -M -CFH2 D- CF2 H- -D -CF2 H T- CF3 - -T -CF3 MO- CFH2 O- -OM -OCFH2 DO- CF2 HO- -OD -OCF2 H TO- CF3 O- -OT -OCF3 T- CF3 - -T -CF3 A- H-C≡C- -A -C≡C-H 除式IIA及/或IIB及/或IIC之化合物及一或多種式I化合物以外,本發明之混合物較佳亦包含一或多種來自下示表A之化合物。 A 使用以下縮寫: (n、m、m'、z:各彼此獨立地為1、2、3、4、5或6;(O)Cm H2m+1 意謂OCm H2m+1 或Cm H2m+1 ) AIK-n-F        AIY-n-Om        AY-n-Om        B-nO-Om        B-n-Om        B(S)-nO-Om        B(S)-n-Om        CB(S)-n-(O)m        CB-n-m        CB-n-Om        PB-n-m        PB-n-Om        BCH-nm        BCH-nmF        CY(Cl,F)-n-Om          CCY-n-Om    CAIY-n-Om          CCY(F,Cl)-n-Om          CCY(Cl,F)-n-Om          CCY-n-m          CCY-V-m          CCY-Vn-m          CCY-n-OmV          CBC-nmF          CBC-nm          CCP-V-m          CCP-Vn-m          CCP-nV-m          CCP-n-m          CPYP-n-(O)m          CYYC-n-m          CCYY-n-(O)m          CCY-n-O2V          CCH-nOm          CY-n-m          CCH-nm          CC-n-V          CC-n-V1          CC-n-Vm          CC-2V-V2          CC-V-V             CC-V-V1          CVC-n-m          CC-n-mV          CCOC-n-m          CP-nOmFF          CH-nm          CEY-n-Om          CEY-V-n          CVY-V-n          CY-V-On          CY-n-O1V          CY-n-OC(CH3 )=CH2          CCN-nm          CY-n-OV          CCPC-nm          CCY-n-zOm          CPY-n-Om          CPY-n-m          CPY-V-Om          CQY-n-(O)m          CQIY-n-(O)m          CCQY-n-(O)m          CCQIY-n-(O)m          CPQY-n-(O)m          CPQIY-n-(O)m          CPYG-n-(O)m          CCY-V-Om          CCY-V2-(O)m          CCY-1V2-(O)m          CCY-3V-(O)m          CCVC-n-V          CPYG-n-(O)m          CPGP-n-m          CY-nV-(O)m          CENaph-n-Om          COChrom-n-Om          COChrom-n-m          CCOChrom-n-Om          CCOChrom-n-m          CONaph-n-Om          CCONaph-n-Om          CCNaph-n-Om          CNaph-n-Om          CETNaph-n-Om          CTNaph-n-Om          CK-n-F          CLY-n-Om          CLY-n-m          LYLI-n-m          CYLI-n-m       LY-n-(O)m          COYOICC-n-m          COYOIC-n-V          CCOY-V-O2V          CCOY-V-O3V          COY-n-Om          CCOY-n-Om          D-nOmFF          PCH-nm          PCH-nOm          PGIGI-n-F          PGP-n-m          PGIY-n-Om          PP-n-m          PP-n-Om          PP-n-2V1          PP-n-mVk          PPGU-n-F          PYP-n-mV          PYP-n-m             PYP-n-Om          PPYY-n-m          YPY-n-m          YPY-n-mV          PY-n-Om          PY-n-m          PY-V2-Om          C-DFDBF-n-(O)m          COY-1V-Om          COY-V-Om          CCOY-V-Om          CCOY-1V-Om          B-n-m          DFDBC-n(O)-(O)m          Y-nO-Om          Y-nO-OmV          Y-nO-OmVm'          YG-n-Om          YG-nO-Om          YGI-n-Om          YGI-nO-Om          YY-n-Om          YY-nO-Om          YG-VnO-Om          YG-nO-OmV          YY-VnO-Om    可根據本發明使用之液晶混合物以本身習知之方式製備。一般而言,宜在高溫下將以較少量使用之所要量之組分溶解於構成主要成分之組分中。亦可能將組分於有機溶劑中(例如丙酮、氯仿或甲醇中)之溶液混合,且例如藉由在充分混合之後蒸餾來再次移除溶劑。 藉助於適合添加劑,本發明之液晶相可以一定方式改質以使得其可用於迄今已揭示之任何類型(例如ECB、VAN、IPS、GH或ASM-VA LCD)顯示器中。 介電質亦可包含熟習此項技術者已知及文獻中所述之其他添加劑,諸如UV吸收劑、抗氧化劑、奈米粒子及自由基清除劑。舉例而言,可添加0至15%多色染料、穩定劑或對掌性摻雜劑。本發明混合物之適合穩定劑尤其為表B中所列之物質。 舉例而言,可添加0至15%多色染料,此外導電鹽,較佳4-己氧基苯甲酸乙基二甲基十二烷基銨、四苯基氫硼化四丁基銨或冠醚之複合鹽(參見例如Haller等人, Mol. Cryst. Liq. Cryst., 第24卷, 第249-258頁(1973))以改良導電性,或可添加物質以改良向列相之介電各向異性、黏度及/或配向。此類型之物質描述於例如DE-A 22 09 127、22 40 864、23 21 632、23 38 281、24 50 088、26 37 430及28 53 728中。 B 表B展示一般添加至本發明之混合物中的可能摻雜劑。混合物較佳包含0至10重量%、尤其0.01至5重量%且尤其較佳0.01至3重量%摻雜劑。若混合物僅包含一種摻雜劑,則其以0.01至4重量%、較佳0.1至1.0重量%之量使用。 C 15 CB 15 CM 21 R/S-811 CM 44 CM 45       CM 47 CN       R/S-2011 R/S-3011       R/S-4011 R/S-5011          R/S-1011    C 下文展示可例如以0至10重量%之量添加至本發明之混合物中的穩定劑。   n = 1、2、3、4、5、6或7   n = 1、2、3、4、5、6或7      n = 1、2、3、4、5、6或7            本發明之介質尤其較佳包含Tinuvin® 770 (雙(2,2,6,6-四甲基-4-哌啶基)癸二酸酯),以液晶介質計,其量較佳為0.001至5重量%。 D 表D展示可較佳作為反應性液晶原基化合物用於本發明之LC介質中的例示性化合物。若本發明之混合物包含一或多種反應性化合物,則其較佳以0.01至5重量%之量使用。亦可能需要添加引發劑或兩種或兩種以上引發劑之混合物以用於聚合。以混合物計,引發劑或引發劑混合物較佳以0.001至2重量%之量添加。適合引發劑為例如Irgacure (BASF)或Irganox (BASF)。 RM-1 RM-2 RM-3 RM-4 RM-5 RM-6 RM-7 RM-8 RM-9 RM-10 RM-11 RM-12 RM-13 RM-14 RM-15 RM-16 RM-17 RM-18 RM-19 RM-20 RM-21 RM-22 RM-23 RM-24 RM-25 RM-26 RM-27 RM-28 RM-29 RM-30 RM-31 RM-32 RM-33 RM-34 RM-35 RM-36 RM-37 RM-38 RM-39 RM-40 RM-41 RM-42 RM-43 RM-44 RM-45 RM-46 RM-47 RM-48 RM-49 RM-50 RM-51 RM-52 RM-53 RM-54 RM-55 RM-56 RM-57 RM-58 RM-59 RM-60 RM-61 RM-62 RM-63 RM-64 RM-65 RM-66 RM-67 RM-68 RM-69 RM-70 RM-71 RM-72 RM-73 RM-74 RM-75 RM-76 RM-77 RM-78 RM-79 RM-80 RM-81 RM-82 RM-83 RM-84 RM-85 RM-86 RM-87 RM-88 RM-89 RM-90 RM-91 RM-92 RM-93 RM-94 RM-95 RM-96 RM-97 RM-98 RM-99 RM-100 RM-101 RM-102 在一較佳實施例中,本發明之混合物包含一或多種可聚合化合物,其較佳選自式RM-1至RM-102之可聚合化合物。此類型之介質尤其適合於PS-FFS及PS-IPS應用。在表D中所示之反應性液晶原基中,化合物RM-1、RM-2、RM-3、RM-4、RM-5、RM-9、RM-17、RM-42、RM-48、RM-68、RM-87、RM-91、RM-98、RM-99及RM-101為尤其較佳。 此外,式M及式RM-1至RM-102之反應性液晶原基或可聚合化合物適合作為穩定劑。在此情形下,可聚合化合物不聚合,而是以>1%之濃度添加至液晶介質中。實施例: 以下實例意欲解釋本發明,而不對其進行限制。在實例中,m.p.表示液晶物質之熔點(攝氏度)且C表示液晶物質之清澈點(攝氏度);沸騰溫度由b.p.表示。此外: C表示結晶固體狀態,S表示近晶相(指數表示相類型),N表示向列狀態,Ch表示膽固醇相,I表示各向同性相,Tg 表示玻璃轉化溫度。兩個符號之間的數字表示轉化溫度(攝氏度)。 用於測定式I化合物之光學各向異性Δn之主體混合物為市售混合物ZLI-4792 (Merck KGaA)。介電各向異性Δε係使用市售混合物ZLI-2857測定。待研究化合物之物理資料由在添加待研究化合物之後主體混合物之介電常數的變化及外推至100%所用化合物獲得。一般而言,視溶解性而定,將10%待研究化合物溶解於主體混合物中。 除非另外指示,否則份數或百分比資料表示重量份或重量百分比。 在上文及下文中,符號及縮寫具有以下含義: V0 在20℃下之臨限電壓,電容[V] Δn           在20℃及589 nm下量測之光學各向異性, Δε           在20℃及1 kHz下之介電各向異性, cl.p.         清澈點[℃] K1 彈性常數,在20℃下之「扇狀」變形[pN] K3 彈性常數,在20℃下之「彎曲」變形[pN] γ1 在20℃下量測之旋轉黏度[mPa·s],其藉由磁場中之旋轉方法測定 LTS         在測試單元中測定之低溫穩定性(向列相)。 用於量測臨限電壓之顯示器具有兩個分隔20 µm之平面平行之外部板及電極層,其中在外部板之內側的頂部上具有包含SE-1211 (Nissan Chemicals)之配向層,其實現液晶之垂直配向。 除非另外明確指示,否則本申請案中之所有濃度與相應混合物或混合物組分有關。除非另外明確指示,否則所有物理特性根據「Merck Liquid Crystals, Physical Properties of Liquid Crystals」, 1997年11月狀態, Merck KGaA, Germany測定,且適用於20℃之溫度。混合物實例 實例 M1 CY-3-O2 16.50%    清澈點[℃]:74.0 CCY-4-O2 10.50%    Δn [589 nm,20℃]:0.1069 CCY-5-O2 6.00%    ∆ε [1 kHz,20℃]:-3.2 CPY-2-O2 9.00%    ε [1 kHz,20℃]:3.5 CPY-3-O2 9.00%    K1 [pN,20℃]:12.9 CCH-34 9.00%    K3 [pN,20℃]:13.7 CCH-13 20.00%    γ1 [mPa·s,20℃]:117 CCP-3-1 2.00%    V0 [20℃,V]:2.18 PYP-2-3 6.50%       PYP-2-4 6.50%       PCH-301 5.00%       實例 M2 CY-3-O2 16.50%    清澈點[℃]:74.5 CCY-4-O2 9.50%    Δn [589 nm,20℃]:0.1070 CCY-5-O2 4.00%    ∆ε [1 kHz,20℃]:-3.2 CPY-2-O2 9.00%    ε [1 kHz,20℃]:3.5 CPY-3-O2 9.00%    K1 [pN,20℃]:13.1 CCH-34 9.00%    K3 [pN,20℃]:13.9 CCH-13 20.00%    γ1 [mPa·s,20℃]:117 CCP-3-1 5.00%    V0 [20℃,V]:2.19 PYP-2-3 4.00%       PYP-2-4 4.00%       PCH-301 5.00%       PGIY-2-O4 5.00%       實例 M3 CY-3-O2 16.00%    清澈點[℃]:75.0 CCY-3-O1 4.50%    Δn [589 nm,20℃]:0.1081 CCY-3-O2 10.00%    ∆ε [1 kHz,20℃]:-3.4 CPY-2-O2 8.00%    ε [1 kHz,20℃]:3.5 CPY-3-O2 10.50%    K1 [pN,20℃]:13.3 CCH-23 9.00%    K3 [pN,20℃]:14.6 CCH-13 20.00%    γ1 [mPa·s,20℃]:118 CCP-3-1 6.00%    V0 [20℃,V]:2.20 PYP-2-3 4.00%       PYP-2-4 4.00%       PCH-301 3.00%       PGIY-2-O4 5.00%       實例 M4 CY-3-O2 17.00%    清澈點[℃]:75.5 CCY-3-O2 11.50%    Δn [589 nm,20℃]:0.1082 CPY-2-O2 8.00%    ∆ε [1 kHz,20℃]:-3.3 CPY-3-O2 11.50%    ε [1 kHz,20℃]:3.5 CCH-23 20.00%    K1 [pN,20℃]:13.2 CCH-13 10.00%    K3 [pN,20℃]:14.5 CCP-3-1 6.00%    γ1 [mPa·s,20℃]:115 PYP-2-3 4.00%    V0 [20℃,V]:2.21 PYP-2-4 4.00%       PCH-301 3.00%       PGIY-2-O4 5.00%       實例 M5 BCH-32 4.25%    清澈點[℃]:75.1 CC-3-V1 10.00%    Δn [589 nm,20℃]:0.0975 CCH-13 12.00%    ∆ε [1 kHz,20℃]:-3.6 CCH-35 3.75%    ε [1 kHz,20℃]:3.5 CCP-3-1 10.00%    K1 [pN,20℃]:14.4 CCY-3-O1 5.00%    K3 [pN,20℃]:16.5 CCY-3-O2 3.25%    γ1 [mPa·s,20℃]:127 CPY-2-O2 7.00%    V0 [20℃,V]:2.26 CPY-3-O2 11.75%       CY-3-O2 15.50%       CY-3-O4 3.50%       CY-5-O2 14.00%       實例 M6 BCH-32 2.50%    清澈點[℃]:75.7 CCH-13 16.75%    Δn [589 nm,20℃]:0.0974 CCH-34 4.50%    ∆ε [1 kHz,20℃]:-3.5 CCH-35 7.25%    ε [1 kHz,20℃]:3.5 CCP-3-1 10.00%    K1 [pN,20℃]:14.7 CCY-3-O1 11.50%    K3 [pN,20℃]:16.1 CCY-3-O2 9.75%    γ1 [mPa·s,20℃]:123 CPY-3-O2 9.25%    V0 [20℃,V]:2.28 CY-3-O2 15.00%       PY-3-O2 13.50%       實例 M7 CC-3-V1 10.00%    清澈點[℃]:75.1 CCH-13 14.50%    Δn [589 nm,20℃]:0.0979 CCH-34 4.00%    ∆ε [1 kHz,20℃]:-3.5 CCH-35 7.00%    ε [1 kHz,20℃]:3.5 CCP-3-1 3.50%    K1 [pN,20℃]:14.7 CCY-3-O1 12.00%    K3 [pN,20℃]:16.0 CCY-3-O2 7.00%    γ1 [mPa·s,20℃]:122 CPY-2-O2 4.25%    V0 [20℃,V]:2.24 CPY-3-O2 12.50%       CY-3-O4 12.75%       PY-3-O2 12.50%       實例 M8 為製備PS-VA混合物,將99.7%實例M1之混合物與0.3%下式之可聚合化合物混合實例 M9 為製備PS-VA混合物,將99.75%實例M1之混合物與0.25%下式之可聚合化合物混合實例 M10 為製備PS-VA混合物,將99.8%實例M1之混合物與0.2%下式之可聚合化合物混合實例 M11 為製備PS-VA混合物,將99.75%實例M1之混合物與0.25%下式之可聚合化合物混合實例 M12 為製備PS-VA混合物,將99.75%實例M1之混合物與0.25%下式之可聚合化合物混合實例 M13 為製備PS-VA混合物,將99.75%實例M1之混合物與0.25%下式之可聚合化合物混合實例 M14 為製備PS-VA混合物,將99.8%實例M1之混合物與0.2%下式之可聚合化合物混合實例 M15 為製備PS-VA混合物,將99.8%實例M1之混合物與0.2%下式之可聚合化合物混合實例 M16 為製備PS-VA混合物,將99.75%實例M2之混合物與0.25%下式之可聚合化合物混合實例 M17 為製備PS-VA混合物,將99.7%實例M2之混合物與0.3%下式之可聚合化合物混合實例 M18 為製備PS-VA混合物,將99.7%實例M2之混合物與0.3%下式之可聚合化合物混合 實例 M19 為製備PS-VA混合物,將99.75%實例M2之混合物與0.25%下式之可聚合化合物混合實例 M20 為製備PS-VA混合物,將99.7%實例M2之混合物與0.3%下式之可聚合化合物混合實例 M21 為製備PS-VA混合物,將99.75%實例M2之混合物與0.25%下式之可聚合化合物混合實例 M22 為製備PS-VA混合物,將99.7%實例M2之混合物與0.3%下式之可聚合化合物混合實例 M23 為製備PS-VA混合物,將99.75%實例M2之混合物與0.25%下式之可聚合化合物混合實例 M24 為製備PS-VA混合物,將99.75%實例M3之混合物與0.25%下式之可聚合化合物混合實例 M25 為製備PS-VA混合物,將99.8%實例M3之混合物與0.2%下式之可聚合化合物混合實例 M26 為製備PS-VA混合物,將99.7%實例M3之混合物與0.3%下式之可聚合化合物混合實例 M27 為製備PS-VA混合物,將99.7%實例M3之混合物與0.3%下式之可聚合化合物混合實例 M28 為製備PS-VA混合物,將99.7%實例M3之混合物與0.3%下式之可聚合化合物混合實例 M29 為製備PS-VA混合物,將99.7%實例M3之混合物與0.3%下式之可聚合化合物混合實例 M30 為製備PS-VA混合物,將99.7%實例M4之混合物與0.3%下式之可聚合化合物混合實例 M31 為製備PS-VA混合物,將99.75%實例M4之混合物與0.25%下式之可聚合化合物混合實例 M32 為製備PS-VA混合物,將99.75%實例M4之混合物與0.25%下式之可聚合化合物混合實例 M33 為製備PS-VA混合物,將99.7%實例M4之混合物與0.3%下式之可聚合化合物混合 實例 M34 為製備PS-VA混合物,將99.75%實例M4之混合物與0.25%下式之可聚合化合物混合實例 M35 為製備PS-VA混合物,將99.75%實例M4之混合物與0.25%下式之可聚合化合物混合實例 M36 為製備PS-VA混合物,將99.7%實例M5之混合物與0.3%下式之可聚合化合物混合實例 M37 為製備PS-VA混合物,將99.75%實例M5之混合物與0.25%下式之可聚合化合物混合 實例 M38 為製備PS-VA混合物,將99.8%實例M5之混合物與0.2%下式之可聚合化合物混合實例 M39 為製備PS-VA混合物,將99.75%實例M5之混合物與0.25%下式之可聚合化合物混合實例 M40 為製備PS-VA混合物,將99.75%實例M5之混合物與0.25%下式之可聚合化合物混合實例 M41 為製備PS-VA混合物,將99.75%實例M5之混合物與0.25%下式之可聚合化合物混合實例 M42 為製備PS-VA混合物,將99.75%實例M5之混合物與0.25%下式之可聚合化合物混合實例 M43 為製備PS-VA混合物,將99.75%實例M6之混合物與0.25%下式之可聚合化合物混合實例 M44 為製備PS-VA混合物,將99.7%實例M6之混合物與0.3%下式之可聚合化合物混合實例 M45 為製備PS-VA混合物,將99.75%實例M6之混合物與0.25%下式之可聚合化合物混合實例 M46 為製備PS-VA混合物,將99.75%實例M7之混合物與0.25%下式之可聚合化合物混合實例 M47 為製備PS-VA混合物,將99.7%實例M7之混合物與0.3%下式之可聚合化合物混合實例 M48 為製備PS-VA混合物,將99.75%實例M7之混合物與0.25%下式之可聚合化合物混合實例 M49 為製備PS-VA混合物,將99.75%實例M7之混合物與0.25%下式之可聚合化合物混合實例 M50 CC-3-V 15.00%    清澈點[℃]:74 CC-3-V1 9.00%    Δn [589 nm,20℃]:0.1085 CCH-23 8.00%    ∆ε [1 kHz,20℃]:-3.3 CCH-13 6.00%    ε [1 kHz,20℃]:3.5 CCY-3-O2 12.00%    ε [1 kHz,20℃]:6.8 CCY-5-O2 8.00%    K1 [pN,20℃]:14.1 CPY-2-O2 3.00%    K3 [pN,20℃]:15.8 CPY-3-O2 9.50%    γ1 [mPa·s,20℃]:102 CY-3-O2 7.50%    V0 [20℃,V]:2.31 PY-3-O2 14.00%       PYP-2-3 8.00%       實例 M51 CY-3-O2 16.50%    清澈點[℃]:74.5 CCY-3-O2 11.50%    Δn [589 nm,20℃]:0.1079 CPY-2-O2 3.00%    ∆ε [1 kHz,20℃]:-3.5 CPY-3-O2 11.00%    ε [1 kHz,20℃]:3.6 CCH-34 10.00%    ε [1 kHz,20℃]:7.1 CCH-13 20.00%    K1 [pN,20℃]:13.9 CCP-3-1 9.00%    K3 [pN,20℃]:15.2 PYP-2-3 7.00%    γ1 [mPa·s,20℃]:115 PCH-301 3.00%    V0 [20℃,V]:2.20 PGIY-2-04 5.00%       B-2O-O5 4.00%       實例 M52 為製備PS-VA混合物,將99.75%實例M51之混合物與0.25%下式之可聚合化合物混合實例 M53 CY-3-O2 18.00%    清澈點[℃]:75 CCY-3-O2 10.50%    Δn [589 nm,20℃]:0.1076 CPY-2-O2 1.50%    ∆ε [1 kHz,20℃]:-3.5 CPY-3-O2 11.00%    ε [1 kHz,20℃]:3.6 CCH-23 20.00%    ε [1 kHz,20℃]:7.0 CCH-13 8.00%    K1 [pN,20℃]:13.7 CCP-3-1 12.00%    K3 [pN,20℃]:15.1 PYP-2-3 7.00%    γ1 [mPa·s,20℃]:113 PCH-301 3.00%    V0 [20℃,V]:2.21 PGIY-2-04 5.00%    LTS [整體-20℃]:> 1000 h B-2O-O5 4.00%       實例 M54 CY-3-O2 15.00%    清澈點[℃]:74.5 CY-5-O2 5.00%    Δn [589 nm,20℃]:0.1071 CCP-3-1 1.00%    ∆ε [1 kHz,20℃]:-2.9 CCY-3-O2 11.00%    ε [1 kHz,20℃]:3.5 CPY-2-O2 5.50%    ε [1 kHz,20℃]:6.4 CPY-3-O2 11.00%    K1 [pN,20℃]:14.0 CC-5-V 19.00%    K3 [pN,20℃]:15.6 CC-3-V1 8.50%    γ1 [mPa·s,20℃]:103 CCH-13 11.00%    V0 [20℃,V]:2.41 PYP-2-3 12.50%       PPGU-3-F 0.50%       實例 M55 為製備PS-VA混合物,將99.75%實例M54之混合物與0.25%下式之可聚合化合物混合實例 M56 CC-5-V 15.00%    清澈點[℃]:74.5 CC-3-V1 9.00%    Δn [589 nm,20℃]:0.1087 CCH-13 8.00%    ∆ε [1 kHz,20℃]:-2.9 CCH-34 7.50%    ε [1 kHz,20℃]:3.5 CCY-3-O2 10.00%    ε [1 kHz,20℃]:6.7 CCY-5-O2 8.00%    K1 [pN,20℃]:14.9 CPY-2-O2 3.00%    K3 [pN,20℃]:15.6 CPY-3-O2 8.50%    γ1 [mPa·s,20℃]:105 CY-3-O2 7.00%    V0 [20℃,V]:2.33 PY-3-O2 16.00%       PYP-2-3 8.00%       實例 M57 CC-5-V 20.00%    清澈點[℃]:75 CCH-13 14.50%    Δn [589 nm,20℃]:0.1078 CC-3-V1 8.00%    ∆ε [1 kHz,20℃]:-2.9 CCP-3-1 2.00%    ε [1 kHz,20℃]:3.4 CCY-3-01 6.00%    ε [1 kHz,20℃]:6.3 CCY-3-O2 10.00%    K1 [pN,20℃]:15.0 CPY-2-O2 5.50%    K3 [pN,20℃]:15.6 CPY-3-O2 11.50%    γ1 [mPa·s,20℃]:98 PY-3-O2 17.50%    V0 [20℃,V]:2.45 PYP-2-3 5.00%    LTS [整體-20℃]:> 1000 h 實例 M58 CC-3-V1 9.00%    清澈點[℃]:74.5 CCH-13 18.00%    Δn [589 nm,20℃]:0.0987 CCH-34 9.00%    ∆ε [1 kHz,20℃]:-3.5 CCP-3-1 5.50%    ε [1 kHz,20℃]:3.5 CCY-3-O1 3.50%    ε [1 kHz,20℃]:6.9 CCY-3-O2 11.50%    K1 [pN,20℃]:14.5 CPY-2-O2 9.00%    K3 [pN,20℃]:16.1 CPY-3-O2 11.00%    γ1 [mPa·s,20℃]:107 CY-3-O2 13.50%    V0 [20℃,V]:2.28 PY-3-O2 10.00%       實例 M59 為製備PS-VA混合物,將99.7%實例M58之混合物與0.3%下式之可聚合化合物混合實例 M60 CC-3-V 25.50%    清澈點[℃]:66.5 CCH-13 12.00%    Δn [589 nm,20℃]:0.0879 PY-3-O2 9.00%    ∆ε [1 kHz,20℃]:-3.6 CEY-3-O2 9.00%    K1 [pN,20℃]:12.1 PY-5-O2 5.00%    K3 [pN,20℃]:14.5 CCP-31 5.00%    γ1 [mPa·s,20℃]:92 CCY-V-O1 5.00%    V0 [20℃,V]:2.13 CCY-V-O2 11.00%       CCP-301 2.00%       CCP-33 2.00%       CAIY-3-O2 7.00%       CCY-V-O4 7.50%       實例 M61 為製備PS-VA混合物,將99.75%實例M60之混合物與0.25%下式之可聚合化合物混合實例 M62 CC-5-V 20.00%    清澈點[℃]:74.5 CCH-13 14.50%    Δn [589 nm,20℃]:0.1083 CC-3-V1 8.00%    ∆ε [1 kHz,20℃]:-3.0 CCP-3-1 2.00%    ε [1 kHz,20℃]:3.4 CCY-3-O1 4.00%    ε [1 kHz,20℃]:6.4 CCY-3-O2 11.00%    K1 [pN,20℃]:15.6 CPY-2-O2 7.50%    K3 [pN,20℃]:15.9 CPY-3-O2 11.50%    γ1 [mPa·s,20℃]:97 PY-3-O2 12.00%    V0 [20℃,V]:2.44 PYP-2-3 1.00%       B-20-05 4.00%       PP-1-2V1 4.50%       實例 M63 CC-5-V 20.00%    清澈點[℃]:74.5 CC-3-V1 8.00%    Δn [589 nm,20℃]:0.1083 CCH-13 10.00%    ∆ε [1 kHz,20℃]:-3.1 CCH-34 4.00%    ε [1 kHz,20℃]:3.5 CCY-3-O2 11.50%    ε [1 kHz,20℃]:6.6 CCY-5-O2 3.00%    K1 [pN,20℃]:14.9 CPY-2-O2 7.50%    K3 [pN,20℃]:15.4 CPY-3-O2 11.00%    γ1 [mPa·s,20℃]:102 CY-3-O2 3.50%    V0 [20℃,V]:2.35 PY-3-O2 16.50%       PYP-2-3 5.00%       實例 M64 CC-5-V 20.00%    清澈點[℃]:74.5 CCH-13 14.50%    Δn [589 nm,20℃]:0.1080 CC-3-V1 8.00%    ∆ε [1 kHz,20℃]:-3.2 CCY-3-O1 4.00%    ε [1 kHz,20℃]:3.5 CCY-3-O2 11.00%    ε [1 kHz,20℃]:6.6 CPY-2-O2 3.50%    K1 [pN,20℃]:15.8 CPY-3-O2 11.50%    K3 [pN,20℃]:16.3 CLY-3-O2 5.00%    γ1 [mPa·s,20℃]:99 PY-3-O2 13.00%    V0 [20℃,V]:2.39 PYP-2-3 1.00%       B-2O-O5 4.00%       PP-1-2V1 4.50%       實例 M65 為製備PS-VA混合物,將99.7%實例M62之混合物與0.3%下式之可聚合化合物混合實例 M66 CC-5-V 20.00%    清澈點[℃]:75 CCH-13 14.50%    Δn [589 nm,20℃]:0.1083 CC-3-V1 8.00%    ∆ε [1 kHz,20℃]:-3.1 CCY-3-O1 4.00%    ε [1 kHz,20℃]:3.5 CCY-3-O2 11.00%    ε [1 kHz,20℃]:6.6 CPY-2-O2 3.50%    K1 [pN,20℃]:15.8 CPY-3-O2 11.50%    K3 [pN,20℃]:16.1 CLY-3-O2 5.00%    γ1 [mPa·s,20℃]:98 PY-3-O2 13.00%    V0 [20℃,V]:2.41 PYP-2-3 1.00%       B-2O-O5 4.00%       PP-1-2V1 4.50%       實例 M67 CC-4-V 16.00%    清澈點[℃]:75 CCH-13 12.00%    Δn [589 nm,20℃]:0.1080 CC-3-V1 8.00%    ∆ε [1 kHz,20℃]:-3.1 CCP-3-1 12.50%    ε [1 kHz,20℃]:3.5 CCY-3-O1 3.50%    ε [1 kHz,20℃]:6.7 CCY-3-O2 11.00%    K1 [pN,20℃]:15.0 CPY-3-O2 10.50%    K3 [pN,20℃]:15.8 PY-3-O2 20.00%    γ1 [mPa·s,20℃]:98 PYP-2-3 2.50%    V0 [20℃,V]:2.37 B-2O-O5 4.00%       實例 M68 CC-3-V 20.00%    清澈點[℃]:72.5 CC-3-V1 8.00%    Δn [589 nm,20℃]:0.1078 CCH-13 7.50%    ∆ε [1 kHz,20℃]:-3.0 CCP-3-1 14.50%    ε [1 kHz,20℃]:3.5 CCP-3-3 5.00%    ε [1 kHz,20℃]:6.5 CCY-3-O2 10.00%    K1 [pN,20℃]:15.0 CY-3-O2 4.00%    K3 [pN,20℃]:15.8 PY-3-O2 16.00%    γ1 [mPa·s,20℃]:83 PYP-2-3 5.00%    V0 [20℃,V]:2.44 B-2O-O5 3.00%       B(S)-2O-O5 3.00%       B(S)-2O-O4 2.00%        B(S)-2O-O6 2.00%        實例 M69 為製備PS-VA混合物,將99.7%實例M68之混合物與0.3%下式之可聚合化合物混合實例 M70 CC-3-V1 10.00%    清澈點[℃]:74.6 CCH-13 16.00%    Δn [589 nm,20℃]:0.0985 CCH-34 6.00%    ∆ε [1 kHz,20℃]:-3.4 CCH-35 2.50%    ε [1 kHz,20℃]:3.5 CCOC-3-3 3.50%    ε [1 kHz,20℃]:6.9 CCOC-4-3 3.50%    K1 [pN,20℃]:14.8 CCP-3-1 1.00%    K3 [pN,20℃]:16.2 CCY-3-O2 12.50%    γ1 [mPa·s,20℃]:120 CPY-2-O2 6.50%    V0 [20℃,V]:2.29 CPY-3-O2 13.00%       CY-3-O2 11.50%       PY-3-O2 14.00%       實例 M71 為製備聚合物穩定型LC混合物,將99.75%實例M70之混合物與0.25%下式之可聚合化合物混合實例 M72 為製備聚合物穩定型LC混合物,將99.7%實例M70之混合物與0.3%下式之可聚合化合物混合實例 M73 為製備聚合物穩定型LC混合物,將99.7%實例M70之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。 實例M73之混合物較佳適用於PS-VA應用,尤其2D及3D TV應用。 用於PS-VA應用之上述混合物實例當然亦適用於PS-IPS及PS-FFS應用。 為改良可靠性,實例M1至M69之混合物可另外用一或兩種選自下述化合物a)至h)之群的穩定劑穩定: a) b) c) d) e) f) g) h), 其中以混合物計,在各情形下添加0.01至0.04%之量的穩定劑。實例 M74 CCY-3-O2 4.50%    清澈點[℃]:74.5 CPY-3-O2 11.00%    Δn [589 nm,20℃]:0.1284 PYP-2-3 9.50%    ∆ε [1 kHz,20℃]:-2.0 PY-3-O2 15.00%    ε [1 kHz,20℃]:3.4 Y-4O-O4 4.00%    ε [1 kHz,20℃]:5.4 CCH-23 15.00%    K1 [pN,20℃]:14.7 CCH-13 8.00%    K3 [pN,20℃]:14.5 CCP-3-1 11.00%    γ1 [mPa·s,20℃]:95 CCP-3-3 2.00%    V0 [20℃,V]:2.81 BCH-32 15.00%    LTS [整體-20℃] > 1000 h PP-1-3 5.00%       實例 M75 CC-3-V1 8.50%    清澈點[℃]:74.5 CCH-13 7.50%    Δn [589 nm,20℃]:0.0998 CCH-23 16.50%    ∆ε [1 kHz,20℃]:-3.4 CCP-3-1 16.00%    ε [1 kHz,20℃]:7.0 CCY-3-O2 11.00%    K1 [pN,20℃]:14.7 CCY-3-O1 6.00%    K3 [pN,20℃]:16.0 CPY-3-O2 11.50%    γ1 [mPa·s,20℃]:98 B-2O-O5 3.00%    V0 [20℃,V]:2.30 Y-4O-O4 5.00%       PY-2-O2 8.00%       PY-1-O2 7.00%       實例 M76 CC-3-V1 4.00%    清澈點[℃]:73.5 CCH-23 14.00%    Δn [589 nm,20℃]:0.0977 CCH-34 3.00%    ∆ε [1 kHz,20℃]:-3.5 CCH-35 4.00%    ε [1 kHz,20℃]:3.6 CCH-13 4.00%    ε [1 kHz,20℃]:7.1 CCP-3-1 14.00%    K1 [pN,20℃]:14.6 CCY-3-O2 11.00%    K3 [pN,20℃]:16.1 CCY-3-O1 5.50%    γ1 [mPa·s,20℃]:107 CPY-3-O2 11.00%    V0 [20℃,V]:2.26 CY-3-O2 12.00%       PY-3-O2 14.50%       Y-4O-O4 3.00%       實例 M77 BCH-32 4.25%    清澈點[℃]:75.1 CC-3-V1 10.00%    Δn [589 nm,20℃]:0.0975 CCH-13 12.00%    ∆ε [1 kHz,20℃]:-3.6 CCH-35 3.75%    ε [1 kHz,20℃]:3.5 CCP-3-1 10.00%    ε [1 kHz,20℃]:7.1 CCY-3-O1 5.00%    K1 [pN,20℃]:14.4 CCY-3-O2 3.25%    K3 [pN,20℃]:16.5 CPY-2-O2 7.00%    γ1 [mPa·s,20℃]: CPY-3-O2 11.75%    V0 [20℃,V]:2.26 CY-3-O2 15.50%       CY-3-O4 3.50%       CY-5-O2 14.00%       實例 M78 BCH-32 6.50%    清澈點[℃]:75.1 CC-3-V1 1.00%    Δn [589 nm,20℃]:0.0888 CCH-13 20.50%    ∆ε [1 kHz,20℃]:-3.0 CCH-301 3.00%    ε [1 kHz,20℃]:3.4 CCH-34 6.00%    ε [1 kHz,20℃]:6.4 CCH-35 6.00%    K1 [pN,20℃]:13.4 CCY-3-O2 5.00%    K3 [pN,20℃]:13.6 CCY-3-O2 10.00%    V0 [20℃,V]:2.22 CCY-4-O2 5.00%       CPY-2-O2 9.00%       CPY-3-O2 7.50%       CY-3-O2 12.00%       CY-5-O2 8.50%       實例 M79 BCH-52 1.50%    清澈點[℃]:74.8 CC-3-V 15.50%    Δn [589 nm,20℃]:0.0980 CC-3-V1 10.00%    ∆ε [1 kHz,20℃]:-3.4 CCH-13 4.50%    ε [1 kHz,20℃]:3.5 CCH-34 5.00%    ε [1 kHz,20℃]:6.9 CCH-35 5.00%    K1 [pN,20℃]:14.7 CCY-3-O1 10.00%    K3 [pN,20℃]:15.4 CCY-3-O2 14.00%    γ1 [mPa·s,20℃]:101 CCY-4-O2 8.50%    V0 [20℃,V]:2.27 PY-1-O4 8.00%       PY-3-O2 17.00%       PYP-3-O2 1.50%       實例 M80 為製備PS-VA混合物,將99.75%實例M60之混合物與0.25%下式之可聚合化合物混合實例 M81 BCH-32 2.00%    清澈點[℃]:74.8 CC-3-V 16.00%    Δn [589 nm,20℃]:0.0980 CC-3-V1 9.50%    ∆ε [1 kHz,20℃]:-3.3 CCH-13 2.00%    ε [1 kHz,20℃]:3.5 CCH-301 3.00%    ε [1 kHz,20℃]:6.8 CCH-34 6.00%    K1 [pN,20℃]:14.4 CCH-35 4.00%    K3 [pN,20℃]:15.0 CCY-3-O1 10.00%    γ1 [mPa·s,20℃]:99 CCY-3-O2 13.50%    V0 [20℃,V]:2.28 CCY-4-O2 8.00%       PY-1-O4 7.50%       PY-3-O2 17.00%       PYP-2-3 1.50%       實例 M82 BCH-52 2.00%    清澈點[℃]:75.1 CC-3-V 16.00%    Δn [589 nm,20℃]:0.0980 CC-3-V1 9.50%    ∆ε [1 kHz,20℃]:-3.3 CCH-13 2.00%    ε [1 kHz,20℃]:3.5 CCH-34 3.00%    ε [1 kHz,20℃]:6.8 CCH-35 6.00%    K1 [pN,20℃]:14.8 CCY-3-O1 4.00%    K3 [pN,20℃]:15.5 CCY-3-O2 10.00%    γ1 [mPa·s,20℃]:103 CCY-3-O3 13.50%    V0 [20℃,V]:2.29 CCY-4-O2 8.00%       PY-1-O4 7.50%       PY-3-O2 17.00%       PYP-2-3 1.50%       實例 M83 CC-3-V1 10.00%    清澈點[℃]:74.6 CCH-13 16.00%    Δn [589 nm,20℃]:0.0985 CCH-34 6.00%    ∆ε [1 kHz,20℃]:-3.4 CCH-35 2.50%    ε [1 kHz,20℃]:3.5 CCOC-3-3 3.50%    ε [1 kHz,20℃]:6.9 CCOC-4-3 3.50%    K1 [pN,20℃]:14.8 CCP-3-1 1.00%    K3 [pN,20℃]:16.2 CCY-3-O2 12.50%    V0 [20℃,V]:2.29 CPY-2-O2 6.50%       CPY-3-O2 13.00%       CY-3-O2 11.50%       PY-3-O2 14.00%       實例 M84 BCH-52 1.00%    清澈點[℃]:74.9 CC-3-V 15.00%    Δn [589 nm,20℃]:0.0980 CC-3-V1 10.00%    ∆ε [1 kHz,20℃]:-3.4 CCH-13 4.50%    ε [1 kHz,20℃]:7.0 CCH-34 5.00%    K1 [pN,20℃]:14.8 CCH-35 5.00%    K3 [pN,20℃]:15.5 CCY-3-O1 8.50%    γ1 [mPa·s,20℃]:104 CCY-3-O2 14.50%    V0 [20℃,V]:2.25 CCY-3-O3 1.00%       CCY-4-O2 9.00%       PY-1-O4 8.50%       PY-3-O2 17.00%       PYP-2-3 1.00%       實例 M85 B-2O-O5 4.50%    清澈點[℃]:74.8 BCH-32 2.50%    Δn [589 nm,20℃]:0.0989 CC-3-V1 13.00%    ∆ε [1 kHz,20℃]:-3.4 CCH-13 13.00%    ε [1 kHz,20℃]:6.9 CCH-34 6.00%    K1 [pN,20℃]:15.7 CCH-35 3.00%    K3 [pN,20℃]:15.8 CCP-V2-1 2.50%    γ1 [mPa·s,20℃]:105 CCY-3-O1 5.00%    V0 [20℃,V]:2.29 CCY-3-O2 8.00%       CCY-3-O3 3.00%       CCY-4-O2 12.00%       PY-1-O4 5.50%       PY-3-O2 15.00%       PYP-2-3 1.00%       實例 M86 B-2O-O5 4.00%    清澈點[℃]:75 BCH-32 6.50%    Δn [589 nm,20℃]:0.1028 CC-3-V 22.50%    ∆ε [1 kHz,20℃]:-3.3 CC-3-V1 9.00%    ε [1 kHz,20℃]:3.6 CCH-13 7.50%    ε [1 kHz,20℃]:6.9 CCY-3-O1 7.00%    K1 [pN,20℃]:14.4 CCY-3-O2 12.50%    K3 [pN,20℃]:15.0 CCY-4-O2 10.00%    γ1 [mPa·s,20℃]:97 PY-1-O4 3.00%    V0 [20℃,V]:2.27 PY-3-O2 16.00%       PYP-2-3 2.00%       實例 M87 B-2O-O5 4.50%    清澈點[℃]:74.5 BCH-32 2.50%    Δn [589 nm,20℃]:0.0978 CC-3-V1 18.50%    ∆ε [1 kHz,20℃]:-3.4 CCH-13 13.00%    ε [1 kHz,20℃]:3.5 CCH-34 6.00%    ε [1 kHz,20℃]:6.9 CCH-35 4.00%    K1 [pN,20℃]:15.6 CCP-V2-1 2.50%    K3 [pN,20℃]:15.8 CCY-3-O1 6.00%    γ1 [mPa·s,20℃]:106 CCY-3-O2 8.00%    V0 [20℃,V]:2.29 CCY-3-O3 4.50%       CCY-4-O2 9.50%       PY-1-O4 5.50%       PY-3-O2 15.0%       PYP-2-3 0.50%       實例 M88 為製備PS-VA混合物,將99.7%實例M87之混合物與0.3%下式之可聚合化合物混合實例 M89 B-2O-O5 4.00%    清澈點[℃]:74.6 BCH-52 1.00%    Δn [589 nm,20℃]:0.0985 CC-3-V 15.00%    ∆ε [1 kHz,20℃]:-3.5 CC-3-V1 10.00%    ε [1 kHz,20℃]:3.6 CCH-13 4.00%    ε [1 kHz,20℃]:7.1 CCH-34 6.00%    K1 [pN,20℃]:14.7 CCH-35 7.50%    K3 [pN,20℃]:15.3 CCY-3-O1 9.50%    γ1 [mPa·s,20℃]:100 CCY-3-O2 14.50%    V0 [20℃,V]:2.22 CCY-4-O2 5.50%       PY-1-O4 5.00%       PY-3-O2 16.00%       PYP-2-3 2.0%       實例 M90 為製備PS-VA混合物,將99.75%實例M89之混合物與0.25%下式之可聚合化合物混合實例 M91 為製備PS-VA混合物,將99.75%實例M89之混合物與0.25%下式之可聚合化合物混合實例 M92 B-2O-O5 4.00%    清澈點[℃]:85.2 CC-3-V 31.50%    Δn [589 nm,20℃]:0.0976 CCH-13 6.00%    ∆ε [1 kHz,20℃]:-3.5 CCH-34 6.00%    ε [1 kHz,20℃]:3.5 CCY-3-O1 5.50%    ε [1 kHz,20℃]:6.9 CCY-3-O2 3.00%    K1 [pN,20℃]:14.7 CCY-4-O2 4.00%    K3 [pN,20℃]:15.1 CLY-2-O4 6.00%    γ1 [mPa·s,20℃]:100 CLY-3-O2 4.00%    V0 [20℃,V]:2.21 CPY-2-O2 10.00%       CPY-3-O2 10.00%       CY-3-O2 7.00%       PGIY-2-O4 16.00%       實例 M93 為製備PS-VA混合物,將99.7%實例M6之混合物與0.3%下式之可聚合化合物混合實例 M94 CC-3-V 20.50%    清澈點[℃]:74.8 CC-3-V1 10.00%    Δn [589 nm,20℃]:0.1024 CCH-13 10.50%    ∆ε [1 kHz,20℃]:-3.2 CCY-3-O1 7.00%    ε [1 kHz,20℃]:3.5 CCY-3-O2 13.00%    ε [1 kHz,20℃]:6.7 CCY-4-O2 4.50%    K1 [pN,20℃]:13.7 CPY-2-O2 5.00%    K3 [pN,20℃]:15.4 CPY-3-O2 8.00%    γ1 [mPa·s,20℃]:97 PY-3-O2 16.00%    V0 [20℃,V]:2.31 PY-4-O2 3.50%       PYP-2-3 2.00%       實例 M95 CC-3-V 20.50%    清澈點[℃]:74.5 CC-3-V1 10.00%    Δn [589 nm,20℃]:0.1018 CCH-13 10.50%    ∆ε [1 kHz,20℃]:-3.2 CCY-3-O1 7.00%    ε [1 kHz,20℃]:3.6 CCY-3-O2 13.00%    ε [1 kHz,20℃]:6.8 CCY-4-O2 4.50%    K1 [pN,20℃]:14.0 CPY-2-O2 5.00%    K3 [pN,20℃]:14.8 CPY-3-O2 8.00%    γ1 [mPa·s,20℃]:95 PY-3-O2 16.00%    V0 [20℃,V]:2.26 PY-4-O2 3.50%       PYP-2-3 2.00%       實例 M96 實例M95之混合物另外包含0.001%下式之化合物實例 M97 BCH-32 0.50%    清澈點[℃]:74.6 CC-3-V 22.50%    Δn [589 nm,20℃]:0.1032 CC-3-V1 9.00%    ∆ε [1 kHz,20℃]:-3.2 CCH-13 1.50%    ε [1 kHz,20℃]:3.5 CCH-34 5.50%    ε [1 kHz,20℃]:6.7 CCH-35 4.00%    K1 [pN,20℃]:14.2 CCY-3-O1 8.50%    K3 [pN,20℃]:14.8 CCY-3-O2 12.00%    γ1 [mPa·s,20℃]:95 CPY-2-O2 12.00%    V0 [20℃,V]:2.28 CPY-3-O2 2.00%       PY-1-O4 3.00%       PY-3-O2 17.00%       PY-4-O2 1.50%       PYP-2-3 1.00%       實例 M98 實例M97之混合物另外用0.01%下式之化合物穩定實例 M99 BCH-52 0.50%    清澈點[℃]:75 CC-3-V 22.50%    Δn [589 nm,20℃]:0.1030 CC-3-V1 9.00%    ∆ε [1 kHz,20℃]:-3.2 CCH-13 1.00%    ε [1 kHz,20℃]:3.5 CCH-34 5.50%    ε [1 kHz,20℃]:6.8 CCH-35 4.00%    K1 [pN,20℃]:14.2 CCY-3-O1 9.50%    K3 [pN,20℃]:15.0 CCY-3-O2 12.50%    γ1 [mPa·s,20℃]:95 CPY-2-O2 10.00%    V0 [20℃,V]:2.29 CPY-3-O2 2.00%       CY-3-O2 0.50%       PY-1-O4 4.50%       PY-3-O2 17.00%       PYP-2-3 1.50%       實例 M100 為製備PS-VA混合物,將99.7%實例M99之混合物與0.3%下式之可聚合化合物混合實例 M101 為製備PS-VA混合物,將99.7%實例M77之混合物與0.3%下式之可聚合化合物混合實例 M102 CC-3-V 22.50%    清澈點[℃]:74.8 CC-3-V1 9.75%    Δn [589 nm,20℃]:0.1027 CCH-13 0.75%    ∆ε [1 kHz,20℃]:-3.2 CCH-34 5.50%    ε [1 kHz,20℃]:3.5 CCH-35 4.00%    ε [1 kHz,20℃]:6.8 CCY-3-O1 10.00%    K1 [pN,20℃]:14.4 CCY-3-O2 12.00%    K3 [pN,20℃]:15.2 CPY-2-O2 10.00%    γ1 [mPa·s,20℃]:94 CPY-3-O2 2.00%    V0 [20℃,V]:2.29 CY-3-O2 0.50%       PP-1-2V1 0.25%       PY-1-O4 4.25%       PY-3-O2 17.00%       PYP-2-3 1.50%       實例 M103 為製備PS-VA混合物,將99.7%實例M102之混合物與0.3%下式之可聚合化合物混合實例 M104 CC-3-V 0.50%    清澈點[℃]:75 CC-3-V1 22.50%    Δn [589 nm,20℃]:0.1023 CCH-13 9.75%    ∆ε [1 kHz,20℃]:-3.2 CCH-34 0.50%    ε [1 kHz,20℃]:3.5 CCH-35 5.75%    ε [1 kHz,20℃]:6.7 CCY-3-O1 4.00%    K1 [pN,20℃]:14.4 CCY-3-O2 10.00%    K3 [pN,20℃]:15.8 CPY-2-O2 11.50%    γ1 [mPa·s,20℃]:95 CPY-3-O2 10.00%    V0 [20℃,V]:2.29 CY-3-O2 2.50%       PP-1-2V1 0.50%       PY-1-O4 4.40%       PY-3-O2 17.00%       PYP-2-3 1.00%       實例 M105 為製備PS-VA混合物,將99.7%實例M102之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M106 為製備PS-VA混合物,將99.7%實例M7之混合物與0.3%下式之可聚合化合物混合實例 M107 CC-3-V 22.50%    清澈點[℃]:74.8 CC-3-V1 9.75%    Δn [589 nm,20℃]:0.1031 CCH-13 0.50%    ∆ε [1 kHz,20℃]:-3.2 CCH-34 5.75%    ε [1 kHz,20℃]:3.5 CCH-35 4.00%    ε [1 kHz,20℃]:6.8 CCY-3-O1 10.00%    K1 [pN,20℃]:14.4 CCY-3-O2 11.00%    K3 [pN,20℃]:15.0 CPY-2-O2 10.00%    γ1 [mPa·s,20℃]:95 CPY-3-O2 3.00%    V0 [20℃,V]:2.28 PY-1-O4 5.50%       PY-3-O2 16.50%       PYP-2-3 1.50%       實例 M108 BCH-52 0.75%    清澈點[℃]:74.5 CC-3-V 22.50%    Δn [589 nm,20℃]:0.1030 CC-3-V1 10.00%    ∆ε [1 kHz,20℃]:-3.2 CCH-13 0.50%    ε [1 kHz,20℃]:3.6 CCH-34 5.75%    ε [1 kHz,20℃]:6.7 CCH-35 3.50%    K1 [pN,20℃]:14.2 CCY-3-O1 9.50%    K3 [pN,20℃]:14.9 CCY-3-O2 11.50%    γ1 [mPa·s,20℃]:95 CPY-2-O2 10.00%    V0 [20℃,V]:2.28 CPY-3-O2 2.50%       PY-1-O4 5.50%       PY-3-O2 17.00%       PYP-2-3 1.00%       實例 M109 實例M108之混合物另外包含0.001%下式之化合物實例 M110 為製備PS-VA混合物,將99.7%實例M109之混合物與0.3%下式之可聚合化合物混合實例 M111 為製備PS-VA混合物,將99.75%實例M108之混合物與0.25%下式之可聚合化合物混合實例 M112 CC-3-V 22.50%    清澈點[℃]:74.8 CC-3-V1 8.00%    Δn [589 nm,20℃]:0.1031 CCH-13 1.00%    ∆ε [1 kHz,20℃]:-3.2 CCH-34 6.00%    ε [1 kHz,20℃]:3.5 CCH-35 5.25%    ε [1 kHz,20℃]:6.8 CCY-3-O1 6.00%    K1 [pN,20℃]:14.5 CCY-3-O2 13.25%    K3 [pN,20℃]:15.0 CPY-2-O2 11.00%    γ1 [mPa·s,20℃]:96 CPY-3-O2 4.00%    V0 [20℃,V]:2.28 CY-3-O2 1.00%       PY-1-O4 4.00%       PY-3-O2 17.00%       PYP-2-3 1.00%       實例 M113 CC-3-V 22.50%    清澈點[℃]:74.5 CC-3-V1 10.50%    Δn [589 nm,20℃]:0.1030 CCH-13 1.50%    ∆ε [1 kHz,20℃]:-3.2 CCH-34 6.00%    ε [1 kHz,20℃]:3.5 CCH-35 3.00%    ε [1 kHz,20℃]:6.7 CCY-3-O1 7.00%    K1 [pN,20℃]:14.2 CCY-3-O2 9.50%    K3 [pN,20℃]:16.0 CPY-2-O2 12.50%    γ1 [mPa·s,20℃]:94 CPY-3-O2 5.50%    V0 [20℃,V]:2.30 CY-3-O2 2.50%       PY-1-O4 6.00%       PY-3-O2 12.50%       PYP-2-3 1.00%       實例 M114 為製備PS-VA混合物,將99.75%實例M113之混合物與0.25%下式之可聚合化合物混合實例 M115 為製備聚合物穩定型LC混合物,將99.7%實例M70之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M116 為製備PS-VA混合物,將99.75%實例M113之混合物與0.25%下式之可聚合化合物混合實例 M117 BCH-32 3.50%    清澈點[℃]:75.1 CC-3-V1 10.00%    Δn [589 nm,20℃]:0.1122 CCH-13 15.50%    ∆ε [1 kHz,20℃]:-3.4 CCH-34 6.00%    ε [1 kHz,20℃]:3.6 CCOC-3-3 3.50%    ε [1 kHz,20℃]:7.0 CCOC-3-4 3.50%    K1 [pN,20℃]:15.0 CCY-3-O2 11.75%    K3 [pN,20℃]:15.6 CPY-2-O2 10.00%    V0 [20℃,V]:2.26 CPY-3-O2 11.00%       PY-1-O4 8.75%       PY-3-O2 14.00%       PY-4-O2 2.50%       實例 M118 為製備PS-VA混合物,將99.7%實例M117之混合物與0.3%下式之可聚合化合物混合實例 M119 為製備PS-VA混合物,將99.7%實例M117之混合物與0.3%下式之可聚合化合物混合實例 M120 BCH-32 7.00%    清澈點[℃]:74 CC-3-V1 10.00%    Δn [589 nm,20℃]:0.1118 CCH-13 15.00%    ∆ε [1 kHz,20℃]:-3.4 CCH-34 3.25%    ε [1 kHz,20℃]:3.6 CCOC-3-3 3.50%    ε [1 kHz,20℃]:7.0 CCOC-4-3 3.50%    K1 [pN,20℃]:14.7 CCY-3-O2 12.50%    K3 [pN,20℃]:15.8 CPY-2-O2 4.50%    V0 [20℃,V]:2.27 CPY-3-O2 12.00%       CY-3-O4 5.25%       PY-1-O4 9.50%       PY-3-O2 14.00%       實例 M121 為製備PS-VA混合物,將99.75%實例M120之混合物與0.25%下式之可聚合化合物混合實例 M122 BCH-32 5.00%    清澈點[℃]:74 CCH-13 17.00%    Δn [589 nm,20℃]:0.1355 CCH-34 6.50%    ∆ε [1 kHz,20℃]:-3.1 CCH-35 6.00%    ε [1 kHz,20℃]:3.7 CCY-3-O2 7.00%    ε [1 kHz,20℃]:6.6 CPY-2-O2 10.00%    K1 [pN,20℃]:14.1 CPY-3-O2 10.00%    K3 [pN,20℃]:13.8 PY-1-O4 8.00%    V0 [20℃,V]:2.24 PY-3-O2 11.00%       PYP-2-3 10.00%       PYP-2-4 9.50%       實例 M123 為製備PS-VA混合物,將99.7%實例M122之混合物與0.3%下式之可聚合化合物混合實例 M124 為製備PS-VA混合物,將99.7%實例M122之混合物與0.3%下式之可聚合化合物混合實例 M125 CC-3-V 15.00%       CC-3-V1 9.00%       CCH-23 8.00%       CCH-13 6.00%       CCOY-3-O2 12.00%       CCY-5-O2 8.00%       CPY-2-O2 3.00%       CPY-3-O2 9.50%       CY-3-O2 7.50%       PY-3-O2 14.00%       PYP-2-3 8.00%       實例 M126 為製備PS-VA混合物,將99.7%實例M125之混合物與0.3%下式之可聚合化合物混合實例 M127 BCH-32 5.00%    清澈點[℃]:74.2 CCH-13 17.00%    Δn [589 nm,20℃]:0.1349 CCH-34 7.00%    ∆ε [1 kHz,20℃]:-2.8 CCH-35 5.00%    ε [1 kHz,20℃]:3.5 CCP-3-1 6.50%    ε [1 kHz,20℃]:6.2 CPY-2-O2 11.00%    K1 [pN,20℃]:14.2 CPY-3-O2 11.00%    K3 [pN,20℃]:13.8 PY-1-O4 7.50%    V0 [20℃,V]:2.40 PY-3-O2 12.00%       PYP-2-3 9.00%       PYP-2-4 9.00%       實例 M128 為製備聚合物穩定型LC混合物,將99.7%實例M127之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M129 為製備PS-VA混合物,將99.7%實例M127之混合物與0.3%下式之可聚合化合物混合實例 M130 BCH-32 8.00%    清澈點[℃]:74.3 BCH-52 2.50%    Δn [589 nm,20℃]:0.1116 CC-3-V1 10.00%    ∆ε [1 kHz,20℃]:-3.4 CCH-13 15.50%    ε [1 kHz,20℃]:3.6 CCOC-3-3 3.50%    ε [1 kHz,20℃]:7.0 CCOC-4-3 3.50%    K1 [pN,20℃]:14.1 CCY-3-O2 6.75%    K3 [pN,20℃]:15.4 CPY-2-O2 10.00%    V0 [20℃,V]:2.26 CPY-3-O2 11.00%       CY-3-O2 14.00%       CY-3-O4 1.25%       PY-3-O2 14.00%       實例 M131 為製備聚合物穩定型LC混合物,將99.99%實例M130之混合物與0.01%下式之可聚合化合物混合實例 M132 BCH-32 6.00%    清澈點[℃]:74.8 CC-3-V1 10.00%       CCH-13 15.50%       CCH-34 6.00%       CCY-3-O1 5.50%       CCOY-3-O2 10.00%       CPY-2-O2 10.00%       CPY-3-O2 11.00%       CY-3-O4 9.00%       PP-1-2V1 2.00%       PY-3-O2 15.00%       實例 M133 BCH-32 6.50%    清澈點[℃]:75.5 CC-3-V1 9.00%    Δn [589 nm,20℃]:0.1120 CCH-13 15.00%    ∆ε [1 kHz,20℃]:-3.5 CCOC-3-3 3.50%    ε [1 kHz,20℃]:3.6 CCOC-4-3 3.50%    K1 [pN,20℃]:14.4 CCY-3-O1 2.50%    K3 [pN,20℃]:15.9 CCY-3-O2 9.00%    V0 [20℃,V]:2.24 CPY-2-O2 11.00%       CPY-3-O2 11.00%       CY-3-O2 14.50%       PP-1-3 3.50%       PY-3-O2 11.00%       實例 M134 BCH-32 4.50%    清澈點[℃]:74.5 BCH-52 3.25%    Δn [589 nm,20℃]:0.1123 CC-3-V1 10.00%    ∆ε [1 kHz,20℃]:-3.4 CCH-13 14.25%    ε [1 kHz,20℃]:3.6 CCOC-3-3 3.50%    ε [1 kHz,20℃]:7.0 CCOC-4-3 3.50%    K1 [pN,20℃]:14.2 CCY-3-O1 2.50%    K3 [pN,20℃]:15.6 CCY-3-O2 7.50%    V0 [20℃,V]:2.26 CPY-2-O2 10.00%       CPY-3-O2 11.00%       CY-3-O2 14.75%       PP-1-3 3.25%       PY-3-O2 12.00%       實例 M135 為製備PS-VA混合物,將99.7%實例M134之混合物與0.3%下式之可聚合化合物混合實例 M136 B-2O-O5 4.00%    清澈點[℃]:85.5 CC-3-V 32.00%       CCH-13 6.00%       CCH-34 5.00%       CCY-3-O1 7.00%       CCOY-3-O2 4.00%       CCOY-4-O2 1.50%       CLY-2-O4 5.50%       CLY-3-O2 4.00%       CPY-2-O2 10.00%       CPY-3-O2 10.00%       CY-3-O2 7.00%       PGIY-2-O4 4.00%       實例 M137 為製備PS-VA混合物,將99.7%實例M136之混合物與0.3%下式之可聚合化合物混合實例 M138 為製備PS-VA混合物,將99.75%實例M136之混合物與0.25%下式之可聚合化合物混合實例 M139 為製備PS-VA混合物,將99.7%實例M136之混合物與0.3%下式之可聚合化合物混合實例 M140 BCH-32 4.50%    清澈點[℃]:74.2 BCH-52 2.50%    Δn [589 nm,20℃]:0.1121 CC-3-V1 10.00%    ∆ε [1 kHz,20℃]:-3.4 CCH-13 13.75%    ε [1 kHz,20℃]:3.7 CCOC-3-3 3.50%    ε [1 kHz,20℃]:7.1 CCOC-4-3 3.50%    K1 [pN,20℃]:14.3 CCY-3-O1 2.50%    K3 [pN,20℃]:15.7 CCY-3-O2 7.50%    V0 [20℃,V]:2.26 CPY-2-O2 10.00%       CPY-3-O2 11.00%       CY-3-O2 15.50%       PP-1-3 3.25%       PY-3-O2 12.00%       PPGU-3-F 0.50%       實例 M141 實例M140之混合物另外包含0.03%實例 M142 B-2O-O5 4.00%    清澈點[℃]:85.1 CC-3-V 32.00%    Δn [589 nm,20℃]:0.0998 CCH-13 6.00%    ∆ε [1 kHz,20℃]:-3.5 CCH-34 5.00%    ε [1 kHz,20℃]:3.5 CCY-3-O1 7.00%    ε [1 kHz,20℃]:7.0 CCY-3-O2 4.00%    K1 [pN,20℃]:14.8 CCY-4-O2 1.50%    K3 [pN,20℃]:15.2 CLY-2-O4 5.50%    V0 [20℃,V]:2.20 CLY-3-O2 4.00%       CPY-2-O2 10.00%       CPY-3-O2 10.00%       CY-3-O2 7.00%       PGIY-2-O4 4.00%       實例 M143 CC-3-V 22.50%    清澈點[℃]:74.7 CC-3-V1 10.50%    Δn [589 nm,20℃]:0.0984 CCH-13 1.00%    ∆ε [1 kHz,20℃]:-3.1 CCH-34 6.50%    ε [1 kHz,20℃]:3.7 CCY-3-O1 7.00%    ε [1 kHz,20℃]:6.6 CCY-3-O2 13.00%    K1 [pN,20℃]:14.0 CPY-2-O2 2.00%    K3 [pN,20℃]:13.7 CPY-3-O2 10.50%    γ1 [mPa·s,20℃]:98 CY-3-O2 12.00%    V0 [20℃,V]:2.24 PCH-301 0.50%       PY-3-O2 11.50%       PYP-2-4 3.00%       實例 M144 B-2O-O5 4.00%    清澈點[℃]:84.9 BCH-32 4.50%    Δn [589 nm,20℃]:0.1066 CC-3-V 29.00%    ∆ε [1 kHz,20℃]:-4.0 CCH-13 6.00%    ε [1 kHz,20℃]:3.6 CCY-3-O1 6.00%    ε [1 kHz,20℃]:7.6 CCY-4-O2 5.50%    K1 [pN,20℃]:15.3 CLY-2-O4 6.00%    K3 [pN,20℃]:15.6 CLY-3-O2 3.00%    V0 [20℃,V]:2.09 CPY-2-O2 10.00%       CPY-3-O2 10.00%       CY-3-O2 6.00%       CY-5-O2 6.00%       PGIY-2-O4 4.00%       實例 M145 為製備PS-VA混合物,將99.7%實例M144之混合物與0.3%下式之可聚合化合物混合實例 M146 為製備PS-VA混合物,將99.7%實例M144之混合物與0.3%下式之可聚合化合物混合實例 M147 CC-3-V1 10.00%    清澈點[℃]:75.5 CCH-13 16.50%    Δn [589 nm,20℃]:0.1110 CCP-3-1 6.50%    ∆ε [1 kHz,20℃]:-3.7 CCY-3-O1 9.00%    ε [1 kHz,20℃]:3.6 CCY-3-O2 9.50%       CPY-2-O2 10.00%       CPY-3-O2 10.00%       CY-3-O4 10.50%       PP-1-2V1 3.50%       PY-V2-O2 14.50%       實例 M148 為製備PS-VA混合物,將99.7%實例M147之混合物與0.3%下式之可聚合化合物混合實例 M149 B-2O-O5 5.00%    清澈點[℃]:74.5 BCH-52 8.00%    Δn [589 nm,20℃]:0.1033 CC-3-V 22.50%    ∆ε [1 kHz,20℃]:-3.0 CCH-13 9.40%    ε [1 kHz,20℃]:3.6 CCH-34 5.50%    ε [1 kHz,20℃]:6.6 CCY-3-O1 8.20%    K1 [pN,20℃]:13.4 CCY-3-O2 8.80%    K3 [pN,20℃]:13.5 CCY-3-O2 11.60%    γ1 [mPa·s,20℃]:96 PP-1-2V1 2.00%    V0 [20℃,V]:2.26 PY-3-O2 15.00%       PY-4-O2 1.00%       PYP-2-3 3.00%       實例 M150 為製備PS-VA混合物,將99.7%實例M149之混合物與0.3%下式之可聚合化合物混合實例 M151 B-2O-O5 5.00%    清澈點[℃]:74.5 BCH-52 7.25%    Δn [589 nm,20℃]:0.1033 CC-3-V 22.50%    ∆ε [1 kHz,20℃]:-3.1 CCH-13 5.75%    ε [1 kHz,20℃]:3.5 CCH-301 1.00%    ε [1 kHz,20℃]:6.6 CCH-34 5.50%    K1 [pN,20℃]:14.4 CCH-35 3.50%    K3 [pN,20℃]:13.9 CCY-3-O1 8.00%    γ1 [mPa·s,20℃]:95 CCY-3-O2 10.00%    V0 [20℃,V]:2.26 CCY-4-O2 9.50%       PP-1-2V1 2.50%       PY-3-O2 11.00%       PY-4-O2 5.50%       PYP-2-3 3.00%       實例 M152 B-2O-O5 4.00%    清澈點[℃]:84.9 BCH-52 4.50%    Δn [589 nm,20℃]:0.1066 CC-3-V 28.50%    ∆ε [1 kHz,20℃]:-4.1 CCH-13 5.00%    ε [1 kHz,20℃]:3.6 CCY-3-O1 6.00%    ε [1 kHz,20℃]:7.7 CCY-4-O2 5.50%    K1 [pN,20℃]:14.9 CLY-2-O4 6.50%    K3 [pN,20℃]:15.4 CLY-3-O2 3.00%    V0 [20℃,V]:2.05 CPY-2-O2 10.00%       CPY-3-O2 10.00%       CY-3-O2 6.50%       CY-5-O2 7.00%       PGIY-2-O4 3.50%       實例 M153 為製備PS-FFS混合物,將99.7%實例M152之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M154 CC-3-V1 10.00%    清澈點[℃]:75.1 CCH-13 16.50%    Δn [589 nm,20℃]:0.1109 CCP-3-1 6.50%    ∆ε [1 kHz,20℃]:-3.8 CCY-3-O1 9.00%    ε [1 kHz,20℃]:3.6 CCY-3-O2 9.50%    ε [1 kHz,20℃]:7.4 CPY-2-O2 10.00%    K1 [pN,20℃]:14.7 CPY-3-O2 10.00%    K3 [pN,20℃]:16.7 CY-3-O4 10.50%    V0 [20℃,V]:2.21 PP-1-2V1 3.50%       PY-3-O2 14.50%       實例 M155 實例M152之混合物另外包含0.04%下式之化合物 及0.02%下式之化合物實例 M156 BCH-32 5.00%    清澈點[℃]:74.6 CC-3-V1 10.00%    Δn [589 nm,20℃]:0.1110 CCH-13 16.00%    ∆ε [1 kHz,20℃]:-3.6 CCH-34 6.00%    ε [1 kHz,20℃]:3.6 CCY-3-O1 6.50%    ε [1 kHz,20℃]:7.2 CCY-3-O2 10.00%    K1 [pN,20℃]:14.4 CPY-2-O2 10.00%    K3 [pN,20℃]:15.8 CPY-3-O2 11.00%    V0 [20℃,V]:2.21 CY-3-O2 9.00%       PP-1-2V1 1.50%       PY-3-O2 15.00%       實例 M157 實例M156之混合物另外包含0.03%下式之化合物實例 M158 為製備PS-VA混合物,將99.7%實例M156之混合物與0.3%下式之可聚合化合物混合實例 M159 CC-3-V1 8.50%    清澈點[℃]:74 CCH-13 15.50%    Δn [589 nm,20℃]:0.1052 CCH-34 7.00%    ∆ε [1 kHz,20℃]:-2.8 CCP-3-1 13.50%    ε [1 kHz,20℃]:3.3 CCY-3-O1 3.50%    ε [1 kHz,20℃]:6.2 CCY-3-O2 10.00%    K1 [pN,20℃]:15.7 CPY-3-O2 12.00%    K3 [pN,20℃]:17.9 CY-3-O2 10.00%    V0 [20℃,V]:2.66 PP-1-2V1 5.50%       PY-3-O2 14.50%       實例 M160 BCH-32 6.00%    清澈點[℃]:74.6 CC-3-V1 10.00%    Δn [589 nm,20℃]:0.1117 CCH-13 15.50%    ∆ε [1 kHz,20℃]:-3.5 CCH-34 6.00%    ε [1 kHz,20℃]:3.5 CCY-3-O1 5.50%    ε [1 kHz,20℃]:7.0 CCY-3-O2 10.00%    K1 [pN,20℃]:14.7 CPY-2-O2 10.00%    K3 [pN,20℃]:15.7 CPY-3-O2 11.00%    V0 [20℃,V]:2.23 CY-3-O4 9.00%       PP-1-2V1 2.00%       PY-3-O2 15.00%       實例 M161 實例M160之混合物另外包含0.03%下式之化合物實例 M162 為製備聚合物穩定型LC混合物,將99.7%實例M160之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M163 BCH-32 6.00%    清澈點[℃]:74.6 CC-3-V1 10.00%    Δn [589 nm,20℃]:0.1117 CCH-13 15.50%    ∆ε [1 kHz,20℃]:-3.4 CCH-34 6.00%    ε [1 kHz,20℃]:3.5 CCY-3-O1 5.50%    ε [1 kHz,20℃]:6.9 CCY-3-O2 10.00%    K1 [pN,20℃]:14.7 CPY-2-O2 10.00%    K3 [pN,20℃]:15.8 CPY-3-O2 11.00%    V0 [20℃,V]:2.27 CY-3-O4 9.00%       PP-1-2V1 3.00%       PY-3-O2 14.00%       實例 M164 為製備聚合物穩定型LC混合物,將99.7%實例M163之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M165 實例M163之混合物另外包含0.03%下式之化合物實例 M166 B-2O-O5 4.00%    清澈點[℃]:85.2 CC-3-V 31.50%    Δn [589 nm,20℃]:0.0976 CCH-13 6.00%    ∆ε [1 kHz,20℃]:-3.5 CCH-34 6.00%    ε [1 kHz,20℃]:3.5 CCY-3-O1 5.50%    ε [1 kHz,20℃]:6.9 CCY-3-O2 3.00%    K1 [pN,20℃]:14.7 CCY-4-O2 4.00%    K3 [pN,20℃]:15.1 CLY-2-O4 6.00%    V0 [20℃,V]:2.21 CLY-3-O2 4.00%       CPY-2-O2 10.00%       CPY-3-O2 10.00%       CY-3-O2 7.00%       PGIY-2-O4 3.00%       實例 M167 為製備PS-VA混合物,將99.7%實例M166之混合物與0.3%下式之可聚合化合物混合 及0.001% Irganox-1076 (BASF)混合。實例 M168 B-2O-O5 4.00%    清澈點[℃]:85.3 CC-3-V 31.50%       CCH-13 6.00%       CCH-34 6.00%       CCY-3-O1 5.50%       CCOY-3-O2 3.00%       CCOY-4-O2 4.00%       CLY-2-O4 6.00%       CLY-3-O2 4.00%       CPY-2-O2 10.00%       CPY-3-O2 10.00%       CY-3-O2 7.00%       PGIY-2-O4 3.00%       實例 M169 為製備聚合物穩定型LC混合物,將99.99%實例M168之混合物與0.01%下式之可聚合化合物混合實例 M169 為製備PS-VA混合物,將99.7%實例M168之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M170 BCH-32 3.00%    清澈點[℃]:110.4 CCH-13 16.50%    Δn [589 nm,20℃]:0.0981 CCH-34 4.50%    ∆ε [1 kHz,20℃]:-3.7 CCH-35 6.00%    ε [1 kHz,20℃]:3.3 CCP-3-1 5.50%    ε [1 kHz,20℃]:7.0 CCY-3-1 4.00%    K1 [pN,20℃]:19.7 CCY-3-O1 11.00%    K3 [pN,20℃]:20.5 CCY-3-O2 13.00%    γ1 [mPa·s,20℃]:212 CCY-4-O2 11.00%    V0 [20℃,V]:2.48 CPY-2-O2 5.50%       CPY-3-O2 11.50%       CY-3-O2 8.00%       CY-5-O2 0.50%       實例 M171 BCH-32 3.00%    清澈點[℃]:110.3 CCH-13 16.50%    Δn [589 nm,20℃]:0.0983 CCH-34 4.50%    ∆ε [1 kHz,20℃]:-3.7 CCH-35 6.00%    ε [1 kHz,20℃]:3.3 CCP-3-1 5.50%    ε [1 kHz,20℃]:7.0 CCY-3-1 4.00%    K1 [pN,20℃]:19.6 CCY-3-O1 11.00%    K3 [pN,20℃]:20.5 CCY-3-O2 11.50%    γ1 [mPa·s,20℃]:213 CCY-4-O2 11.00%    V0 [20℃,V]:2.49 CCY-5-O2 1.50%       CPY-2-O2 5.50%       CPY-3-O2 11.50%       CY-3-O2 8.50%       實例 M172 為製備聚合物穩定型LC混合物,將99.9%實例M171之混合物與0.1%下式之可聚合化合物混合實例 M173 BCH-32 3.00%    清澈點[℃]:110.1 CCH-13 14.25%    Δn [589 nm,20℃]:0.0980 CCH-34 5.00%    ∆ε [1 kHz,20℃]:-3.7 CCH-35 6.50%    ε [1 kHz,20℃]:3.3 CCP-3-1 4.50%    ε [1 kHz,20℃]:7.0 CCY-3-1 6.50%    K1 [pN,20℃]:19.2 CCY-3-O1 9.00%    K3 [pN,20℃]:20.3 CCY-3-O2 14.50%    γ1 [mPa·s,20℃]: CCY-4-O2 10.00%    V0 [20℃,V]:2.48 CPY-2-O2 92.75%       CPY-3-O2 14.00%       CY-3-O4 9.50%       實例 M174 BCH-32 5.50%    清澈點[℃]:75.1 CC-3-V1 8.50%    Δn [589 nm,20℃]:0.984 CCH-13 19.00%    ∆ε [1 kHz,20℃]:-3.3 CCH-301 4.00%    ε [1 kHz,20℃]:3.5 CCH-34 5.50%    ε [1 kHz,20℃]:6.8 CCY-3-O1 9.00%    K1 [pN,20℃]:14.1 CCY-3-O2 9.00%    K3 [pN,20℃]:15.1 CPY-2-O2 10.00%    γ1 [mPa·s,20℃]: CPY-3-O2 10.00%    V0 [20℃,V]:2.25 CY-3-O2 13.00%       PY-3-O2 6.50%       實例 M175 B-2O-O5 4.00%    清澈點[℃]:74.1 BCH-32 8.00%    Δn [589 nm,20℃]:0.1084 CC-3-V1 9.00%    ∆ε [1 kHz,20℃]:-3.2 CCH-13 5.00%    ε [1 kHz,20℃]:3.6 CCH-34 8.00%    ε [1 kHz,20℃]:6.8 CCH-35 8.00%    K1 [pN,20℃]:14.6 CCP-3-1 8.00%    K3 [pN,20℃]:16.0 CCY-3-O2 4.50%    γ1 [mPa·s,20℃]: CLY-3-O2 10.00%    V0 [20℃,V]:2.35 CY-3-O2 14.00%       PCH-301 5.00%       PGIY-2-O4 5.00%       PY-3-O2 11.50%       實例 M176 B-2O-O5 4.00%    清澈點[℃]:74.5 BCH-32 8.00%    Δn [589 nm,20℃]:0.1090 CC-3-V1 9.00%    ∆ε [1 kHz,20℃]:-3.1 CCH-13 10.00%    ε [1 kHz,20℃]:3.5 CCH-34 8.00%    ε [1 kHz,20℃]:6.6 CCH-35 4.00%    K1 [pN,20℃]:14.7 CCP-3-1 8.00%    K3 [pN,20℃]:16.5 CCY-3-O2 11.00%    γ1 [mPa·s,20℃]: CCY-4-O2 3.00%    V0 [20℃,V]:2.43 CPY-3-O2 7.00%       CY-3-O2 6.00%       PCH-301 4.00%       PY-3-O2 18.00%       實例 M177 B-2O-O5 4.00%    清澈點[℃]:74.5 BCH-32 8.00%    Δn [589 nm,20℃]:0.1089 CC-3-V1 9.00%    ∆ε [1 kHz,20℃]:-3.1 CCH-13 6.00%    ε [1 kHz,20℃]:3.5 CCH-34 8.00%    ε [1 kHz,20℃]:6.6 CCH-35 7.00%    K1 [pN,20℃]:14.7 CCP-3-1 8.00%    K3 [pN,20℃]:16.6 CCY-3-O2 11.00%    γ1 [mPa·s,20℃]: CCY-4-O2 2.50%    V0 [20℃,V]:2.42 CPY-3-O2 6.00%       CY-3-O2 7.50%       PCH-301 5.00%       PY-3-O2 18.00%       實例 M178 B-2O-O5 4.00%    清澈點[℃]:74.3 BCH-32 8.00%    Δn [589 nm,20℃]:0.1088 CC-3-V1 9.00%    ∆ε [1 kHz,20℃]:-3.2 CCH-13 10.00%    ε [1 kHz,20℃]:3.5 CCH-34 8.00%    ε [1 kHz,20℃]:6.7 CCH-35 4.00%    K1 [pN,20℃]:14.9 CCP-3-1 8.00%    K3 [pN,20℃]:16.6 CCY-3-O2 11.00%    γ1 [mPa·s,20℃]:102 CCY-4-O2 3.00%    V0 [20℃,V]:2.39 CPY-3-O2 7.00%       CY-3-O2 7.50%       PCH-301 2.50%       PY-3-O2 18.00%       實例 M179 為製備聚合物穩定型LC混合物,將99.7%實例M173之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M180 CC-5-V 20.00%    清澈點[℃]:75.0 CCH-13 14.50%    Δn [589 nm,20℃]:0.1078 CC-3-V1 8.00%    ∆ε [1 kHz,20℃]:-2.9 CCP-3-1 2.00%    ε [1 kHz,20℃]:3.4 CCY-3-O1 6.00%    ε [1 kHz,20℃]:6.3 CCY-3-O2 10.00%    K1 [pN,20℃]:15.0 CPY-2-O2 5.50%    K3 [pN,20℃]:15.6 CCY-3-O2 11.50%    γ1 [mPa·s,20℃]:98 PY-3-O2 17.50%    V0 [20℃,V]:2.45 PYP-2-3 5.00%       實例 M181 CC-3-V1 8.50%    清澈點[℃]:74.5 CCH-13 11.00%    Δn [589 nm,20℃]:0.0983 CCH-35 7.00%    ∆ε [1 kHz,20℃]:-3.5 CCH-34 5.00%    ε [1 kHz,20℃]:3.6 CCP-3-1 13.50%    ε [1 kHz,20℃]:7.1 CCY-3-O1 6.00%    K1 [pN,20℃]:15.5 CCY-3-O2 9.00%    K3 [pN,20℃]:16.5 CPY-3-O2 10.50%    γ1 [mPa·s,20℃]:101 CY-3-O2 11.50%    V0 [20℃,V]:2.30 Y-4O-O4 6.00%    LTS [整體-20℃]:> 1000 h B(S)-2O-O5 4.00%       PP-1-3 5.00%       B(S)-2O-O4 3.00%       實例 M182 CC-V-V 10.00%    清澈點[℃]:73.5 CCH-13 10.00%    Δn [589 nm,20℃]:0.1067 CCP-V-1 10.00%    ∆ε [1 kHz,20℃]:-2.8 CCY-2-1 10.00%    ε [1 kHz,20℃]:3.5 CCY-3-1 10.00%    ε [1 kHz,20℃]:6.2 CCY-3-O1 10.00%    K1 [pN,20℃]:12.8 CCY-3-O2 7.00%    K3 [pN,20℃]:14.5 CPY-2-O2 10.00%    γ1 [mPa·s,20℃]: CY-3-O2 4.00%    V0 [20℃,V]:2.42 PP-1-3 10.00%       PY-3-O2 9.00%       實例 M183 CC-3-V1 11.00%    清澈點[℃]:75 CCH-13 9.00%    Δn [589 nm,20℃]:0.0983 CC-1-4 8.00%    ∆ε [1 kHz,20℃]:-3.4 CCH-34 10.00%    ε [1 kHz,20℃]:3.4 CCP-V-1 5.00%    ε [1 kHz,20℃]:6.8 CCY-3-O1 1.50%    K1 [pN,20℃]:14.8 CCY-3-O2 9.50%    K3 [pN,20℃]:15.8 CLY-3-O2 5.00%    γ1 [mPa·s,20℃]:104 CLY-3-O3 5.00%    V0 [20℃,V]:2.29 CPY-3-O2 10.00%       CY-3-O2 11.50%       PGIY-2-O4 2.50%       PY-3-O2 12.00%       實例 M184 BCH-32 15.00%    清澈點[℃]:75.2 CCH-13 15.00%    Δn [589 nm,20℃]:0.1101 CCH-23 10.00%    ∆ε [1 kHz,20℃]:-2.5 CCH-34 5.00%    ε [1 kHz,20℃]:3.5 CCP-3-1 11.50%    ε [1 kHz,20℃]:6.0 CLY-3-O2 8.00%    K1 [pN,20℃]:14.6 CPY-2-O2 4.50%    K3 [pN,20℃]:13.9 CPY-3-O2 10.00%    γ1 [mPa·s,20℃]: PGIY-2-O4 6.00%    V0 [20℃,V]:2.39 PY-3-2 5.00%    LTS [整體-20℃]:> 1000 h Y-4O-O4 10.00%       實例 M185 BCH-32 13.00%    清澈點[℃]:71.2 BCH-52 10.00%    Δn [589 nm,20℃]:0.1092 CCH-13 15.00%    ∆ε [1 kHz,20℃]:-2.2 CCH-23 9.00%    ε [1 kHz,20℃]:3.5 CCH-301 7.00%    ε [1 kHz,20℃]:5.7 CCH-34 5.00%    K1 [pN,20℃]:12.8 CLY-3-O2 8.00%    K3 [pN,20℃]:11.9 CPY-2-O2 8.00%    γ1 [mPa·s,20℃]:104 CPY-3-O2 6.50%    V0 [20℃,V]:2.47 PGIY-2-O4 6.00%       PYP-2-4 2.50%       Y-4O-O4 10.00%       實例 M186 CC-3-V1 10.00%    清澈點[℃]:75.5 CCH-13 11.50%    Δn [589 nm,20℃]:0.0984 CCH-34 5.50%    ∆ε [1 kHz,20℃]:-3.5 CCH-35 9.00%    ε [1 kHz,20℃]:3.5 CCP-3-1 5.50%    ε [1 kHz,20℃]:7.0 CCY-3-O2 12.50%    K1 [pN,20℃]:15.2 CPY-2-O2 8.00%    K3 [pN,20℃]:16.9 CPY-3-O2 11.00%    γ1 [mPa·s,20℃]:112 CY-3-O2 15.50%    V0 [20℃,V]:2.31 PGIY-2-O4 2.00%       PY-3-O2 9.50%       實例 M187 為製備聚合物穩定型LC混合物,將99.7%實例M186之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M188 BCH-32 2.50%    清澈點[℃]:75 CC-3-V1 8.00%    Δn [589 nm,20℃]:0.01057 CCH-13 15.00%    ∆ε [1 kHz,20℃]:-2.8 CCH-34 2.50%    ε [1 kHz,20℃]:3.3 CCH-35 5.00%    ε [1 kHz,20℃]:6.2 CCP-3-1 11.00%    K1 [pN,20℃]:15.9 CCY-3-O1 6.00%    K3 [pN,20℃]:18.2 CCY-3-O2 10.00%    γ1 [mPa·s,20℃]:106 CPY-3-O2 10.00%    V0 [20℃,V]:2.68 CPY-3-O2 10.00%       CY-3-O2 12.00%       PP-1-2V1 6.00%       PY-3-O2 12.00%       實例 M189 BCH-32 4.50%    清澈點[℃]:75 CC-3-V1 8.50%    Δn [589 nm,20℃]:0.1055 CCH-13 14.50%    ∆ε [1 kHz,20℃]:-2.8 CCH-34 3.00%    ε [1 kHz,20℃]:3.3 CCH-35 4.50%    ε [1 kHz,20℃]:6.1 CCP-3-1 11.00%    K1 [pN,20℃]:15.6 CCY-3-O1 4.50%    K3 [pN,20℃]:17.6 CCY-3-O2 10.00%    γ1 [mPa·s,20℃]:102 CPY-3-O2 9.00%    V0 [20℃,V]:2.67 CY-3-O2 12.00%       PP-1-2V1 5.00%       PY-3-O2 11.00%       PY-4-O2 2.00%       實例 M190 B-2O-O5 5.00%    清澈點[℃]:74.5 BCH-52 8.00%    Δn [589 nm,20℃]:0.1033 CC-3-V 22.50%    ∆ε [1 kHz,20℃]:-3.0 CCH-13 9.40%    ε [1 kHz,20℃]:3.6 CCH-34 5.50%    K1 [pN,20℃]:13.4 CCY-3-O1 8.20%    K3 [pN,20℃]:13.5 CCY-3-O2 8.80%    γ1 [mPa·s,20℃]:96 CCY-4-O2 11.60%    V0 [20℃,V]:2.26 PP-1-2V1 2.00%       PY-3-O2 15.00%       PY-4-O2 1.00%       PYP-2-3 3.00%       實例 M191 為製備聚合物穩定型LC混合物,將99.7%實例M190之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M192 CC-3-V1 12.50%       CCH-13 19.00%       CCH-34 6.50%       CCY-3-O1 12.00%       CCY-3-O2 12.00%       CCY-4-O2 9.00%       CPY-3-O2 1.00%       CY-3-O2 7.00%       PY-3-O2 13.00%       PYP-2-3 5.50%       PYP-2-4 2.50%       實例 M193 為製備聚合物穩定型LC混合物,將99.7%實例M192之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M194 CC-3-V1 11.25%       CCH-13 16.00%       CCH-301 0.75%       CCH-34 6.50%       CCH-35 5.00%       CCY-3-O1 11.50%       CCY-3-O2 13.50%       CCY-4-O2 6.25%       CPY-3-O2 0.50%       CY-3-O2 6.50%       PY-3-O2 14.50%       PYP-2-3 7.25%       PYP-2-4 0.50%       實例 M195 為製備聚合物穩定型LC混合物,將99.7%實例M194之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M196 為製備聚合物穩定型LC混合物,將99.8%實例M194之混合物與0.2%下式之可聚合化合物混合實例 M197 B-2O-O5 5.00%    清澈點[℃]:75 BCH-52 7.25%    Δn [589 nm,20℃]:0.1034 CC-3-V 22.50%       CCH-13 5.75%       CCH-301 1.00%       CCH-34 5.50%       CCH-35 3.50%       CCY-3-O1 8.00%       CCOY-3-O2 10.00%       CCOY-4-O2 9.50%       PP-1-2V1 2.50%       PY-V2-O2 11.00%       PY-4-O2 5.50%       PYP-2-3 3.00%       實例 M198 為製備聚合物穩定型LC混合物,將99.7%實例M197之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M199 為製備聚合物穩定型LC混合物,將99.8%實例M197之混合物與0.2%下式之可聚合化合物混合實例 M200 實例M188之混合物另外包含0.03%下式之化合物實例 M201 實例M188之混合物另外包含0.04%下式之化合物 及0.02%下式之化合物實例 M202 實例M99之混合物另外包含0.03%下式之化合物實例 M203 實例M99之混合物另外包含0.04%下式之化合物 及0.02%下式之化合物實例 M204 CC-3-V1 9.00%    清澈點[℃]:74.8 CCH-13 18.00%       CCH-34 9.00%       CCP-3-1 5.50%       CCY-3-O1 3.50%       CCY-3-O2 11.50%       CPY-V-O2 9.00%       CPY-3-O2 11.00%       CY-3-O2 13.50%       PY-3-O2 10.00%       實例 M205 實例M204之混合物另外包含0.03%下式之化合物實例 M206 CC-3-V1 10.00%    清澈點[℃]:77 CCH-13 11.50%       CCH-34 5.50%       CCH-35 9.00%       CCP-3-1 5.50%       CCY-3-O2 12.50%       CPY-2-O2 8.00%       CPY-3-O2 11.00%       CY-3-O2 15.50%       CK-3-F 2.00%       PY-3-O2 9.50%       實例 M207 CC-3-V1 12.50%    清澈點[℃]:74.9 CCH-13 19.00%    Δn [589 nm,20℃]:0.0980 CCH-34 6.50%    ∆ε [1 kHz,20℃]:-3.3 CCY-3-O1 12.00%    ε [1 kHz,20℃]:3.4 CCY-3-O2 12.00%    K1 [pN,20℃]:14.7 CCY-4-O2 9.00%    K3 [pN,20℃]:15.6 CPY-3-O2 1.00%    γ1 [mPa·s,20℃]:109 CY-3-O2 7.00%    V0 [20℃,V]:2.29 PY-3-O2 13.00%       PYP-2-3 5.50%       PYP-2-4 2.50%       實例 M208 為製備PS-VA混合物,將99.7%實例M207之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M209 CC-3-V1 11.25%    清澈點[℃]:74.7 CCH-13 16.00%    Δn [589 nm,20℃]:0.0977 CCH-301 0.75%    ∆ε [1 kHz,20℃]:-3.2 CCH-34 6.50%    ε [1 kHz,20℃]:3.4 CCH-35 5.00%    K1 [pN,20℃]:14.7 CCY-3-O1 11.50%    K3 [pN,20℃]:15.6 CCY-3-O2 13.50%    γ1 [mPa·s,20℃]:106 CCY-4-O2 6.25%    V0 [20℃,V]:2.33 CPY-3-O2 0.50%       CY-3-O2 6.50%       PY-3-O2 14.50%       PYP-2-3 7.25%       PYP-2-4 0.50%       實例 M210 為製備PS-VA混合物,將99.7%實例M209之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。實例 M211 為製備PS-VA混合物,將99.7%實例M151之混合物與0.3%下式之可聚合化合物 及0.001% Irganox-1076 (BASF)混合。The expression "having a nematic phase" means here that on the one hand, no smectic phase and crystallization are observed at low temperatures at the corresponding temperatures, and on the other hand, no clearing of the nematic phase occurs on heating. Studies at low temperatures were carried out in a flow viscometer at the corresponding temperatures and verified by storage in a test cell with a layer thickness corresponding to the electro-optical use for at least 100 hours. If the storage stability at -20°C in the corresponding test unit is 1000 hours or more, the medium is said to be stable at this temperature. At temperatures of -30°C and -40°C, the corresponding times are 500 hours and 250 hours respectively. At high temperatures, the clear point is measured in the capillary tube by conventional methods. The liquid crystal mixture preferably has a nematic range of at least 60 K and at most 30 mm at 20°C2 ∙s- 1 The flow viscosity ν20 . The birefringence value Δn in the liquid crystal mixture is generally from 0.07 to 0.16, preferably from 0.08 to 0.13. The liquid crystal mixture of the present invention has a Δε of -0.5 to -8.0, especially -2.5 to -6.0, where Δε represents dielectric anisotropy. Rotational viscosity γ at 20℃1 Preferably it is ≤150 mPa∙s, especially ≤130 mPa∙s. The liquid crystal medium of the present invention has a relatively small threshold voltage (V0 )value. It is preferably in the range of 1.7 V to 3.0 V, preferably ≤2.5 V and most preferably ≤2.3 V. For the purpose of this invention, unless otherwise expressly indicated, the term "threshold voltage" refers to the capacitance threshold value (V0 ), also known as the Fredericks threshold. In addition, the liquid crystal medium of the present invention has a high voltage retention value in the liquid crystal cell. Generally speaking, a liquid crystal medium with a low addressing voltage or threshold voltage exhibits a lower voltage retention than a liquid crystal medium with a higher addressing voltage or threshold voltage, and vice versa. For the purpose of the present invention, the term "dielectrically positive compound" means a compound with Δε>1.5, the term "dielectrically neutral compound" means a compound with -1.5≤Δε≤1.5, and the term "dielectrically negative compound" means a compound with Δε Compounds with ε<-1.5. In this article, the dielectric anisotropy of a compound is determined by dissolving 10% of the compound in a liquid crystal host and measuring the capacitance of the resulting mixture in at least one test cell, the layer thickness of which in each case being 20 µm with vertical and homogeneous surface alignment at 1 kHz. The measured voltages were typically 0.5 V to 1.0 V, but were always below the capacitance threshold of the respective liquid crystal mixtures studied. All temperature values indicated for the present invention are in °C. The mixtures of the present invention are suitable for all VA-TFT applications such as VAN, MVA, (S)-PVA, ASV, PSA (polymer-supported VA), SS (surface-stabilized)-VA and PS-VA (polymer-stabilized type VA). In addition, it is suitable for IPS (in-plane switching type) and FFS (fringe field switching type) with negative Δε, especially UB-FFS. The nematic liquid crystal mixture in the display of the present invention generally contains two components A and B, which itself is composed of one or more individual compounds. Component A has significant negative dielectric anisotropy and imparts a dielectric anisotropy of ≤-0.5 to the nematic phase. In addition to one or more compounds of formula I, they preferably comprise compounds of formula IIA, IIB and/or IIC, in addition to compounds of formula III. The proportion of component A is preferably from 45 to 100%, especially from 60 to 100%. For component A, it is preferred to select one (or more) individual compounds with a Δε value ≤ -0.8. It must be true that the more negative this value is, the smaller the proportion of A in the overall mixture. Component B has obvious nematic primordial groups, and the flow viscosity is not greater than 30 mm at 20°C.2 ∙s- 1 , preferably no larger than 25 mm2 ∙s- 1 . A variety of suitable materials are known to those skilled in the art from the literature. Particularly preferred are compounds of formula III. Especially preferred individual compounds in component B have a flow viscosity of not more than 18 mm at 20°C.2 ∙ s- 1 , preferably no larger than 12 mm2 ∙ s- 1 Very low viscosity nematic liquid crystal. Component B is unitropic or tautotropic nematic, has no smectic phase and can prevent the occurrence of smectic phase in the liquid crystal mixture when the temperature drops to extremely low temperatures. For example, if various highly nematic primitive materials are in each case added to a smectic liquid crystal mixture, the nematic primitives of these materials can be compared by the degree of smectic phase suppression achieved. The mixture optionally also contains component C, which contains compounds having a dielectric anisotropy Δε of ≥1.5. Taking the mixture of negative dielectric anisotropy as a whole, these so-called positive compounds are generally present in an amount of ≤20% by weight in the mixture. If the mixture of the present invention contains one or more compounds with dielectric anisotropy Δε≥1.5, it is preferably one or more compounds of the formula P-1 and/or P-2, P-1 P-2 in R represents a straight-chain alkyl, alkoxy or alkenyl group, each having 1 or 2 to 6 C atoms, respectively, and X represents F, Cl, CF3 ,OCF3 ,OCHFCF3 or CCF2 CHFCF3 , preferably F or OCF3 . The compounds of formula P-1 and/or P-2 are preferably used in the mixture of the invention at a concentration of 0.5 to 10% by weight, especially 0.5 to 8% by weight. Particularly preferred are compounds of the following formula, It is preferably used in an amount of 0.5 to 3% by weight. In addition, these liquid crystal phases may also contain more than 18 components, preferably 18 to 25 components. In addition to one or more compounds of formula I, the phases preferably contain from 4 to 15, especially from 5 to 12 and especially preferably <10 compounds of formula IIA, IIB and/or IIC and optionally III. In addition to the compounds of the formula I and the compounds of the formulas IIA, IIB and/or IIC and optionally III, other ingredients may also be present, for example, in an amount of up to 45%, but preferably up to 35%, especially up to 10%, of the total mixture. . The other ingredients are preferably selected from nematic or nematic protosubstances, in particular known substances of the following classes: oxyazobenzene, benzylidene aniline, biphenyl, terphenyl, phenyl benzoate or benzoic acid Cyclohexyl ester, phenyl cyclohexanecarboxylate or cyclohexanecarboxylate, phenylcyclohexane, cyclohexylbiphenyl, cyclohexylcyclohexane, cyclohexylnaphthalene, 1,4-dicyclohexylbiphenyl or cyclohexylbiphenyl Hexylpyrimidine, phenyl- or cyclohexyldioxane, optionally halogenated stilbene, benzyl phenyl ether, diphenyl acetylene and substituted cinnamate esters. The most important compounds suitable as components of this type of liquid crystal phase can be characterized by formula IV, R20 -L-G-E-Rtwenty one IV Among them, L and E each represent derived from 1,4-disubstituted benzene and cyclohexane rings, 4,4'-disubstituted biphenyl, phenylcyclohexane and cyclohexylcyclohexane systems, 2,5- Carbocyclic or heterocyclic systems formed by disubstituted pyrimidines and 1,3-dioxane rings, 2,6-disubstituted naphthalenes, dihydronaphthalenes and tetrahydronaphthalenes, quinazolines and tetrahydroquinazolines . G means -CH=CH- -N(O)=N- -CH=CQ-        CH=N(O)- -C≡C- -CH2 -CH2 - -CO-O-                             -CH2 -O- -CO-S- -CH2 -S- -CH=N-                                                                       -COO-Phe-COO- -CF2 O-                                                                                                                                                                       -OCF2 -                         -OCH2 - -(CH2 )4 -                                                               (CH2 )3 O- Or C-C single bond, Q represents halogen, preferably chlorine or -CN, and R20 and Rtwenty one Each represents an alkyl, alkenyl, alkoxy, alkoxyalkyl or alkoxycarbonyloxy group having up to 18, preferably up to 8 carbon atoms, or one of these groups represents CN, NC,NO2 ,NCS,CF3 ,SF5 ,OCF3 , F, Cl or Br. In most of these compounds, R20 and Rtwenty one Unlike each other, one of these groups is usually an alkyl or alkoxy group. Other variations of the proposed substituents are also common. A variety of these materials or mixtures thereof are also commercially available. All such substances can be prepared by methods known from the literature. It will be obvious to those skilled in the art that the VA, IPS or FFS mixture of the present invention may also contain compounds in which, for example, H, N, O, Cl and F have been correspondingly isotopically substituted. In addition, based on the mixture of the present invention, the polymerizable compound (so-called reactive mesogen (RM), for example disclosed in U.S. 6,861,107) can be preferably present in an amount of 0.01 to 5% by weight, particularly preferably 0.2 to 2% by weight. concentration was added to the mixture. These mixtures may optionally also contain an initiator, as described, for example, in U.S. 6,781,665. Preferably an initiator (eg Irganox-1076 from BASF) is added to the mixture containing the polymerizable compound in an amount of 0 to 1%. Mixtures of this type can be used in so-called polymer-stabilized VA modes (PS-VA) or PSA (polymer-supported VA), where the polymerization of reactive mesogen groups is intended to take place in the liquid crystal mixture. The prerequisite for this is that the liquid crystal mixture itself does not contain polymerizable components that are also polymerized under the conditions in which the compound of formula M is polymerized. The polymerization is preferably carried out under the following conditions: using a UV-A lamp with a specified intensity for a specified period of time to polymerize the polymerizable components in the unit and applying a voltage (usually 10 to 30 V AC voltage, with a frequency in the range of 60 Hz to 1 kHz ). The UV-A light source used usually has an intensity of 50 mW/cm2 Metal-halide vapor lamp or high-pressure mercury lamp. These are, for example, liquid crystalline compounds containing alkenyl or alkenyloxy side chains, such as compounds of the formula where n = 2, 3, 4, 5 or 6, Conditions for non-aggregation. In a preferred embodiment of the present invention, the polymerizable compound is selected from the group consisting of compounds of formula M RMa -AM1 -(ZM1 -AM2 )m1 -RMb M The individual groups have the following meanings: RMa and RMb Each independently represents P, P-Sp-, H, halogen, SF5 ,NO2 , alkyl, alkenyl or alkynyl, where the group RMa and RMb At least one of them preferably represents or contains the group P or P-Sp-, P represents a polymerizable group, Sp represents a spacer group or single bond, AM1 and AM2 Each independently represents an aromatic group, heteroaromatic group, alicyclic group or heterocyclic group, which preferably has 4 to 25 ring atoms, preferably C atoms, which also includes or may contain cyclized rings and which can be The situation is replaced by L alone or multiple times, L represents P; P-Sp-; OH; CH2 OH; F; Cl; Br; I; -CN; -NO2 ;-NCO;-NCS;-OCN;-SCN;-C(=O)N(Rx )2 ;-C(=O)Y1 ;-C(=O)Rx ;-N(Rx )2 ; Optionally substituted silyl group; Optionally substituted aryl group with 6 to 20 C atoms; or linear or branched chain alkyl, alkoxy, alkylcarbonyl group with 1 to 25 C atoms, Alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy, wherein, in addition, one or more H atoms may be replaced by: F, Cl, P or P-Sp-, preferably P, P- Sp-, H, OH, CH2 OH, halogen, SF5 ,NO2 , alkyl, alkenyl or alkynyl, Y1 means halogen, ZM1 Represents -O-, -S-, -CO-, -CO-O-, -OCO-, -O-CO-O-, -OCH2 -, -CH2 O-,-SCH2 -, -CH2 S-, -CF2 O-, -OCF2 -, -CF2 S-,-SCF2 -,-(CH2 )n1 -, -CF2 CH2 -, -CH2 CF2 -,-(CF2 )n1 -, -CH=CH-, -CF=CF-, -C≡C-, -CH=CH-, -COO-, -OCO-CH=CH-, CR0 R00 or single key, R0 and R00 Each independently represents H or an alkyl group having 1 to 12 C atoms, Rx represents P; P-Sp-; H; halogen; straight chain, branched chain or cyclic alkyl group with 1 to 25 C atoms, wherein, in addition, one or more non-adjacent CH2 A group may be substituted by -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a way that the O and/or S atoms are not directly bonded to each other. , and wherein, in addition, one or more H atoms may be replaced by F, Cl, P or P-Sp-; , optionally substituted aryl or aryloxy group having 6 to 40 C atoms; or optionally Substituted heteroaryl or heteroaryloxy groups having 2 to 40 C atoms, m1 represents 0, 1, 2, 3 or 4, and n1 means 1, 2, 3 or 4, The group R present inMa ,RMb At least one, preferably one, two or three of the substituents L, especially one or both of the substituents L represent the group P or P-Sp- or contain at least one group P or P-Sp-. Particularly preferred compounds of formula M are the following compounds, wherein RMa and RMb Each independently represents P; P-Sp-; H; F; Cl; Br; I; -CN; -NO2 ;-NCO;-NCS;-OCN;-SCN;SF5 ; Or a straight or branched chain alkyl group having 1 to 25 C atoms, wherein, in addition, one or more non-adjacent CH2 The groups may each independently be replaced by the following substitutions in such a way that the O and/or S atoms are not directly bonded to each other: -C(R0 )=C(R00 )-, -C≡C-, -N(R00 )-, -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O-, and wherein, in addition, one or more H atoms may be via F, Cl, Br, I, CN, P or P-Sp-substitution, where group RMa and RMb At least one of them preferably represents or contains the group P or P-Sp-, AM1 and AM2 Each independently represents 1,4-phenylene; naphthalene-1,4-diyl; naphthalene-2,6-diyl; phenanthrene-2,7-diyl; anthracene-2,7-diyl; fluorine- 2,7-diyl; coumarin; flavonoid, wherein, in addition, one or more CH groups in these groups may be replaced by N; cyclohexane-1,4-diyl, wherein, in addition, One or more non-adjacent CHs2 The group can be replaced by O and/or S; 1,4-cyclohexenyl; bicyclo[1.1.1]pentane-1,3-diyl; bicyclo[2.2.2]octane-1,4- Diyl; spiro[3.3]heptane-2,6-diyl; piperidine-1,4-diyl; decalin-2,6-diyl; 1,2,3,4-tetralin- 2,6-diyl; indan-2,5-diyl; or octahydro-4,7-methyleneindane-2,5-diyl, where all such groups may be unsubstituted or L is single or poly-substituted, L represents P; P-Sp-; OH; CH2 OH; F; Cl; Br; I; -CN; -NO2 ;-NCO;-NCS;-OCN;-SCN;-C(=O)N(Rx )2 ;-C(=O)Y1 ;-C(=O)Rx ;-N(Rx )2 ; Optionally substituted silyl group; Optionally substituted aryl group with 6 to 20 C atoms; or linear or branched chain alkyl, alkoxy, alkylcarbonyl group with 1 to 25 C atoms, Alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy, wherein in addition one or more H atoms may be replaced by F, Cl, P or P-Sp-, p represents a polymerizable group, Y1 means halogen, Rx represents P; P-Sp-; H; halogen; straight chain, branched chain or cyclic alkyl group with 1 to 25 C atoms, wherein, in addition, one or more non-adjacent CH2 A group may be substituted by -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a way that the O and/or S atoms are not directly bonded to each other. , and wherein, in addition, one or more H atoms may be replaced by F, Cl, P or P-Sp-; optionally substituted aryl or aryloxy having 6 to 40 C atoms; or optionally substituted by Substituted heteroaryl or heteroaryloxy groups having 2 to 40 C atoms. Extremely preferred is RMa and RMb One or both of them represent compounds of formula M of P or P-Sp-. Suitable and preferred RMs for the liquid crystal medium and PS-VA display or PSA display of the present invention are selected from the following formula: M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 M11 M12 M13 M14 M15 M16 M17 M18 M19 M20 M21 M22 M23 M24 M25 M26 M27 M28 M29 The individual groups have the following meanings: P1 and P2 Each independently represents a polymerizable group, which preferably has one of the meanings indicated above and below for P, especially acrylate, methacrylate, fluoroacrylate, oxetane, vinyloxy or epoxy, Sp1 and Sp2 Each independently represents a single bond or a spacer, which preferably has one of the meanings indicated above and below for Sp, and is particularly preferably -(CH2 )p1 -,-(CH2 )p1 -O-、-(CH2 )p1 -CO-O-or-(CH2 )p1 -O-CO-O-, where p1 is an integer from 1 to 12, and wherein the bond to the adjacent ring in the last-mentioned group is via an O atom, where the group P1 -Sp1 - and P2 -Sp2 - One of them can also represent Raa , Raa represents H; F; Cl; CN; or a straight or branched chain alkyl group with 1 to 25 C atoms, wherein, in addition, one or more non-adjacent CH2 The groups may each independently undergo -C(R0 )=C(R00 )-, -C≡C-, -N(R0 )-, -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- are substituted in such a way that the O and/or S atoms are not directly bonded to each other , and wherein, in addition, one or more H atoms may be via F, Cl, CN or P1 -Sp1 - Substitution, especially preferably linear or branched chain, optionally mono- or polyfluorinated, having 1 to 12 C atoms alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl or alkylcarbonyloxy (where alkenyl and alkynyl groups have at least two C atoms and branched chain groups have at least three C atoms), R0 ,R00 each independently of the other and identically or differently on each occurrence represents H or an alkyl group having 1 to 12 C atoms, Ry and Rz Each represents H, F, CH independently of each other3 or CF3 , ZM1 Represents -O-, -CO-, -C(Ry Rz )-or-CF2 CF2 -, ZM2 and ZM3 Each independently represents -CO-O-, -O-CO-, -CH2 O-, -OCH2 -, -CF2 O-, -OCF2 -or-(CH2 )n -, where n is 2, 3 or 4, L represents, identically or differently on each occurrence, F, Cl, CN or straight or branched chain, optionally mono- or polyfluorinated alkyl, alkoxy, alkenyl groups having 1 to 12 C atoms, Alkynyl, alkylcarbonyl, alkoxycarbonyl or alkylcarbonyloxy, preferably F, L' and L'' each independently represent H, F or Cl, r represents 0, 1, 2, 3 or 4, s represents 0, 1, 2 or 3, t represents 0, 1 or 2, and x represents 0 or 1. Suitable polymerizable compounds are listed, for example, in Table D. The liquid crystal medium of the present application preferably contains a total of 0.1 to 10%, preferably 0.2 to 4.0%, and especially preferably 0.2 to 2.0% of polymerizable compounds. Particularly preferred are polymerizable compounds of formula M and formulas RM-1 to RM-102. In addition, the mixture of the present invention may contain conventional additives, such as stabilizers, antioxidants, UV absorbers, nanoparticles, microparticles, etc. The structure of the liquid crystal display of the invention corresponds to common geometries as described, for example, in EP-A 0 240 379. The following examples are intended to explain the invention without limiting it. Above and below, percentage information represents weight percent; all temperatures are expressed in degrees Celsius. Throughout the patent application, 1,4-cyclohexylene ring and 1,4-phenylene ring are depicted as follows: The cyclohexyl ring is trans-1,4-cyclohexyl ring. Throughout the patent application and in the examples, the structure of the liquid crystal compounds is indicated by means of acronyms. Unless otherwise indicated, conversion to chemical formulas was performed according to Tables 1-3. All groups Cn H2n + 1 ,Cm H2m + 1 and Cm ' H2m '+ 1 orCn H2n and Cm H2m All are straight-chain alkyl or alkylene groups, with n, m, m' or z C atoms in each case. n, m, m' and z each independently represent 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12, preferably 1, 2, 3, 4, 5 or 6. In Table 1, the ring elements of the respective compounds are coded, in Table 2, the bridging members are listed, and in Table 3, the meaning of the symbols indicating the left or right side chain of the compound.surface 1 : Ring element A AI B B(S) C D DI F FI G GI K L LI M MI N NI P S U UI Y Y(F,Cl) Y(Cl,F) surface 2 : bridge member E -CH 2 CH 2 - V -CH=CH- T -C≡C- W -CF 2 CF 2 - Z -COO- ZI -OCO- O -CH 2 O- O.I. -OCH 2 - Q -CF 2 O- QI -OCF 2 - surface 3 : side chain left side chain right side chain n- C n H 2n+1 - -n -C n H 2n+1 nO- C n H 2n+1 -O- -On -OC n H 2n+1 V- CH 2 =CH- -V -CH=CH 2 nV- C n H 2n+1 -CH=CH- -nV -C n H 2n -CH=CH 2 Vn- CH 2 =CH-C n H 2n - -Vn -CH=CH-C n H 2n+1 nVm- C n H 2n+1 -CH=CH-C m H 2m - -nVm -C n H 2n -CH=CH-C m H 2m+1 N- N≡C- -N -C≡N F- F- -F -F Cl- Cl- -Cl -Cl M- CFH 2 - -M -CFH 2 D- CF 2 H- -D -CF2H T- CF 3 - -T -CF 3 MO- CFH 2 O- -OM -OCFH 2 DO- CF 2 HO- -OD -OCF 2 H TO- CF 3 O- -OT -OCF 3 T- CF 3 - -T -CF 3 A- HC≡C- -A -C≡CH In addition to the compounds of formula IIA and/or IIB and/or IIC and one or more compounds of formula I, the mixtures of the invention preferably also contain one or more compounds from Table A shown below.surface A Use the following abbreviations: (n, m, m', z: each independently 1, 2, 3, 4, 5 or 6; (O)Cm H2m+1 Meaning OCm H2m+1 orCm H2m+1 ) AIK-nF AIY-n-Om AY-n-Om B-nO-Om Bn-Om B(S)-nO-Om B(S)-n-Om CB(S)-n-(O)m CB-nm CB-n-Om PB-nm PB-n-Om BCH-nm BCH-nmF CY(Cl,F)-n-Om CCY-n-Om CAIY-n-Om CCY(F,Cl)-n-Om CCY(Cl,F)-n-Om CCY-nm CCY-Vm CCY-Vn-m CCY-n-OmV CBC-nmF CBC-nm CCP-Vm CCP-Vn-m CCP-nV-m CCP-nm CPYP-n-(O)m CYYC-nm CCYY-n-(O)m CCY-n-O2V CCH-nOm CY-nm CCH-nm CC-nV CC-n-V1 CC-n-Vm CC-2V-V2 CC-VV CC-V-V1 CVC-nm CC-n-mV CCOC-nm CP-nOmFF CH-nm CEY-n-Om CEY-Vn CVY-Vn CY-V-On CY-n-O1V CY-n-OC(CH 3 )=CH 2 CCN-nm CY-n-OV CCPC-nm CCY-n-zOm CPY-n-Om CPY-nm CPY-V-Om CQY-n-(O)m CQIY-n-(O)m CCQY-n-(O)m CCQIY-n-(O)m CPQY-n-(O)m CPQIY-n-(O)m CPYG-n-(O)m CCY-V-Om CCY-V2-(O)m CCY-1V2-(O)m CCY-3V-(O)m CCVC-nV CPYG-n-(O)m CPGP-nm CY-nV-(O)m CENaph-n-Om COChrom-n-Om COChrom-nm CCOChrom-n-Om CCOChrom-nm CONaph-n-Om CCONaph-n-Om CCNaph-n-Om CNaph-n-Om CETNaph-n-Om CTNaph-n-Om CK-nF CLY-n-Om CLY-nm LYLI-nm CYLI-nm LY-n-(O)m COYOICC-nm COYOIC-nV CCOY-V-O2V CCOY-V-O3V COY-n-Om CCOY-n-Om D-nOmFF PCH-nm PCH-nOm PGIGI-nF PGP-nm PGIY-n-Om PP-nm PP-n-Om PP-n-2V1 PP-n-mVk PPGU-nF PYP-n-mV PYP-nm PYP-n-Om PPYY-nm YPY-nm YPY-n-mV PY-n-Om PY-nm PY-V2-Om C-DFDBF-n-(O)m COY-1V-Om COY-V-Om CCOY-V-Om CCOY-1V-Om BNm DFDBC-n(O)-(O)m Y-nO-Om Y-nO-OmV Y-nO-OmVm' YG-n-Om YG-nO-Om YGI-n-Om YGI-nO-Om YY-n-Om YY-nO-Om YG-VnO-Om YG-nO-OmV YY-VnO-Om The liquid crystal mixtures which can be used according to the invention are prepared in a manner known per se. In general, it is advisable to dissolve the required amount of the component used in smaller amounts in the components constituting the main component at high temperatures. It is also possible to mix solutions of the components in organic solvents, such as acetone, chloroform or methanol, and remove the solvent again, for example by distillation after thorough mixing. With the help of suitable additives, the liquid crystal phase of the invention can be modified in such a way that it can be used in any type of display disclosed so far (eg ECB, VAN, IPS, GH or ASM-VA LCD). The dielectric may also contain other additives known to those skilled in the art and described in the literature, such as UV absorbers, antioxidants, nanoparticles and free radical scavengers. For example, 0 to 15% polychromatic dyes, stabilizers or chiral dopants may be added. Suitable stabilizers for the mixtures according to the invention are in particular the substances listed in Table B. For example, 0 to 15% of polychromatic dyes can be added, in addition to conductive salts, preferably ethyldimethyldodecyl ammonium 4-hexyloxybenzoate, tetrabutylammonium tetraphenylborohydride or corona Complex salts of ethers (see, e.g., Haller et al., Mol. Cryst. Liq. Cryst., Vol. 24, pp. 249-258 (1973)) to improve conductivity, or substances may be added to improve the dielectric anisotropy of the nematic phase Opposite sex, viscosity and/or orientation. Substances of this type are described, for example, in DE-A 22 09 127, 22 40 864, 23 21 632, 23 38 281, 24 50 088, 26 37 430 and 28 53 728.surface B Table B shows possible dopants typically added to the mixtures of the present invention. The mixture preferably contains 0 to 10% by weight, especially 0.01 to 5% by weight and particularly preferably 0.01 to 3% by weight of dopant. If the mixture contains only one dopant, it is used in an amount of 0.01 to 4% by weight, preferably 0.1 to 1.0% by weight. C 15 CB 15 CM 21 R/S-811 CM 44 CM 45 CM 47 EN R/S-2011 R/S-3011 R/S-4011 R/S-5011 R/S-1011 surface C Stabilizers which can be added to the mixture of the invention, for example in an amount of 0 to 10% by weight, are shown below. n = 1, 2, 3, 4, 5, 6 or 7 n = 1, 2, 3, 4, 5, 6 or 7 n = 1, 2, 3, 4, 5, 6 or 7 The medium of the present invention particularly preferably contains Tinuvin® 770 (bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate), the amount is preferably 0.001 to 5% by weight based on the liquid crystal medium.surface D Table D shows exemplary compounds that may be preferred as reactive mesogen compounds for use in the LC media of the present invention. If the mixture according to the invention contains one or more reactive compounds, they are preferably used in an amount of 0.01 to 5% by weight. It may also be necessary to add an initiator or a mixture of two or more initiators for polymerization. The initiator or initiator mixture is preferably added in an amount of 0.001 to 2% by weight, based on the mixture. Suitable initiators are, for example, Irgacure (BASF) or Irganox (BASF). RM-1 RM-2 RM-3 RM-4 RM-5 RM-6 RM-7 RM-8 RM-9 RM-10 RM-11 RM-12 RM-13 RM-14 RM-15 RM-16 RM-17 RM-18 RM-19 RM-20 RM-21 RM-22 RM-23 RM-24 RM-25 RM-26 RM-27 RM-28 RM-29 RM-30 RM-31 RM-32 RM-33 RM-34 RM-35 RM-36 RM-37 RM-38 RM-39 RM-40 RM-41 RM-42 RM-43 RM-44 RM-45 RM-46 RM-47 RM-48 RM-49 RM-50 RM-51 RM-52 RM-53 RM-54 RM-55 RM-56 RM-57 RM-58 RM-59 RM-60 RM-61 RM-62 RM-63 RM-64 RM-65 RM-66 RM-67 RM-68 RM-69 RM-70 RM-71 RM-72 RM-73 RM-74 RM-75 RM-76 RM-77 RM-78 RM-79 RM-80 RM-81 RM-82 RM-83 RM-84 RM-85 RM-86 RM-87 RM-88 RM-89 RM-90 RM-91 RM-92 RM-93 RM-94 RM-95 RM-96 RM-97 RM-98 RM-99 RM-100 RM-101 RM-102 In a preferred embodiment, the mixture of the present invention contains one or more polymerizable compounds, preferably selected from the group consisting of polymerizable compounds of formulas RM-1 to RM-102. This type of media is particularly suitable for PS-FFS and PS-IPS applications. Among the reactive mesogens shown in Table D, compounds RM-1, RM-2, RM-3, RM-4, RM-5, RM-9, RM-17, RM-42, RM-48 , RM-68, RM-87, RM-91, RM-98, RM-99 and RM-101 are particularly preferred. Furthermore, reactive mesogens or polymerizable compounds of formula M and formulas RM-1 to RM-102 are suitable as stabilizers. In this case, the polymerizable compound is not polymerized but is added to the liquid crystal medium at a concentration of >1%.Example: The following examples are intended to explain the invention without limiting it. In the examples, m.p. represents the melting point of the liquid crystal substance (Celsius) and C represents the clearing point of the liquid crystal substance (Celsius); the boiling temperature is represented by b.p. also: C represents the crystalline solid state, S represents the smectic phase (the index represents the phase type), N represents the nematic state, Ch represents the cholesterol phase, I represents the isotropic phase, and Tg Represents the glass transition temperature. The number between the two symbols indicates the conversion temperature in degrees Celsius. The host mixture used for the determination of the optical anisotropy Δn of the compounds of formula I is the commercial mixture ZLI-4792 (Merck KGaA). The dielectric anisotropy Δε was measured using a commercial mixture ZLI-2857. Physical data on the compounds under investigation are obtained from the change in the dielectric constant of the bulk mixture after addition of the compounds under investigation and extrapolated to 100% of the compounds used. Generally, 10% of the compound under study is dissolved in the bulk mixture, depending on solubility. Unless otherwise indicated, part or percentage information represents parts by weight or percentage by weight. In the text above and below, the symbols and abbreviations have the following meanings: V0 Threshold voltage at 20℃, capacitance [V] Δn Optical anisotropy measured at 20℃ and 589 nm, Δε Dielectric anisotropy at 20℃ and 1 kHz, cl.p. Clear point [℃] K1 Elastic constant, "fan-like" deformation at 20°C [pN] K3 Elastic constant, "bending" deformation at 20°C [pN] γ1 Rotational viscosity [mPa·s] measured at 20°C, measured by rotation in a magnetic field LTS Low temperature stability (nematic phase) determined in test cells. The display used to measure the threshold voltage has two plane-parallel outer plates separated by 20 µm and an electrode layer, with an alignment layer containing SE-1211 (Nissan Chemicals) on top of the inner plate, which implements the liquid crystal The vertical alignment. Unless expressly indicated otherwise, all concentrations in this application relate to the corresponding mixture or mixture components. Unless otherwise expressly indicated, all physical properties are determined in accordance with "Merck Liquid Crystals, Physical Properties of Liquid Crystals", November 1997, Merck KGaA, Germany, and apply at a temperature of 20°C.Mixture examples Example M1 CY-3-O2 16.50% Clear point [℃]: 74.0 CCY-4-O2 10.50% Δn [589 nm, 20°C]: 0.1069 CCY-5-O2 6.00% Δε [1 kHz, 20℃]: -3.2 CPY-2-O2 9.00% ε [1 kHz, 20℃]: 3.5 CPY-3-O2 9.00% K 1 [pN, 20°C]: 12.9 CCH-34 9.00% K 3 [pN, 20°C]: 13.7 CCH-13 20.00% γ 1 [mPa·s, 20℃]: 117 CCP-3-1 2.00% V 0 [20℃, V]: 2.18 PYP-2-3 6.50% PYP-2-4 6.50% PCH-301 5.00% Example M2 CY-3-O2 16.50% Clear point [℃]: 74.5 CCY-4-O2 9.50% Δn [589 nm, 20℃]: 0.1070 CCY-5-O2 4.00% Δε [1 kHz, 20℃]: -3.2 CPY-2-O2 9.00% ε [1 kHz, 20℃]: 3.5 CPY-3-O2 9.00% K 1 [pN, 20°C]: 13.1 CCH-34 9.00% K 3 [pN, 20°C]: 13.9 CCH-13 20.00% γ 1 [mPa·s, 20℃]: 117 CCP-3-1 5.00% V 0 [20℃, V]: 2.19 PYP-2-3 4.00% PYP-2-4 4.00% PCH-301 5.00% PGIY-2-O4 5.00% Example M3 CY-3-O2 16.00% Clear point [℃]: 75.0 CCY-3-O1 4.50% Δn [589 nm, 20°C]: 0.1081 CCY-3-O2 10.00% Δε [1 kHz, 20°C]: -3.4 CPY-2-O2 8.00% ε [1 kHz, 20℃]: 3.5 CPY-3-O2 10.50% K 1 [pN, 20°C]: 13.3 CCH-23 9.00% K 3 [pN, 20°C]: 14.6 CCH-13 20.00% γ 1 [mPa·s, 20℃]: 118 CCP-3-1 6.00% V 0 [20℃, V]: 2.20 PYP-2-3 4.00% PYP-2-4 4.00% PCH-301 3.00% PGIY-2-O4 5.00% Example M4 CY-3-O2 17.00% Clear point [℃]: 75.5 CCY-3-O2 11.50% Δn [589 nm, 20℃]: 0.1082 CPY-2-O2 8.00% Δε [1 kHz, 20°C]: -3.3 CPY-3-O2 11.50% ε [1 kHz, 20℃]: 3.5 CCH-23 20.00% K 1 [pN, 20°C]: 13.2 CCH-13 10.00% K 3 [pN, 20°C]: 14.5 CCP-3-1 6.00% γ 1 [mPa·s, 20℃]: 115 PYP-2-3 4.00% V 0 [20℃, V]: 2.21 PYP-2-4 4.00% PCH-301 3.00% PGIY-2-O4 5.00% Example M5 BCH-32 4.25% Clear point [℃]: 75.1 CC-3-V1 10.00% Δn [589 nm, 20°C]: 0.0975 CCH-13 12.00% Δε [1 kHz, 20℃]: -3.6 CCH-35 3.75% ε [1 kHz, 20℃]: 3.5 CCP-3-1 10.00% K 1 [pN, 20°C]: 14.4 CCY-3-O1 5.00% K 3 [pN, 20°C]: 16.5 CCY-3-O2 3.25% γ 1 [mPa·s, 20℃]: 127 CPY-2-O2 7.00% V 0 [20℃, V]: 2.26 CPY-3-O2 11.75% CY-3-O2 15.50% CY-3-O4 3.50% CY-5-O2 14.00% Example M6 BCH-32 2.50% Clear point [℃]: 75.7 CCH-13 16.75% Δn [589 nm, 20°C]: 0.0974 CCH-34 4.50% Δε [1 kHz, 20℃]: -3.5 CCH-35 7.25% ε [1 kHz, 20℃]: 3.5 CCP-3-1 10.00% K 1 [pN, 20°C]: 14.7 CCY-3-O1 11.50% K 3 [pN, 20°C]: 16.1 CCY-3-O2 9.75% γ 1 [mPa·s, 20℃]: 123 CPY-3-O2 9.25% V 0 [20℃, V]: 2.28 CY-3-O2 15.00% PY-3-O2 13.50% Example M7 CC-3-V1 10.00% Clear point [℃]: 75.1 CCH-13 14.50% Δn [589 nm, 20°C]: 0.0979 CCH-34 4.00% Δε [1 kHz, 20℃]: -3.5 CCH-35 7.00% ε [1 kHz, 20℃]: 3.5 CCP-3-1 3.50% K 1 [pN, 20°C]: 14.7 CCY-3-O1 12.00% K 3 [pN, 20°C]: 16.0 CCY-3-O2 7.00% γ 1 [mPa·s, 20℃]: 122 CPY-2-O2 4.25% V 0 [20℃, V]: 2.24 CPY-3-O2 12.50% CY-3-O4 12.75% PY-3-O2 12.50% Example M8 To prepare the PS-VA mixture, 99.7% of the mixture of Example M1 is mixed with 0.3% of the polymerizable compound of the formula.Example M9 To prepare the PS-VA mixture, 99.75% of the mixture of Example M1 is mixed with 0.25% of the polymerizable compound of the formula.Example M10 To prepare the PS-VA mixture, 99.8% of the mixture of Example M1 was mixed with 0.2% of the polymerizable compound of the formula.Example M11 To prepare the PS-VA mixture, 99.75% of the mixture of Example M1 is mixed with 0.25% of the polymerizable compound of the formula.Example M12 To prepare the PS-VA mixture, 99.75% of the mixture of Example M1 is mixed with 0.25% of the polymerizable compound of the formula.Example M13 To prepare the PS-VA mixture, 99.75% of the mixture of Example M1 is mixed with 0.25% of the polymerizable compound of the formula.Example M14 To prepare the PS-VA mixture, 99.8% of the mixture of Example M1 was mixed with 0.2% of the polymerizable compound of the formula.Example M15 To prepare the PS-VA mixture, 99.8% of the mixture of Example M1 is mixed with 0.2% of the polymerizable compound of the formula.Example M16 To prepare the PS-VA mixture, 99.75% of the mixture of Example M2 is mixed with 0.25% of the polymerizable compound of the formula.Example M17 To prepare the PS-VA mixture, 99.7% of the mixture of Example M2 was mixed with 0.3% of the polymerizable compound of the formula.Example M18 To prepare the PS-VA mixture, 99.7% of the mixture of Example M2 was mixed with 0.3% of the polymerizable compound of the formula .Example M19 To prepare the PS-VA mixture, 99.75% of the mixture of Example M2 is mixed with 0.25% of the polymerizable compound of the formula.Example M20 To prepare the PS-VA mixture, 99.7% of the mixture of Example M2 was mixed with 0.3% of the polymerizable compound of the formula.Example M21 To prepare the PS-VA mixture, 99.75% of the mixture of Example M2 is mixed with 0.25% of the polymerizable compound of the formula.Example M22 To prepare the PS-VA mixture, 99.7% of the mixture of Example M2 was mixed with 0.3% of the polymerizable compound of the formula.Example M23 To prepare the PS-VA mixture, 99.75% of the mixture of Example M2 is mixed with 0.25% of the polymerizable compound of the formula.Example M24 To prepare the PS-VA mixture, 99.75% of the mixture of Example M3 was mixed with 0.25% of the polymerizable compound of the formula.Example M25 To prepare the PS-VA mixture, 99.8% of the mixture of Example M3 was mixed with 0.2% of the polymerizable compound of the formula.Example M26 To prepare the PS-VA mixture, 99.7% of the mixture of Example M3 was mixed with 0.3% of the polymerizable compound of the formula.Example M27 To prepare the PS-VA mixture, 99.7% of the mixture of Example M3 was mixed with 0.3% of the polymerizable compound of the formula.Example M28 To prepare the PS-VA mixture, 99.7% of the mixture of Example M3 was mixed with 0.3% of the polymerizable compound of the formula.Example M29 To prepare the PS-VA mixture, 99.7% of the mixture of Example M3 was mixed with 0.3% of the polymerizable compound of the formula.Example M30 To prepare the PS-VA mixture, 99.7% of the mixture of Example M4 was mixed with 0.3% of the polymerizable compound of the formula.Example M31 To prepare the PS-VA mixture, 99.75% of the mixture of Example M4 was mixed with 0.25% of the polymerizable compound of the formula.Example M32 To prepare the PS-VA mixture, 99.75% of the mixture of Example M4 was mixed with 0.25% of the polymerizable compound of the formula.Example M33 To prepare the PS-VA mixture, 99.7% of the mixture of Example M4 was mixed with 0.3% of the polymerizable compound of the formula Example M34 To prepare the PS-VA mixture, 99.75% of the mixture of Example M4 was mixed with 0.25% of the polymerizable compound of the formula.Example M35 To prepare the PS-VA mixture, 99.75% of the mixture of Example M4 was mixed with 0.25% of the polymerizable compound of the formula.Example M36 To prepare the PS-VA mixture, 99.7% of the mixture of Example M5 was mixed with 0.3% of the polymerizable compound of the formula.Example M37 To prepare the PS-VA mixture, 99.75% of the mixture of Example M5 is mixed with 0.25% of the polymerizable compound of the formula Example M38 To prepare the PS-VA mixture, 99.8% of the mixture of Example M5 was mixed with 0.2% of the polymerizable compound of the formula.Example M39 To prepare the PS-VA mixture, 99.75% of the mixture of Example M5 is mixed with 0.25% of the polymerizable compound of the formula.Example M40 To prepare the PS-VA mixture, 99.75% of the mixture of Example M5 is mixed with 0.25% of the polymerizable compound of the formula.Example M41 To prepare the PS-VA mixture, 99.75% of the mixture of Example M5 is mixed with 0.25% of the polymerizable compound of the formula.Example M42 To prepare the PS-VA mixture, 99.75% of the mixture of Example M5 was mixed with 0.25% of the polymerizable compound of the formula.Example M43 To prepare the PS-VA mixture, 99.75% of the mixture of Example M6 was mixed with 0.25% of the polymerizable compound of the formula.Example M44 To prepare the PS-VA mixture, 99.7% of the mixture of Example M6 was mixed with 0.3% of the polymerizable compound of the formula.Example M45 To prepare the PS-VA mixture, 99.75% of the mixture of Example M6 was mixed with 0.25% of the polymerizable compound of the formula.Example M46 To prepare the PS-VA mixture, 99.75% of the mixture of Example M7 was mixed with 0.25% of the polymerizable compound of the formula.Example M47 To prepare the PS-VA mixture, 99.7% of the mixture of Example M7 was mixed with 0.3% of the polymerizable compound of the formula.Example M48 To prepare the PS-VA mixture, 99.75% of the mixture of Example M7 was mixed with 0.25% of the polymerizable compound of the formula.Example M49 To prepare the PS-VA mixture, 99.75% of the mixture of Example M7 was mixed with 0.25% of the polymerizable compound of the formula.Example M50 CC-3-V 15.00% Clear point [℃]: 74 CC-3-V1 9.00% Δn [589 nm, 20℃]: 0.1085 CCH-23 8.00% Δε [1 kHz, 20℃]: -3.3 CCH-13 6.00% ε [1 kHz, 20℃]: 3.5 CCY-3-O2 12.00% ε [1 kHz, 20℃]: 6.8 CCY-5-O2 8.00% K 1 [pN, 20°C]: 14.1 CPY-2-O2 3.00% K 3 [pN, 20°C]: 15.8 CPY-3-O2 9.50% γ 1 [mPa·s, 20℃]: 102 CY-3-O2 7.50% V 0 [20℃, V]: 2.31 PY-3-O2 14.00% PYP-2-3 8.00% Example M51 CY-3-O2 16.50% Clear point [℃]: 74.5 CCY-3-O2 11.50% Δn [589 nm, 20°C]: 0.1079 CPY-2-O2 3.00% Δε [1 kHz, 20℃]: -3.5 CPY-3-O2 11.00% ε [1 kHz, 20℃]: 3.6 CCH-34 10.00% ε [1 kHz, 20℃]: 7.1 CCH-13 20.00% K 1 [pN, 20°C]: 13.9 CCP-3-1 9.00% K 3 [pN, 20°C]: 15.2 PYP-2-3 7.00% γ 1 [mPa·s, 20℃]: 115 PCH-301 3.00% V 0 [20℃, V]: 2.20 PGIY-2-04 5.00% B-2O-O5 4.00% Example M52 To prepare the PS-VA mixture, 99.75% of the mixture of Example M51 is mixed with 0.25% of the polymerizable compound of the formula.Example M53 CY-3-O2 18.00% Clear point [℃]: 75 CCY-3-O2 10.50% Δn [589 nm, 20°C]: 0.1076 CPY-2-O2 1.50% Δε [1 kHz, 20℃]: -3.5 CPY-3-O2 11.00% ε [1 kHz, 20℃]: 3.6 CCH-23 20.00% ε [1 kHz, 20℃]: 7.0 CCH-13 8.00% K 1 [pN, 20°C]: 13.7 CCP-3-1 12.00% K 3 [pN, 20°C]: 15.1 PYP-2-3 7.00% γ 1 [mPa·s, 20℃]: 113 PCH-301 3.00% V 0 [20℃, V]: 2.21 PGIY-2-04 5.00% LTS [overall-20℃]: > 1000 h B-2O-O5 4.00% Example M54 CY-3-O2 15.00% Clear point [℃]: 74.5 CY-5-O2 5.00% Δn [589 nm, 20℃]: 0.1071 CCP-3-1 1.00% Δε [1 kHz, 20℃]: -2.9 CCY-3-O2 11.00% ε [1 kHz, 20℃]: 3.5 CPY-2-O2 5.50% ε [1 kHz, 20℃]: 6.4 CPY-3-O2 11.00% K 1 [pN, 20°C]: 14.0 CC-5-V 19.00% K 3 [pN, 20°C]: 15.6 CC-3-V1 8.50% γ 1 [mPa·s, 20℃]: 103 CCH-13 11.00% V 0 [20℃, V]: 2.41 PYP-2-3 12.50% PPGU-3-F 0.50% Example M55 To prepare the PS-VA mixture, 99.75% of the mixture of Example M54 was mixed with 0.25% of the polymerizable compound of the formula.Example M56 CC-5-V 15.00% Clear point [℃]: 74.5 CC-3-V1 9.00% Δn [589 nm, 20°C]: 0.1087 CCH-13 8.00% Δε [1 kHz, 20℃]: -2.9 CCH-34 7.50% ε [1 kHz, 20℃]: 3.5 CCY-3-O2 10.00% ε [1 kHz, 20℃]: 6.7 CCY-5-O2 8.00% K 1 [pN, 20°C]: 14.9 CPY-2-O2 3.00% K 3 [pN, 20°C]: 15.6 CPY-3-O2 8.50% γ 1 [mPa·s, 20℃]: 105 CY-3-O2 7.00% V 0 [20℃, V]: 2.33 PY-3-O2 16.00% PYP-2-3 8.00% Example M57 CC-5-V 20.00% Clear point [℃]: 75 CCH-13 14.50% Δn [589 nm, 20°C]: 0.1078 CC-3-V1 8.00% Δε [1 kHz, 20℃]: -2.9 CCP-3-1 2.00% ε [1 kHz, 20℃]: 3.4 CCY-3-01 6.00% ε [1 kHz, 20℃]: 6.3 CCY-3-O2 10.00% K 1 [pN, 20°C]: 15.0 CPY-2-O2 5.50% K 3 [pN, 20°C]: 15.6 CPY-3-O2 11.50% γ 1 [mPa·s, 20℃]: 98 PY-3-O2 17.50% V 0 [20℃, V]: 2.45 PYP-2-3 5.00% LTS [overall-20℃]: > 1000 h Example M58 CC-3-V1 9.00% Clear point [℃]: 74.5 CCH-13 18.00% Δn [589 nm, 20°C]: 0.0987 CCH-34 9.00% Δε [1 kHz, 20℃]: -3.5 CCP-3-1 5.50% ε [1 kHz, 20℃]: 3.5 CCY-3-O1 3.50% ε [1 kHz, 20℃]: 6.9 CCY-3-O2 11.50% K 1 [pN, 20°C]: 14.5 CPY-2-O2 9.00% K 3 [pN, 20°C]: 16.1 CPY-3-O2 11.00% γ 1 [mPa·s, 20℃]: 107 CY-3-O2 13.50% V 0 [20℃, V]: 2.28 PY-3-O2 10.00% Example M59 To prepare the PS-VA mixture, 99.7% of the mixture of Example M58 was mixed with 0.3% of the polymerizable compound of the formula.Example M60 CC-3-V 25.50% Clear point [℃]: 66.5 CCH-13 12.00% Δn [589 nm, 20°C]: 0.0879 PY-3-O2 9.00% Δε [1 kHz, 20℃]: -3.6 CEY-3-O2 9.00% K 1 [pN, 20°C]: 12.1 PY-5-O2 5.00% K 3 [pN, 20°C]: 14.5 CCP-31 5.00% γ 1 [mPa·s, 20℃]: 92 CCY-V-O1 5.00% V 0 [20℃, V]: 2.13 CCY-V-O2 11.00% CCP-301 2.00% CCP-33 2.00% CAIY-3-O2 7.00% CCY-V-O4 7.50% Example M61 To prepare the PS-VA mixture, 99.75% of the mixture of Example M60 is mixed with 0.25% of the polymerizable compound of the formula.Example M62 CC-5-V 20.00% Clear point [℃]: 74.5 CCH-13 14.50% Δn [589 nm, 20°C]: 0.1083 CC-3-V1 8.00% Δε [1 kHz, 20℃]: -3.0 CCP-3-1 2.00% ε [1 kHz, 20℃]: 3.4 CCY-3-O1 4.00% ε [1 kHz, 20℃]: 6.4 CCY-3-O2 11.00% K 1 [pN, 20°C]: 15.6 CPY-2-O2 7.50% K 3 [pN, 20°C]: 15.9 CPY-3-O2 11.50% γ 1 [mPa·s, 20℃]: 97 PY-3-O2 12.00% V 0 [20℃, V]: 2.44 PYP-2-3 1.00% B-20-05 4.00% PP-1-2V1 4.50% Example M63 CC-5-V 20.00% Clear point [℃]: 74.5 CC-3-V1 8.00% Δn [589 nm, 20°C]: 0.1083 CCH-13 10.00% Δε [1 kHz, 20℃]: -3.1 CCH-34 4.00% ε [1 kHz, 20℃]: 3.5 CCY-3-O2 11.50% ε [1 kHz, 20℃]: 6.6 CCY-5-O2 3.00% K 1 [pN, 20°C]: 14.9 CPY-2-O2 7.50% K 3 [pN, 20°C]: 15.4 CPY-3-O2 11.00% γ 1 [mPa·s, 20℃]: 102 CY-3-O2 3.50% V 0 [20℃, V]: 2.35 PY-3-O2 16.50% PYP-2-3 5.00% Example M64 CC-5-V 20.00% Clear point [℃]: 74.5 CCH-13 14.50% Δn [589 nm, 20℃]: 0.1080 CC-3-V1 8.00% Δε [1 kHz, 20℃]: -3.2 CCY-3-O1 4.00% ε [1 kHz, 20℃]: 3.5 CCY-3-O2 11.00% ε [1 kHz, 20℃]: 6.6 CPY-2-O2 3.50% K 1 [pN, 20°C]: 15.8 CPY-3-O2 11.50% K 3 [pN, 20°C]: 16.3 CLY-3-O2 5.00% γ 1 [mPa·s, 20℃]: 99 PY-3-O2 13.00% V 0 [20℃, V]: 2.39 PYP-2-3 1.00% B-2O-O5 4.00% PP-1-2V1 4.50% Example M65 To prepare the PS-VA mixture, 99.7% of the mixture of Example M62 was mixed with 0.3% of the polymerizable compound of the formula.Example M66 CC-5-V 20.00% Clear point [℃]: 75 CCH-13 14.50% Δn [589 nm, 20°C]: 0.1083 CC-3-V1 8.00% Δε [1 kHz, 20℃]: -3.1 CCY-3-O1 4.00% ε [1 kHz, 20℃]: 3.5 CCY-3-O2 11.00% ε [1 kHz, 20℃]: 6.6 CPY-2-O2 3.50% K 1 [pN, 20°C]: 15.8 CPY-3-O2 11.50% K 3 [pN, 20°C]: 16.1 CLY-3-O2 5.00% γ 1 [mPa·s, 20℃]: 98 PY-3-O2 13.00% V 0 [20℃, V]: 2.41 PYP-2-3 1.00% B-2O-O5 4.00% PP-1-2V1 4.50% Example M67 CC-4-V 16.00% Clear point [℃]: 75 CCH-13 12.00% Δn [589 nm, 20℃]: 0.1080 CC-3-V1 8.00% Δε [1 kHz, 20℃]: -3.1 CCP-3-1 12.50% ε [1 kHz, 20℃]: 3.5 CCY-3-O1 3.50% ε [1 kHz, 20℃]: 6.7 CCY-3-O2 11.00% K 1 [pN, 20°C]: 15.0 CPY-3-O2 10.50% K 3 [pN, 20°C]: 15.8 PY-3-O2 20.00% γ 1 [mPa·s, 20℃]: 98 PYP-2-3 2.50% V 0 [20℃, V]: 2.37 B-2O-O5 4.00% Example M68 CC-3-V 20.00% Clear point [℃]: 72.5 CC-3-V1 8.00% Δn [589 nm, 20°C]: 0.1078 CCH-13 7.50% Δε [1 kHz, 20℃]: -3.0 CCP-3-1 14.50% ε [1 kHz, 20℃]: 3.5 CCP-3-3 5.00% ε [1 kHz, 20℃]: 6.5 CCY-3-O2 10.00% K 1 [pN, 20°C]: 15.0 CY-3-O2 4.00% K 3 [pN, 20°C]: 15.8 PY-3-O2 16.00% γ 1 [mPa·s, 20℃]: 83 PYP-2-3 5.00% V 0 [20℃, V]: 2.44 B-2O-O5 3.00% B(S)-2O-O5 3.00% B(S)-2O-O4 2.00% B(S)-2O-O6 2.00% Example M69 To prepare the PS-VA mixture, 99.7% of the mixture of Example M68 was mixed with 0.3% of the polymerizable compound of the formula.Example M70 CC-3-V1 10.00% Clear point [℃]: 74.6 CCH-13 16.00% Δn [589 nm, 20°C]: 0.0985 CCH-34 6.00% Δε [1 kHz, 20°C]: -3.4 CCH-35 2.50% ε [1 kHz, 20℃]: 3.5 CCOC-3-3 3.50% ε [1 kHz, 20℃]: 6.9 CCOC-4-3 3.50% K 1 [pN, 20°C]: 14.8 CCP-3-1 1.00% K 3 [pN, 20°C]: 16.2 CCY-3-O2 12.50% γ 1 [mPa·s, 20℃]: 120 CPY-2-O2 6.50% V 0 [20℃, V]: 2.29 CPY-3-O2 13.00% CY-3-O2 11.50% PY-3-O2 14.00% Example M71 To prepare a polymer-stabilized LC mixture, 99.75% of the mixture of Example M70 was mixed with 0.25% of the polymerizable compound of the formula.Example M72 To prepare a polymer-stabilized LC mixture, 99.7% of the mixture of Example M70 was mixed with 0.3% of the polymerizable compound of the formula.Example M73 To prepare a polymer-stable LC mixture, 99.7% of a mixture of Example M70 and 0.3% of a polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed. The mixture of Example M73 is preferably suitable for PS-VA applications, especially 2D and 3D TV applications. The above mixture examples for PS-VA applications are of course also applicable to PS-IPS and PS-FFS applications. To improve reliability, the mixtures of examples M1 to M69 can be additionally stabilized with one or two stabilizers selected from the group of compounds a) to h) below: a) b) c) d) e) f) g) h), Stabilizer is added in each case in an amount of 0.01 to 0.04%, based on the mixture.Example M74 CCY-3-O2 4.50% Clear point [℃]: 74.5 CPY-3-O2 11.00% Δn [589 nm, 20°C]: 0.1284 PYP-2-3 9.50% Δε [1 kHz, 20℃]: -2.0 PY-3-O2 15.00% ε [1 kHz, 20℃]: 3.4 Y-4O-O4 4.00% ε [1 kHz, 20℃]: 5.4 CCH-23 15.00% K 1 [pN, 20°C]: 14.7 CCH-13 8.00% K 3 [pN, 20°C]: 14.5 CCP-3-1 11.00% γ 1 [mPa·s, 20℃]: 95 CCP-3-3 2.00% V 0 [20℃, V]: 2.81 BCH-32 15.00% LTS [Overall -20℃] > 1000 h PP-1-3 5.00% Example M75 CC-3-V1 8.50% Clear point [℃]: 74.5 CCH-13 7.50% Δn [589 nm, 20°C]: 0.0998 CCH-23 16.50% Δε [1 kHz, 20°C]: -3.4 CCP-3-1 16.00% ε [1 kHz, 20℃]: 7.0 CCY-3-O2 11.00% K 1 [pN, 20°C]: 14.7 CCY-3-O1 6.00% K 3 [pN, 20°C]: 16.0 CPY-3-O2 11.50% γ 1 [mPa·s, 20℃]: 98 B-2O-O5 3.00% V 0 [20℃, V]: 2.30 Y-4O-O4 5.00% PY-2-O2 8.00% PY-1-O2 7.00% Example M76 CC-3-V1 4.00% Clear point [℃]: 73.5 CCH-23 14.00% Δn [589 nm, 20℃]: 0.0977 CCH-34 3.00% Δε [1 kHz, 20℃]: -3.5 CCH-35 4.00% ε [1 kHz, 20℃]: 3.6 CCH-13 4.00% ε [1 kHz, 20℃]: 7.1 CCP-3-1 14.00% K 1 [pN, 20°C]: 14.6 CCY-3-O2 11.00% K 3 [pN, 20°C]: 16.1 CCY-3-O1 5.50% γ 1 [mPa·s, 20℃]: 107 CPY-3-O2 11.00% V 0 [20℃, V]: 2.26 CY-3-O2 12.00% PY-3-O2 14.50% Y-4O-O4 3.00% Example M77 BCH-32 4.25% Clear point [℃]: 75.1 CC-3-V1 10.00% Δn [589 nm, 20°C]: 0.0975 CCH-13 12.00% Δε [1 kHz, 20℃]: -3.6 CCH-35 3.75% ε [1 kHz, 20℃]: 3.5 CCP-3-1 10.00% ε [1 kHz, 20℃]: 7.1 CCY-3-O1 5.00% K 1 [pN, 20°C]: 14.4 CCY-3-O2 3.25% K 3 [pN, 20°C]: 16.5 CPY-2-O2 7.00% γ 1 [mPa·s, 20℃]: CPY-3-O2 11.75% V 0 [20℃, V]: 2.26 CY-3-O2 15.50% CY-3-O4 3.50% CY-5-O2 14.00% Example M78 BCH-32 6.50% Clear point [℃]: 75.1 CC-3-V1 1.00% Δn [589 nm, 20°C]: 0.0888 CCH-13 20.50% Δε [1 kHz, 20℃]: -3.0 CCH-301 3.00% ε [1 kHz, 20℃]: 3.4 CCH-34 6.00% ε [1 kHz, 20℃]: 6.4 CCH-35 6.00% K 1 [pN, 20°C]: 13.4 CCY-3-O2 5.00% K 3 [pN, 20°C]: 13.6 CCY-3-O2 10.00% V 0 [20℃, V]: 2.22 CCY-4-O2 5.00% CPY-2-O2 9.00% CPY-3-O2 7.50% CY-3-O2 12.00% CY-5-O2 8.50% Example M79 BCH-52 1.50% Clear point [℃]: 74.8 CC-3-V 15.50% Δn [589 nm, 20℃]: 0.0980 CC-3-V1 10.00% Δε [1 kHz, 20°C]: -3.4 CCH-13 4.50% ε [1 kHz, 20℃]: 3.5 CCH-34 5.00% ε [1 kHz, 20℃]: 6.9 CCH-35 5.00% K 1 [pN, 20°C]: 14.7 CCY-3-O1 10.00% K 3 [pN, 20°C]: 15.4 CCY-3-O2 14.00% γ 1 [mPa·s, 20℃]: 101 CCY-4-O2 8.50% V 0 [20℃, V]: 2.27 PY-1-O4 8.00% PY-3-O2 17.00% PYP-3-O2 1.50% Example M80 To prepare the PS-VA mixture, 99.75% of the mixture of Example M60 is mixed with 0.25% of the polymerizable compound of the formula.Example M81 BCH-32 2.00% Clear point [℃]: 74.8 CC-3-V 16.00% Δn [589 nm, 20℃]: 0.0980 CC-3-V1 9.50% Δε [1 kHz, 20°C]: -3.3 CCH-13 2.00% ε [1 kHz, 20℃]: 3.5 CCH-301 3.00% ε [1 kHz, 20℃]: 6.8 CCH-34 6.00% K 1 [pN, 20°C]: 14.4 CCH-35 4.00% K 3 [pN, 20°C]: 15.0 CCY-3-O1 10.00% γ 1 [mPa·s, 20℃]: 99 CCY-3-O2 13.50% V 0 [20℃, V]: 2.28 CCY-4-O2 8.00% PY-1-O4 7.50% PY-3-O2 17.00% PYP-2-3 1.50% Example M82 BCH-52 2.00% Clear point [℃]: 75.1 CC-3-V 16.00% Δn [589 nm, 20℃]: 0.0980 CC-3-V1 9.50% Δε [1 kHz, 20°C]: -3.3 CCH-13 2.00% ε [1 kHz, 20℃]: 3.5 CCH-34 3.00% ε [1 kHz, 20℃]: 6.8 CCH-35 6.00% K 1 [pN, 20°C]: 14.8 CCY-3-O1 4.00% K 3 [pN, 20°C]: 15.5 CCY-3-O2 10.00% γ 1 [mPa·s, 20℃]: 103 CCY-3-O3 13.50% V 0 [20℃, V]: 2.29 CCY-4-O2 8.00% PY-1-O4 7.50% PY-3-O2 17.00% PYP-2-3 1.50% Example M83 CC-3-V1 10.00% Clear point [℃]: 74.6 CCH-13 16.00% Δn [589 nm, 20°C]: 0.0985 CCH-34 6.00% Δε [1 kHz, 20°C]: -3.4 CCH-35 2.50% ε [1 kHz, 20℃]: 3.5 CCOC-3-3 3.50% ε [1 kHz, 20℃]: 6.9 CCOC-4-3 3.50% K 1 [pN, 20°C]: 14.8 CCP-3-1 1.00% K 3 [pN, 20°C]: 16.2 CCY-3-O2 12.50% V 0 [20℃, V]: 2.29 CPY-2-O2 6.50% CPY-3-O2 13.00% CY-3-O2 11.50% PY-3-O2 14.00% Example M84 BCH-52 1.00% Clear point [℃]: 74.9 CC-3-V 15.00% Δn [589 nm, 20℃]: 0.0980 CC-3-V1 10.00% Δε [1 kHz, 20°C]: -3.4 CCH-13 4.50% ε [1 kHz, 20℃]: 7.0 CCH-34 5.00% K 1 [pN, 20°C]: 14.8 CCH-35 5.00% K 3 [pN, 20°C]: 15.5 CCY-3-O1 8.50% γ 1 [mPa·s, 20℃]: 104 CCY-3-O2 14.50% V 0 [20℃, V]: 2.25 CCY-3-O3 1.00% CCY-4-O2 9.00% PY-1-O4 8.50% PY-3-O2 17.00% PYP-2-3 1.00% Example M85 B-2O-O5 4.50% Clear point [℃]: 74.8 BCH-32 2.50% Δn [589 nm, 20℃]: 0.0989 CC-3-V1 13.00% Δε [1 kHz, 20°C]: -3.4 CCH-13 13.00% ε [1 kHz, 20℃]: 6.9 CCH-34 6.00% K 1 [pN, 20°C]: 15.7 CCH-35 3.00% K 3 [pN, 20°C]: 15.8 CCP-V2-1 2.50% γ 1 [mPa·s, 20℃]: 105 CCY-3-O1 5.00% V 0 [20℃, V]: 2.29 CCY-3-O2 8.00% CCY-3-O3 3.00% CCY-4-O2 12.00% PY-1-O4 5.50% PY-3-O2 15.00% PYP-2-3 1.00% Example M86 B-2O-O5 4.00% Clear point [℃]: 75 BCH-32 6.50% Δn [589 nm, 20°C]: 0.1028 CC-3-V 22.50% Δε [1 kHz, 20°C]: -3.3 CC-3-V1 9.00% ε [1 kHz, 20℃]: 3.6 CCH-13 7.50% ε [1 kHz, 20℃]: 6.9 CCY-3-O1 7.00% K 1 [pN, 20°C]: 14.4 CCY-3-O2 12.50% K 3 [pN, 20°C]: 15.0 CCY-4-O2 10.00% γ 1 [mPa·s, 20℃]: 97 PY-1-O4 3.00% V 0 [20℃, V]: 2.27 PY-3-O2 16.00% PYP-2-3 2.00% Example M87 B-2O-O5 4.50% Clear point [℃]: 74.5 BCH-32 2.50% Δn [589 nm, 20°C]: 0.0978 CC-3-V1 18.50% Δε [1 kHz, 20°C]: -3.4 CCH-13 13.00% ε [1 kHz, 20℃]: 3.5 CCH-34 6.00% ε [1 kHz, 20℃]: 6.9 CCH-35 4.00% K 1 [pN, 20°C]: 15.6 CCP-V2-1 2.50% K 3 [pN, 20°C]: 15.8 CCY-3-O1 6.00% γ 1 [mPa·s, 20℃]: 106 CCY-3-O2 8.00% V 0 [20℃, V]: 2.29 CCY-3-O3 4.50% CCY-4-O2 9.50% PY-1-O4 5.50% PY-3-O2 15.0% PYP-2-3 0.50% Example M88 To prepare the PS-VA mixture, 99.7% of the mixture of Example M87 was mixed with 0.3% of the polymerizable compound of the formula.Example M89 B-2O-O5 4.00% Clear point [℃]: 74.6 BCH-52 1.00% Δn [589 nm, 20°C]: 0.0985 CC-3-V 15.00% Δε [1 kHz, 20℃]: -3.5 CC-3-V1 10.00% ε [1 kHz, 20℃]: 3.6 CCH-13 4.00% ε [1 kHz, 20℃]: 7.1 CCH-34 6.00% K 1 [pN, 20°C]: 14.7 CCH-35 7.50% K 3 [pN, 20°C]: 15.3 CCY-3-O1 9.50% γ 1 [mPa·s, 20℃]: 100 CCY-3-O2 14.50% V 0 [20℃, V]: 2.22 CCY-4-O2 5.50% PY-1-O4 5.00% PY-3-O2 16.00% PYP-2-3 2.0% Example M90 To prepare the PS-VA mixture, 99.75% of the mixture of Example M89 is mixed with 0.25% of the polymerizable compound of the formula.Example M91 To prepare the PS-VA mixture, 99.75% of the mixture of Example M89 is mixed with 0.25% of the polymerizable compound of the formula.Example M92 B-2O-O5 4.00% Clear point [℃]: 85.2 CC-3-V 31.50% Δn [589 nm, 20℃]: 0.0976 CCH-13 6.00% Δε [1 kHz, 20℃]: -3.5 CCH-34 6.00% ε [1 kHz, 20℃]: 3.5 CCY-3-O1 5.50% ε [1 kHz, 20℃]: 6.9 CCY-3-O2 3.00% K 1 [pN, 20°C]: 14.7 CCY-4-O2 4.00% K 3 [pN, 20°C]: 15.1 CLY-2-O4 6.00% γ 1 [mPa·s, 20℃]: 100 CLY-3-O2 4.00% V 0 [20℃, V]: 2.21 CPY-2-O2 10.00% CPY-3-O2 10.00% CY-3-O2 7.00% PGIY-2-O4 16.00% Example M93 To prepare the PS-VA mixture, 99.7% of the mixture of Example M6 was mixed with 0.3% of the polymerizable compound of the formula.Example M94 CC-3-V 20.50% Clear point [℃]: 74.8 CC-3-V1 10.00% Δn [589 nm, 20°C]: 0.1024 CCH-13 10.50% Δε [1 kHz, 20℃]: -3.2 CCY-3-O1 7.00% ε [1 kHz, 20℃]: 3.5 CCY-3-O2 13.00% ε [1 kHz, 20℃]: 6.7 CCY-4-O2 4.50% K 1 [pN, 20°C]: 13.7 CPY-2-O2 5.00% K 3 [pN, 20°C]: 15.4 CPY-3-O2 8.00% γ 1 [mPa·s, 20℃]: 97 PY-3-O2 16.00% V 0 [20℃, V]: 2.31 PY-4-O2 3.50% PYP-2-3 2.00% Example M95 CC-3-V 20.50% Clear point [℃]: 74.5 CC-3-V1 10.00% Δn [589 nm, 20℃]: 0.1018 CCH-13 10.50% Δε [1 kHz, 20℃]: -3.2 CCY-3-O1 7.00% ε [1 kHz, 20℃]: 3.6 CCY-3-O2 13.00% ε [1 kHz, 20℃]: 6.8 CCY-4-O2 4.50% K 1 [pN, 20°C]: 14.0 CPY-2-O2 5.00% K 3 [pN, 20°C]: 14.8 CPY-3-O2 8.00% γ 1 [mPa·s, 20℃]: 95 PY-3-O2 16.00% V 0 [20℃, V]: 2.26 PY-4-O2 3.50% PYP-2-3 2.00% Example M96 The mixture of Example M95 additionally contained 0.001% of a compound of the formula.Example M97 BCH-32 0.50% Clear point [℃]: 74.6 CC-3-V 22.50% Δn [589 nm, 20℃]: 0.1032 CC-3-V1 9.00% Δε [1 kHz, 20℃]: -3.2 CCH-13 1.50% ε [1 kHz, 20℃]: 3.5 CCH-34 5.50% ε [1 kHz, 20℃]: 6.7 CCH-35 4.00% K 1 [pN, 20°C]: 14.2 CCY-3-O1 8.50% K 3 [pN, 20°C]: 14.8 CCY-3-O2 12.00% γ 1 [mPa·s, 20℃]: 95 CPY-2-O2 12.00% V 0 [20℃, V]: 2.28 CPY-3-O2 2.00% PY-1-O4 3.00% PY-3-O2 17.00% PY-4-O2 1.50% PYP-2-3 1.00% Example M98 The mixture of Example M97 was additionally stabilized with 0.01% of a compound of the formula.Example M99 BCH-52 0.50% Clear point [℃]: 75 CC-3-V 22.50% Δn [589 nm, 20℃]: 0.1030 CC-3-V1 9.00% Δε [1 kHz, 20℃]: -3.2 CCH-13 1.00% ε [1 kHz, 20℃]: 3.5 CCH-34 5.50% ε [1 kHz, 20℃]: 6.8 CCH-35 4.00% K 1 [pN, 20°C]: 14.2 CCY-3-O1 9.50% K 3 [pN, 20°C]: 15.0 CCY-3-O2 12.50% γ 1 [mPa·s, 20℃]: 95 CPY-2-O2 10.00% V 0 [20℃, V]: 2.29 CPY-3-O2 2.00% CY-3-O2 0.50% PY-1-O4 4.50% PY-3-O2 17.00% PYP-2-3 1.50% Example M100 To prepare the PS-VA mixture, 99.7% of the mixture of Example M99 was mixed with 0.3% of the polymerizable compound of the formula.Example M101 To prepare the PS-VA mixture, 99.7% of the mixture of Example M77 was mixed with 0.3% of the polymerizable compound of the formula.Example M102 CC-3-V 22.50% Clear point [℃]: 74.8 CC-3-V1 9.75% Δn [589 nm, 20℃]: 0.1027 CCH-13 0.75% Δε [1 kHz, 20℃]: -3.2 CCH-34 5.50% ε [1 kHz, 20℃]: 3.5 CCH-35 4.00% ε [1 kHz, 20℃]: 6.8 CCY-3-O1 10.00% K 1 [pN, 20°C]: 14.4 CCY-3-O2 12.00% K 3 [pN, 20°C]: 15.2 CPY-2-O2 10.00% γ 1 [mPa·s, 20℃]: 94 CPY-3-O2 2.00% V 0 [20℃, V]: 2.29 CY-3-O2 0.50% PP-1-2V1 0.25% PY-1-O4 4.25% PY-3-O2 17.00% PYP-2-3 1.50% Example M103 To prepare the PS-VA mixture, 99.7% of the mixture of Example M102 was mixed with 0.3% of the polymerizable compound of the formula.Example M104 CC-3-V 0.50% Clear point [℃]: 75 CC-3-V1 22.50% Δn [589 nm, 20°C]: 0.1023 CCH-13 9.75% Δε [1 kHz, 20℃]: -3.2 CCH-34 0.50% ε [1 kHz, 20℃]: 3.5 CCH-35 5.75% ε [1 kHz, 20℃]: 6.7 CCY-3-O1 4.00% K 1 [pN, 20°C]: 14.4 CCY-3-O2 10.00% K 3 [pN, 20°C]: 15.8 CPY-2-O2 11.50% γ 1 [mPa·s, 20℃]: 95 CPY-3-O2 10.00% V 0 [20℃, V]: 2.29 CY-3-O2 2.50% PP-1-2V1 0.50% PY-1-O4 4.40% PY-3-O2 17.00% PYP-2-3 1.00% Example M105 To prepare the PS-VA mixture, 99.7% of the mixture of Example M102 and 0.3% of the polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M106 To prepare the PS-VA mixture, 99.7% of the mixture of Example M7 was mixed with 0.3% of the polymerizable compound of the formula.Example M107 CC-3-V 22.50% Clear point [℃]: 74.8 CC-3-V1 9.75% Δn [589 nm, 20°C]: 0.1031 CCH-13 0.50% Δε [1 kHz, 20℃]: -3.2 CCH-34 5.75% ε [1 kHz, 20℃]: 3.5 CCH-35 4.00% ε [1 kHz, 20℃]: 6.8 CCY-3-O1 10.00% K 1 [pN, 20°C]: 14.4 CCY-3-O2 11.00% K 3 [pN, 20°C]: 15.0 CPY-2-O2 10.00% γ 1 [mPa·s, 20℃]: 95 CPY-3-O2 3.00% V 0 [20℃, V]: 2.28 PY-1-O4 5.50% PY-3-O2 16.50% PYP-2-3 1.50% Example M108 BCH-52 0.75% Clear point [℃]: 74.5 CC-3-V 22.50% Δn [589 nm, 20℃]: 0.1030 CC-3-V1 10.00% Δε [1 kHz, 20℃]: -3.2 CCH-13 0.50% ε [1 kHz, 20℃]: 3.6 CCH-34 5.75% ε [1 kHz, 20℃]: 6.7 CCH-35 3.50% K 1 [pN, 20°C]: 14.2 CCY-3-O1 9.50% K 3 [pN, 20°C]: 14.9 CCY-3-O2 11.50% γ 1 [mPa·s, 20℃]: 95 CPY-2-O2 10.00% V 0 [20℃, V]: 2.28 CPY-3-O2 2.50% PY-1-O4 5.50% PY-3-O2 17.00% PYP-2-3 1.00% Example M109 The mixture of Example M108 additionally contained 0.001% of a compound of the formula.Example M110 To prepare the PS-VA mixture, 99.7% of the mixture of Example M109 was mixed with 0.3% of the polymerizable compound of the formula.Example M111 To prepare the PS-VA mixture, 99.75% of the mixture of Example M108 was mixed with 0.25% of the polymerizable compound of the formula.Example M112 CC-3-V 22.50% Clear point [℃]: 74.8 CC-3-V1 8.00% Δn [589 nm, 20°C]: 0.1031 CCH-13 1.00% Δε [1 kHz, 20℃]: -3.2 CCH-34 6.00% ε [1 kHz, 20℃]: 3.5 CCH-35 5.25% ε [1 kHz, 20℃]: 6.8 CCY-3-O1 6.00% K 1 [pN, 20°C]: 14.5 CCY-3-O2 13.25% K 3 [pN, 20°C]: 15.0 CPY-2-O2 11.00% γ 1 [mPa·s, 20℃]: 96 CPY-3-O2 4.00% V 0 [20℃, V]: 2.28 CY-3-O2 1.00% PY-1-O4 4.00% PY-3-O2 17.00% PYP-2-3 1.00% Example M113 CC-3-V 22.50% Clear point [℃]: 74.5 CC-3-V1 10.50% Δn [589 nm, 20℃]: 0.1030 CCH-13 1.50% Δε [1 kHz, 20℃]: -3.2 CCH-34 6.00% ε [1 kHz, 20℃]: 3.5 CCH-35 3.00% ε [1 kHz, 20℃]: 6.7 CCY-3-O1 7.00% K 1 [pN, 20°C]: 14.2 CCY-3-O2 9.50% K 3 [pN, 20°C]: 16.0 CPY-2-O2 12.50% γ 1 [mPa·s, 20℃]: 94 CPY-3-O2 5.50% V 0 [20℃, V]: 2.30 CY-3-O2 2.50% PY-1-O4 6.00% PY-3-O2 12.50% PYP-2-3 1.00% Example M114 To prepare the PS-VA mixture, 99.75% of the mixture of Example M113 was mixed with 0.25% of the polymerizable compound of the formula.Example M115 To prepare a polymer-stable LC mixture, 99.7% of a mixture of Example M70 and 0.3% of a polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M116 To prepare the PS-VA mixture, 99.75% of the mixture of Example M113 was mixed with 0.25% of the polymerizable compound of the formula.Example M117 BCH-32 3.50% Clear point [℃]: 75.1 CC-3-V1 10.00% Δn [589 nm, 20°C]: 0.1122 CCH-13 15.50% Δε [1 kHz, 20°C]: -3.4 CCH-34 6.00% ε [1 kHz, 20℃]: 3.6 CCOC-3-3 3.50% ε [1 kHz, 20℃]: 7.0 CCOC-3-4 3.50% K 1 [pN, 20°C]: 15.0 CCY-3-O2 11.75% K 3 [pN, 20°C]: 15.6 CPY-2-O2 10.00% V 0 [20℃, V]: 2.26 CPY-3-O2 11.00% PY-1-O4 8.75% PY-3-O2 14.00% PY-4-O2 2.50% Example M118 To prepare the PS-VA mixture, 99.7% of the mixture of Example M117 was mixed with 0.3% of the polymerizable compound of the formula.Example M119 To prepare the PS-VA mixture, 99.7% of the mixture of Example M117 was mixed with 0.3% of the polymerizable compound of the formula.Example M120 BCH-32 7.00% Clear point [℃]: 74 CC-3-V1 10.00% Δn [589 nm, 20°C]: 0.1118 CCH-13 15.00% Δε [1 kHz, 20°C]: -3.4 CCH-34 3.25% ε [1 kHz, 20℃]: 3.6 CCOC-3-3 3.50% ε [1 kHz, 20℃]: 7.0 CCOC-4-3 3.50% K 1 [pN, 20°C]: 14.7 CCY-3-O2 12.50% K 3 [pN, 20°C]: 15.8 CPY-2-O2 4.50% V 0 [20℃, V]: 2.27 CPY-3-O2 12.00% CY-3-O4 5.25% PY-1-O4 9.50% PY-3-O2 14.00% Example M121 To prepare the PS-VA mixture, 99.75% of the mixture of Example M120 is mixed with 0.25% of the polymerizable compound of the formula.Example M122 BCH-32 5.00% Clear point [℃]: 74 CCH-13 17.00% Δn [589 nm, 20℃]: 0.1355 CCH-34 6.50% Δε [1 kHz, 20℃]: -3.1 CCH-35 6.00% ε [1 kHz, 20℃]: 3.7 CCY-3-O2 7.00% ε [1 kHz, 20℃]: 6.6 CPY-2-O2 10.00% K 1 [pN, 20°C]: 14.1 CPY-3-O2 10.00% K 3 [pN, 20°C]: 13.8 PY-1-O4 8.00% V 0 [20℃, V]: 2.24 PY-3-O2 11.00% PYP-2-3 10.00% PYP-2-4 9.50% Example M123 To prepare the PS-VA mixture, 99.7% of the mixture of Example M122 was mixed with 0.3% of the polymerizable compound of the formula.Example M124 To prepare the PS-VA mixture, 99.7% of the mixture of Example M122 was mixed with 0.3% of the polymerizable compound of the formula.Example M125 CC-3-V 15.00% CC-3-V1 9.00% CCH-23 8.00% CCH-13 6.00% CCOY-3-O2 12.00% CCY-5-O2 8.00% CPY-2-O2 3.00% CPY-3-O2 9.50% CY-3-O2 7.50% PY-3-O2 14.00% PYP-2-3 8.00% Example M126 To prepare the PS-VA mixture, 99.7% of the mixture of Example M125 was mixed with 0.3% of the polymerizable compound of the formula.Example M127 BCH-32 5.00% Clear point [℃]: 74.2 CCH-13 17.00% Δn [589 nm, 20°C]: 0.1349 CCH-34 7.00% Δε [1 kHz, 20℃]: -2.8 CCH-35 5.00% ε [1 kHz, 20℃]: 3.5 CCP-3-1 6.50% ε [1 kHz, 20℃]: 6.2 CPY-2-O2 11.00% K 1 [pN, 20°C]: 14.2 CPY-3-O2 11.00% K 3 [pN, 20°C]: 13.8 PY-1-O4 7.50% V 0 [20℃, V]: 2.40 PY-3-O2 12.00% PYP-2-3 9.00% PYP-2-4 9.00% Example M128 To prepare a polymer-stable LC mixture, 99.7% of a mixture of Example M127 and 0.3% of a polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M129 To prepare the PS-VA mixture, 99.7% of the mixture of Example M127 was mixed with 0.3% of the polymerizable compound of the formula.Example M130 BCH-32 8.00% Clear point [℃]: 74.3 BCH-52 2.50% Δn [589 nm, 20°C]: 0.1116 CC-3-V1 10.00% Δε [1 kHz, 20°C]: -3.4 CCH-13 15.50% ε [1 kHz, 20℃]: 3.6 CCOC-3-3 3.50% ε [1 kHz, 20℃]: 7.0 CCOC-4-3 3.50% K 1 [pN, 20°C]: 14.1 CCY-3-O2 6.75% K 3 [pN, 20°C]: 15.4 CPY-2-O2 10.00% V 0 [20℃, V]: 2.26 CPY-3-O2 11.00% CY-3-O2 14.00% CY-3-O4 1.25% PY-3-O2 14.00% Example M131 To prepare a polymer-stabilized LC mixture, 99.99% of the mixture of Example M130 was mixed with 0.01% of the polymerizable compound of the formula:.Example M132 BCH-32 6.00% Clear point [℃]: 74.8 CC-3-V1 10.00% CCH-13 15.50% CCH-34 6.00% CCY-3-O1 5.50% CCOY-3-O2 10.00% CPY-2-O2 10.00% CPY-3-O2 11.00% CY-3-O4 9.00% PP-1-2V1 2.00% PY-3-O2 15.00% Example M133 BCH-32 6.50% Clear point [℃]: 75.5 CC-3-V1 9.00% Δn [589 nm, 20℃]: 0.1120 CCH-13 15.00% Δε [1 kHz, 20℃]: -3.5 CCOC-3-3 3.50% ε [1 kHz, 20℃]: 3.6 CCOC-4-3 3.50% K 1 [pN, 20°C]: 14.4 CCY-3-O1 2.50% K 3 [pN, 20°C]: 15.9 CCY-3-O2 9.00% V 0 [20℃, V]: 2.24 CPY-2-O2 11.00% CPY-3-O2 11.00% CY-3-O2 14.50% PP-1-3 3.50% PY-3-O2 11.00% Example M134 BCH-32 4.50% Clear point [℃]: 74.5 BCH-52 3.25% Δn [589 nm, 20°C]: 0.1123 CC-3-V1 10.00% Δε [1 kHz, 20°C]: -3.4 CCH-13 14.25% ε [1 kHz, 20℃]: 3.6 CCOC-3-3 3.50% ε [1 kHz, 20℃]: 7.0 CCOC-4-3 3.50% K 1 [pN, 20°C]: 14.2 CCY-3-O1 2.50% K 3 [pN, 20°C]: 15.6 CCY-3-O2 7.50% V 0 [20℃, V]: 2.26 CPY-2-O2 10.00% CPY-3-O2 11.00% CY-3-O2 14.75% PP-1-3 3.25% PY-3-O2 12.00% Example M135 To prepare the PS-VA mixture, 99.7% of the mixture of Example M134 was mixed with 0.3% of the polymerizable compound of the formula.Example M136 B-2O-O5 4.00% Clear point [℃]: 85.5 CC-3-V 32.00% CCH-13 6.00% CCH-34 5.00% CCY-3-O1 7.00% CCOY-3-O2 4.00% CCOY-4-O2 1.50% CLY-2-O4 5.50% CLY-3-O2 4.00% CPY-2-O2 10.00% CPY-3-O2 10.00% CY-3-O2 7.00% PGIY-2-O4 4.00% Example M137 To prepare the PS-VA mixture, 99.7% of the mixture of Example M136 was mixed with 0.3% of the polymerizable compound of the formula.Example M138 To prepare the PS-VA mixture, 99.75% of the mixture of Example M136 was mixed with 0.25% of the polymerizable compound of the formula.Example M139 To prepare the PS-VA mixture, 99.7% of the mixture of Example M136 was mixed with 0.3% of the polymerizable compound of the formula.Example M140 BCH-32 4.50% Clear point [℃]: 74.2 BCH-52 2.50% Δn [589 nm, 20°C]: 0.1121 CC-3-V1 10.00% Δε [1 kHz, 20°C]: -3.4 CCH-13 13.75% ε [1 kHz, 20℃]: 3.7 CCOC-3-3 3.50% ε [1 kHz, 20℃]: 7.1 CCOC-4-3 3.50% K 1 [pN, 20°C]: 14.3 CCY-3-O1 2.50% K 3 [pN, 20°C]: 15.7 CCY-3-O2 7.50% V 0 [20℃, V]: 2.26 CPY-2-O2 10.00% CPY-3-O2 11.00% CY-3-O2 15.50% PP-1-3 3.25% PY-3-O2 12.00% PPGU-3-F 0.50% Example M141 The mixture of Example M140 additionally contained 0.03%.Example M142 B-2O-O5 4.00% Clear point [℃]: 85.1 CC-3-V 32.00% Δn [589 nm, 20°C]: 0.0998 CCH-13 6.00% Δε [1 kHz, 20℃]: -3.5 CCH-34 5.00% ε [1 kHz, 20℃]: 3.5 CCY-3-O1 7.00% ε [1 kHz, 20℃]: 7.0 CCY-3-O2 4.00% K 1 [pN, 20°C]: 14.8 CCY-4-O2 1.50% K 3 [pN, 20°C]: 15.2 CLY-2-O4 5.50% V 0 [20℃, V]: 2.20 CLY-3-O2 4.00% CPY-2-O2 10.00% CPY-3-O2 10.00% CY-3-O2 7.00% PGIY-2-O4 4.00% Example M143 CC-3-V 22.50% Clear point [℃]: 74.7 CC-3-V1 10.50% Δn [589 nm, 20°C]: 0.0984 CCH-13 1.00% Δε [1 kHz, 20℃]: -3.1 CCH-34 6.50% ε [1 kHz, 20℃]: 3.7 CCY-3-O1 7.00% ε [1 kHz, 20℃]: 6.6 CCY-3-O2 13.00% K 1 [pN, 20°C]: 14.0 CPY-2-O2 2.00% K 3 [pN, 20°C]: 13.7 CPY-3-O2 10.50% γ 1 [mPa·s, 20℃]: 98 CY-3-O2 12.00% V 0 [20℃, V]: 2.24 PCH-301 0.50% PY-3-O2 11.50% PYP-2-4 3.00% Example M144 B-2O-O5 4.00% Clear point [℃]: 84.9 BCH-32 4.50% Δn [589 nm, 20℃]: 0.1066 CC-3-V 29.00% Δε [1 kHz, 20℃]: -4.0 CCH-13 6.00% ε [1 kHz, 20℃]: 3.6 CCY-3-O1 6.00% ε [1 kHz, 20℃]: 7.6 CCY-4-O2 5.50% K 1 [pN, 20°C]: 15.3 CLY-2-O4 6.00% K 3 [pN, 20°C]: 15.6 CLY-3-O2 3.00% V 0 [20℃, V]: 2.09 CPY-2-O2 10.00% CPY-3-O2 10.00% CY-3-O2 6.00% CY-5-O2 6.00% PGIY-2-O4 4.00% Example M145 To prepare the PS-VA mixture, 99.7% of the mixture of Example M144 was mixed with 0.3% of the polymerizable compound of the formula.Example M146 To prepare the PS-VA mixture, 99.7% of the mixture of Example M144 was mixed with 0.3% of the polymerizable compound of the formula.Example M147 CC-3-V1 10.00% Clear point [℃]: 75.5 CCH-13 16.50% Δn [589 nm, 20℃]: 0.1110 CCP-3-1 6.50% Δε [1 kHz, 20°C]: -3.7 CCY-3-O1 9.00% ε [1 kHz, 20℃]: 3.6 CCY-3-O2 9.50% CPY-2-O2 10.00% CPY-3-O2 10.00% CY-3-O4 10.50% PP-1-2V1 3.50% PY-V2-O2 14.50% Example M148 To prepare the PS-VA mixture, 99.7% of the mixture of Example M147 was mixed with 0.3% of the polymerizable compound of the formula.Example M149 B-2O-O5 5.00% Clear point [℃]: 74.5 BCH-52 8.00% Δn [589 nm, 20°C]: 0.1033 CC-3-V 22.50% Δε [1 kHz, 20℃]: -3.0 CCH-13 9.40% ε [1 kHz, 20℃]: 3.6 CCH-34 5.50% ε [1 kHz, 20℃]: 6.6 CCY-3-O1 8.20% K 1 [pN, 20°C]: 13.4 CCY-3-O2 8.80% K 3 [pN, 20°C]: 13.5 CCY-3-O2 11.60% γ 1 [mPa·s, 20℃]: 96 PP-1-2V1 2.00% V 0 [20℃, V]: 2.26 PY-3-O2 15.00% PY-4-O2 1.00% PYP-2-3 3.00% Example M150 To prepare the PS-VA mixture, 99.7% of the mixture of Example M149 was mixed with 0.3% of the polymerizable compound of the formula.Example M151 B-2O-O5 5.00% Clear point [℃]: 74.5 BCH-52 7.25% Δn [589 nm, 20°C]: 0.1033 CC-3-V 22.50% Δε [1 kHz, 20℃]: -3.1 CCH-13 5.75% ε [1 kHz, 20℃]: 3.5 CCH-301 1.00% ε [1 kHz, 20℃]: 6.6 CCH-34 5.50% K 1 [pN, 20°C]: 14.4 CCH-35 3.50% K 3 [pN, 20°C]: 13.9 CCY-3-O1 8.00% γ 1 [mPa·s, 20℃]: 95 CCY-3-O2 10.00% V 0 [20℃, V]: 2.26 CCY-4-O2 9.50% PP-1-2V1 2.50% PY-3-O2 11.00% PY-4-O2 5.50% PYP-2-3 3.00% Example M152 B-2O-O5 4.00% Clear point [℃]: 84.9 BCH-52 4.50% Δn [589 nm, 20℃]: 0.1066 CC-3-V 28.50% Δε [1 kHz, 20℃]: -4.1 CCH-13 5.00% ε [1 kHz, 20℃]: 3.6 CCY-3-O1 6.00% ε [1 kHz, 20℃]: 7.7 CCY-4-O2 5.50% K 1 [pN, 20°C]: 14.9 CLY-2-O4 6.50% K 3 [pN, 20°C]: 15.4 CLY-3-O2 3.00% V 0 [20℃, V]: 2.05 CPY-2-O2 10.00% CPY-3-O2 10.00% CY-3-O2 6.50% CY-5-O2 7.00% PGIY-2-O4 3.50% Example M153 To prepare the PS-FFS mixture, 99.7% of the mixture of Example M152 and 0.3% of the polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M154 CC-3-V1 10.00% Clear point [℃]: 75.1 CCH-13 16.50% Δn [589 nm, 20℃]: 0.1109 CCP-3-1 6.50% Δε [1 kHz, 20℃]: -3.8 CCY-3-O1 9.00% ε [1 kHz, 20℃]: 3.6 CCY-3-O2 9.50% ε [1 kHz, 20℃]: 7.4 CPY-2-O2 10.00% K 1 [pN, 20°C]: 14.7 CPY-3-O2 10.00% K 3 [pN, 20°C]: 16.7 CY-3-O4 10.50% V 0 [20℃, V]: 2.21 PP-1-2V1 3.50% PY-3-O2 14.50% Example M155 The mixture of Example M152 additionally contained 0.04% of a compound of the formula And 0.02% of the compound of the following formula.Example M156 BCH-32 5.00% Clear point [℃]: 74.6 CC-3-V1 10.00% Δn [589 nm, 20℃]: 0.1110 CCH-13 16.00% Δε [1 kHz, 20℃]: -3.6 CCH-34 6.00% ε [1 kHz, 20℃]: 3.6 CCY-3-O1 6.50% ε [1 kHz, 20℃]: 7.2 CCY-3-O2 10.00% K 1 [pN, 20°C]: 14.4 CPY-2-O2 10.00% K 3 [pN, 20°C]: 15.8 CPY-3-O2 11.00% V 0 [20℃, V]: 2.21 CY-3-O2 9.00% PP-1-2V1 1.50% PY-3-O2 15.00% Example M157 The mixture of Example M156 additionally contained 0.03% of a compound of the formula.Example M158 To prepare the PS-VA mixture, 99.7% of the mixture of Example M156 was mixed with 0.3% of the polymerizable compound of the formula.Example M159 CC-3-V1 8.50% Clear point [℃]: 74 CCH-13 15.50% Δn [589 nm, 20℃]: 0.1052 CCH-34 7.00% Δε [1 kHz, 20℃]: -2.8 CCP-3-1 13.50% ε [1 kHz, 20℃]: 3.3 CCY-3-O1 3.50% ε [1 kHz, 20℃]: 6.2 CCY-3-O2 10.00% K 1 [pN, 20°C]: 15.7 CPY-3-O2 12.00% K 3 [pN, 20°C]: 17.9 CY-3-O2 10.00% V 0 [20℃, V]: 2.66 PP-1-2V1 5.50% PY-3-O2 14.50% Example M160 BCH-32 6.00% Clear point [℃]: 74.6 CC-3-V1 10.00% Δn [589 nm, 20°C]: 0.1117 CCH-13 15.50% Δε [1 kHz, 20℃]: -3.5 CCH-34 6.00% ε [1 kHz, 20℃]: 3.5 CCY-3-O1 5.50% ε [1 kHz, 20℃]: 7.0 CCY-3-O2 10.00% K 1 [pN, 20°C]: 14.7 CPY-2-O2 10.00% K 3 [pN, 20°C]: 15.7 CPY-3-O2 11.00% V 0 [20℃, V]: 2.23 CY-3-O4 9.00% PP-1-2V1 2.00% PY-3-O2 15.00% Example M161 The mixture of Example M160 additionally contained 0.03% of a compound of the formula.Example M162 To prepare a polymer-stabilized LC mixture, 99.7% of a mixture of Example M160 and 0.3% of a polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M163 BCH-32 6.00% Clear point [℃]: 74.6 CC-3-V1 10.00% Δn [589 nm, 20°C]: 0.1117 CCH-13 15.50% Δε [1 kHz, 20°C]: -3.4 CCH-34 6.00% ε [1 kHz, 20℃]: 3.5 CCY-3-O1 5.50% ε [1 kHz, 20℃]: 6.9 CCY-3-O2 10.00% K 1 [pN, 20°C]: 14.7 CPY-2-O2 10.00% K 3 [pN, 20°C]: 15.8 CPY-3-O2 11.00% V 0 [20℃, V]: 2.27 CY-3-O4 9.00% PP-1-2V1 3.00% PY-3-O2 14.00% Example M164 To prepare a polymer-stabilized LC mixture, 99.7% of a mixture of Example M163 and 0.3% of a polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M165 The mixture of Example M163 additionally contained 0.03% of a compound of the formula.Example M166 B-2O-O5 4.00% Clear point [℃]: 85.2 CC-3-V 31.50% Δn [589 nm, 20℃]: 0.0976 CCH-13 6.00% Δε [1 kHz, 20℃]: -3.5 CCH-34 6.00% ε [1 kHz, 20℃]: 3.5 CCY-3-O1 5.50% ε [1 kHz, 20℃]: 6.9 CCY-3-O2 3.00% K 1 [pN, 20°C]: 14.7 CCY-4-O2 4.00% K 3 [pN, 20°C]: 15.1 CLY-2-O4 6.00% V 0 [20℃, V]: 2.21 CLY-3-O2 4.00% CPY-2-O2 10.00% CPY-3-O2 10.00% CY-3-O2 7.00% PGIY-2-O4 3.00% Example M167 To prepare the PS-VA mixture, 99.7% of the mixture of Example M166 was mixed with 0.3% of the polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M168 B-2O-O5 4.00% Clear point [℃]: 85.3 CC-3-V 31.50% CCH-13 6.00% CCH-34 6.00% CCY-3-O1 5.50% CCOY-3-O2 3.00% CCOY-4-O2 4.00% CLY-2-O4 6.00% CLY-3-O2 4.00% CPY-2-O2 10.00% CPY-3-O2 10.00% CY-3-O2 7.00% PGIY-2-O4 3.00% Example M169 To prepare a polymer-stabilized LC mixture, 99.99% of the mixture of Example M168 was mixed with 0.01% of the polymerizable compound of the formula:.Example M169 To prepare the PS-VA mixture, 99.7% of the mixture of Example M168 and 0.3% of the polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M170 BCH-32 3.00% Clear point [℃]: 110.4 CCH-13 16.50% Δn [589 nm, 20°C]: 0.0981 CCH-34 4.50% Δε [1 kHz, 20°C]: -3.7 CCH-35 6.00% ε [1 kHz, 20℃]: 3.3 CCP-3-1 5.50% ε [1 kHz, 20℃]: 7.0 CCY-3-1 4.00% K 1 [pN, 20°C]: 19.7 CCY-3-O1 11.00% K 3 [pN, 20°C]: 20.5 CCY-3-O2 13.00% γ 1 [mPa·s, 20℃]: 212 CCY-4-O2 11.00% V 0 [20℃, V]: 2.48 CPY-2-O2 5.50% CPY-3-O2 11.50% CY-3-O2 8.00% CY-5-O2 0.50% Example M171 BCH-32 3.00% Clear point [℃]: 110.3 CCH-13 16.50% Δn [589 nm, 20°C]: 0.0983 CCH-34 4.50% Δε [1 kHz, 20°C]: -3.7 CCH-35 6.00% ε [1 kHz, 20℃]: 3.3 CCP-3-1 5.50% ε [1 kHz, 20℃]: 7.0 CCY-3-1 4.00% K 1 [pN, 20°C]: 19.6 CCY-3-O1 11.00% K 3 [pN, 20°C]: 20.5 CCY-3-O2 11.50% γ 1 [mPa·s, 20℃]: 213 CCY-4-O2 11.00% V 0 [20℃, V]: 2.49 CCY-5-O2 1.50% CPY-2-O2 5.50% CPY-3-O2 11.50% CY-3-O2 8.50% Example M172 To prepare a polymer-stabilized LC mixture, 99.9% of the mixture of Example M171 was mixed with 0.1% of the polymerizable compound of the formula.Example M173 BCH-32 3.00% Clear point [℃]: 110.1 CCH-13 14.25% Δn [589 nm, 20℃]: 0.0980 CCH-34 5.00% Δε [1 kHz, 20°C]: -3.7 CCH-35 6.50% ε [1 kHz, 20℃]: 3.3 CCP-3-1 4.50% ε [1 kHz, 20℃]: 7.0 CCY-3-1 6.50% K 1 [pN, 20°C]: 19.2 CCY-3-O1 9.00% K 3 [pN, 20°C]: 20.3 CCY-3-O2 14.50% γ 1 [mPa·s, 20℃]: CCY-4-O2 10.00% V 0 [20℃, V]: 2.48 CPY-2-O2 92.75% CPY-3-O2 14.00% CY-3-O4 9.50% Example M174 BCH-32 5.50% Clear point [℃]: 75.1 CC-3-V1 8.50% Δn [589 nm, 20°C]: 0.984 CCH-13 19.00% Δε [1 kHz, 20°C]: -3.3 CCH-301 4.00% ε [1 kHz, 20℃]: 3.5 CCH-34 5.50% ε [1 kHz, 20℃]: 6.8 CCY-3-O1 9.00% K 1 [pN, 20°C]: 14.1 CCY-3-O2 9.00% K 3 [pN, 20°C]: 15.1 CPY-2-O2 10.00% γ 1 [mPa·s, 20℃]: CPY-3-O2 10.00% V 0 [20℃, V]: 2.25 CY-3-O2 13.00% PY-3-O2 6.50% Example M175 B-2O-O5 4.00% Clear point [℃]: 74.1 BCH-32 8.00% Δn [589 nm, 20°C]: 0.1084 CC-3-V1 9.00% Δε [1 kHz, 20℃]: -3.2 CCH-13 5.00% ε [1 kHz, 20℃]: 3.6 CCH-34 8.00% ε [1 kHz, 20℃]: 6.8 CCH-35 8.00% K 1 [pN, 20°C]: 14.6 CCP-3-1 8.00% K 3 [pN, 20°C]: 16.0 CCY-3-O2 4.50% γ 1 [mPa·s, 20℃]: CLY-3-O2 10.00% V 0 [20℃, V]: 2.35 CY-3-O2 14.00% PCH-301 5.00% PGIY-2-O4 5.00% PY-3-O2 11.50% Example M176 B-2O-O5 4.00% Clear point [℃]: 74.5 BCH-32 8.00% Δn [589 nm, 20℃]: 0.1090 CC-3-V1 9.00% Δε [1 kHz, 20℃]: -3.1 CCH-13 10.00% ε [1 kHz, 20℃]: 3.5 CCH-34 8.00% ε [1 kHz, 20℃]: 6.6 CCH-35 4.00% K 1 [pN, 20°C]: 14.7 CCP-3-1 8.00% K 3 [pN, 20°C]: 16.5 CCY-3-O2 11.00% γ 1 [mPa·s, 20℃]: CCY-4-O2 3.00% V 0 [20℃, V]: 2.43 CPY-3-O2 7.00% CY-3-O2 6.00% PCH-301 4.00% PY-3-O2 18.00% Example M177 B-2O-O5 4.00% Clear point [℃]: 74.5 BCH-32 8.00% Δn [589 nm, 20°C]: 0.1089 CC-3-V1 9.00% Δε [1 kHz, 20℃]: -3.1 CCH-13 6.00% ε [1 kHz, 20℃]: 3.5 CCH-34 8.00% ε [1 kHz, 20℃]: 6.6 CCH-35 7.00% K 1 [pN, 20°C]: 14.7 CCP-3-1 8.00% K 3 [pN, 20°C]: 16.6 CCY-3-O2 11.00% γ 1 [mPa·s, 20℃]: CCY-4-O2 2.50% V 0 [20℃, V]: 2.42 CPY-3-O2 6.00% CY-3-O2 7.50% PCH-301 5.00% PY-3-O2 18.00% Example M178 B-2O-O5 4.00% Clear point [℃]: 74.3 BCH-32 8.00% Δn [589 nm, 20°C]: 0.1088 CC-3-V1 9.00% Δε [1 kHz, 20℃]: -3.2 CCH-13 10.00% ε [1 kHz, 20℃]: 3.5 CCH-34 8.00% ε [1 kHz, 20℃]: 6.7 CCH-35 4.00% K 1 [pN, 20°C]: 14.9 CCP-3-1 8.00% K 3 [pN, 20°C]: 16.6 CCY-3-O2 11.00% γ 1 [mPa·s, 20℃]: 102 CCY-4-O2 3.00% V 0 [20℃, V]: 2.39 CPY-3-O2 7.00% CY-3-O2 7.50% PCH-301 2.50% PY-3-O2 18.00% Example M179 To prepare a polymer-stabilized LC mixture, 99.7% of a mixture of Example M173 and 0.3% of a polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M180 CC-5-V 20.00% Clear point [℃]: 75.0 CCH-13 14.50% Δn [589 nm, 20°C]: 0.1078 CC-3-V1 8.00% Δε [1 kHz, 20℃]: -2.9 CCP-3-1 2.00% ε [1 kHz, 20℃]: 3.4 CCY-3-O1 6.00% ε [1 kHz, 20℃]: 6.3 CCY-3-O2 10.00% K 1 [pN, 20°C]: 15.0 CPY-2-O2 5.50% K 3 [pN, 20°C]: 15.6 CCY-3-O2 11.50% γ 1 [mPa·s, 20℃]: 98 PY-3-O2 17.50% V 0 [20℃, V]: 2.45 PYP-2-3 5.00% Example M181 CC-3-V1 8.50% Clear point [℃]: 74.5 CCH-13 11.00% Δn [589 nm, 20°C]: 0.0983 CCH-35 7.00% Δε [1 kHz, 20℃]: -3.5 CCH-34 5.00% ε [1 kHz, 20℃]: 3.6 CCP-3-1 13.50% ε [1 kHz, 20℃]: 7.1 CCY-3-O1 6.00% K 1 [pN, 20°C]: 15.5 CCY-3-O2 9.00% K 3 [pN, 20°C]: 16.5 CPY-3-O2 10.50% γ 1 [mPa·s, 20℃]: 101 CY-3-O2 11.50% V 0 [20℃, V]: 2.30 Y-4O-O4 6.00% LTS [overall-20℃]: > 1000 h B(S)-2O-O5 4.00% PP-1-3 5.00% B(S)-2O-O4 3.00% Example M182 CC-VV 10.00% Clear point [℃]: 73.5 CCH-13 10.00% Δn [589 nm, 20℃]: 0.1067 CCP-V-1 10.00% Δε [1 kHz, 20℃]: -2.8 CCY-2-1 10.00% ε [1 kHz, 20℃]: 3.5 CCY-3-1 10.00% ε [1 kHz, 20℃]: 6.2 CCY-3-O1 10.00% K 1 [pN, 20°C]: 12.8 CCY-3-O2 7.00% K 3 [pN, 20°C]: 14.5 CPY-2-O2 10.00% γ 1 [mPa·s, 20℃]: CY-3-O2 4.00% V 0 [20℃, V]: 2.42 PP-1-3 10.00% PY-3-O2 9.00% Example M183 CC-3-V1 11.00% Clear point [℃]: 75 CCH-13 9.00% Δn [589 nm, 20°C]: 0.0983 CC-1-4 8.00% Δε [1 kHz, 20°C]: -3.4 CCH-34 10.00% ε [1 kHz, 20℃]: 3.4 CCP-V-1 5.00% ε [1 kHz, 20℃]: 6.8 CCY-3-O1 1.50% K 1 [pN, 20°C]: 14.8 CCY-3-O2 9.50% K 3 [pN, 20°C]: 15.8 CLY-3-O2 5.00% γ 1 [mPa·s, 20℃]: 104 CLY-3-O3 5.00% V 0 [20℃, V]: 2.29 CPY-3-O2 10.00% CY-3-O2 11.50% PGIY-2-O4 2.50% PY-3-O2 12.00% Example M184 BCH-32 15.00% Clear point [℃]: 75.2 CCH-13 15.00% Δn [589 nm, 20°C]: 0.1101 CCH-23 10.00% Δε [1 kHz, 20℃]: -2.5 CCH-34 5.00% ε [1 kHz, 20℃]: 3.5 CCP-3-1 11.50% ε [1 kHz, 20℃]: 6.0 CLY-3-O2 8.00% K 1 [pN, 20°C]: 14.6 CPY-2-O2 4.50% K 3 [pN, 20°C]: 13.9 CPY-3-O2 10.00% γ 1 [mPa·s, 20℃]: PGIY-2-O4 6.00% V 0 [20℃, V]: 2.39 PY-3-2 5.00% LTS [overall-20℃]: > 1000 h Y-4O-O4 10.00% Example M185 BCH-32 13.00% Clear point [℃]: 71.2 BCH-52 10.00% Δn [589 nm, 20℃]: 0.1092 CCH-13 15.00% Δε [1 kHz, 20℃]: -2.2 CCH-23 9.00% ε [1 kHz, 20℃]: 3.5 CCH-301 7.00% ε [1 kHz, 20℃]: 5.7 CCH-34 5.00% K 1 [pN, 20°C]: 12.8 CLY-3-O2 8.00% K 3 [pN, 20°C]: 11.9 CPY-2-O2 8.00% γ 1 [mPa·s, 20℃]: 104 CPY-3-O2 6.50% V 0 [20℃, V]: 2.47 PGIY-2-O4 6.00% PYP-2-4 2.50% Y-4O-O4 10.00% Example M186 CC-3-V1 10.00% Clear point [℃]: 75.5 CCH-13 11.50% Δn [589 nm, 20°C]: 0.0984 CCH-34 5.50% Δε [1 kHz, 20℃]: -3.5 CCH-35 9.00% ε [1 kHz, 20℃]: 3.5 CCP-3-1 5.50% ε [1 kHz, 20℃]: 7.0 CCY-3-O2 12.50% K 1 [pN, 20°C]: 15.2 CPY-2-O2 8.00% K 3 [pN, 20°C]: 16.9 CPY-3-O2 11.00% γ 1 [mPa·s, 20℃]: 112 CY-3-O2 15.50% V 0 [20℃, V]: 2.31 PGIY-2-O4 2.00% PY-3-O2 9.50% Example M187 To prepare a polymer-stabilized LC mixture, 99.7% of a mixture of Example M186 and 0.3% of a polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M188 BCH-32 2.50% Clear point [℃]: 75 CC-3-V1 8.00% Δn [589 nm, 20°C]: 0.01057 CCH-13 15.00% Δε [1 kHz, 20℃]: -2.8 CCH-34 2.50% ε [1 kHz, 20℃]: 3.3 CCH-35 5.00% ε [1 kHz, 20℃]: 6.2 CCP-3-1 11.00% K 1 [pN, 20°C]: 15.9 CCY-3-O1 6.00% K 3 [pN, 20°C]: 18.2 CCY-3-O2 10.00% γ 1 [mPa·s, 20℃]: 106 CPY-3-O2 10.00% V 0 [20℃, V]: 2.68 CPY-3-O2 10.00% CY-3-O2 12.00% PP-1-2V1 6.00% PY-3-O2 12.00% Example M189 BCH-32 4.50% Clear point [℃]: 75 CC-3-V1 8.50% Δn [589 nm, 20℃]: 0.1055 CCH-13 14.50% Δε [1 kHz, 20℃]: -2.8 CCH-34 3.00% ε [1 kHz, 20℃]: 3.3 CCH-35 4.50% ε [1 kHz, 20℃]: 6.1 CCP-3-1 11.00% K 1 [pN, 20°C]: 15.6 CCY-3-O1 4.50% K 3 [pN, 20°C]: 17.6 CCY-3-O2 10.00% γ 1 [mPa·s, 20℃]: 102 CPY-3-O2 9.00% V 0 [20℃, V]: 2.67 CY-3-O2 12.00% PP-1-2V1 5.00% PY-3-O2 11.00% PY-4-O2 2.00% Example M190 B-2O-O5 5.00% Clear point [℃]: 74.5 BCH-52 8.00% Δn [589 nm, 20°C]: 0.1033 CC-3-V 22.50% Δε [1 kHz, 20℃]: -3.0 CCH-13 9.40% ε [1 kHz, 20℃]: 3.6 CCH-34 5.50% K 1 [pN, 20°C]: 13.4 CCY-3-O1 8.20% K 3 [pN, 20°C]: 13.5 CCY-3-O2 8.80% γ 1 [mPa·s, 20℃]: 96 CCY-4-O2 11.60% V 0 [20℃, V]: 2.26 PP-1-2V1 2.00% PY-3-O2 15.00% PY-4-O2 1.00% PYP-2-3 3.00% Example M191 To prepare a polymer-stabilized LC mixture, 99.7% of a mixture of Example M190 and 0.3% of a polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M192 CC-3-V1 12.50% CCH-13 19.00% CCH-34 6.50% CCY-3-O1 12.00% CCY-3-O2 12.00% CCY-4-O2 9.00% CPY-3-O2 1.00% CY-3-O2 7.00% PY-3-O2 13.00% PYP-2-3 5.50% PYP-2-4 2.50% Example M193 To prepare a polymer-stabilized LC mixture, 99.7% of a mixture of Example M192 and 0.3% of a polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M194 CC-3-V1 11.25% CCH-13 16.00% CCH-301 0.75% CCH-34 6.50% CCH-35 5.00% CCY-3-O1 11.50% CCY-3-O2 13.50% CCY-4-O2 6.25% CPY-3-O2 0.50% CY-3-O2 6.50% PY-3-O2 14.50% PYP-2-3 7.25% PYP-2-4 0.50% Example M195 To prepare a polymer-stable LC mixture, 99.7% of a mixture of Example M194 and 0.3% of a polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M196 To prepare a polymer-stabilized LC mixture, 99.8% of the mixture of Example M194 was mixed with 0.2% of the polymerizable compound of the formula.Example M197 B-2O-O5 5.00% Clear point [℃]: 75 BCH-52 7.25% Δn [589 nm, 20℃]: 0.1034 CC-3-V 22.50% CCH-13 5.75% CCH-301 1.00% CCH-34 5.50% CCH-35 3.50% CCY-3-O1 8.00% CCOY-3-O2 10.00% CCOY-4-O2 9.50% PP-1-2V1 2.50% PY-V2-O2 11.00% PY-4-O2 5.50% PYP-2-3 3.00% Example M198 To prepare a polymer-stabilized LC mixture, 99.7% of a mixture of Example M197 and 0.3% of a polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M199 To prepare a polymer-stabilized LC mixture, 99.8% of the mixture of Example M197 was mixed with 0.2% of the polymerizable compound of the formula.Example M200 The mixture of Example M188 additionally contained 0.03% of a compound of the formula.Example M201 The mixture of Example M188 additionally contained 0.04% of a compound of the formula And 0.02% of the compound of the following formula.Example M202 The mixture of Example M99 additionally contained 0.03% of a compound of the formula.Example M203 The mixture of Example M99 additionally contained 0.04% of a compound of the formula And 0.02% of the compound of the following formula.Example M204 CC-3-V1 9.00% Clear point [℃]: 74.8 CCH-13 18.00% CCH-34 9.00% CCP-3-1 5.50% CCY-3-O1 3.50% CCY-3-O2 11.50% CPY-V-O2 9.00% CPY-3-O2 11.00% CY-3-O2 13.50% PY-3-O2 10.00% Example M205 The mixture of Example M204 additionally contained 0.03% of a compound of the formula.Example M206 CC-3-V1 10.00% Clear point [℃]: 77 CCH-13 11.50% CCH-34 5.50% CCH-35 9.00% CCP-3-1 5.50% CCY-3-O2 12.50% CPY-2-O2 8.00% CPY-3-O2 11.00% CY-3-O2 15.50% CK-3-F 2.00% PY-3-O2 9.50% Example M207 CC-3-V1 12.50% Clear point [℃]: 74.9 CCH-13 19.00% Δn [589 nm, 20℃]: 0.0980 CCH-34 6.50% Δε [1 kHz, 20°C]: -3.3 CCY-3-O1 12.00% ε [1 kHz, 20℃]: 3.4 CCY-3-O2 12.00% K 1 [pN, 20°C]: 14.7 CCY-4-O2 9.00% K 3 [pN, 20°C]: 15.6 CPY-3-O2 1.00% γ 1 [mPa·s, 20℃]: 109 CY-3-O2 7.00% V 0 [20℃, V]: 2.29 PY-3-O2 13.00% PYP-2-3 5.50% PYP-2-4 2.50% Example M208 To prepare the PS-VA mixture, 99.7% of the mixture of Example M207 and 0.3% of the polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M209 CC-3-V1 11.25% Clear point [℃]: 74.7 CCH-13 16.00% Δn [589 nm, 20℃]: 0.0977 CCH-301 0.75% Δε [1 kHz, 20℃]: -3.2 CCH-34 6.50% ε [1 kHz, 20℃]: 3.4 CCH-35 5.00% K 1 [pN, 20°C]: 14.7 CCY-3-O1 11.50% K 3 [pN, 20°C]: 15.6 CCY-3-O2 13.50% γ 1 [mPa·s, 20℃]: 106 CCY-4-O2 6.25% V 0 [20℃, V]: 2.33 CPY-3-O2 0.50% CY-3-O2 6.50% PY-3-O2 14.50% PYP-2-3 7.25% PYP-2-4 0.50% Example M210 To prepare the PS-VA mixture, 99.7% of the mixture of Example M209 and 0.3% of the polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.Example M211 To prepare the PS-VA mixture, 99.7% of the mixture of Example M151 and 0.3% of the polymerizable compound of the formula and 0.001% Irganox-1076 (BASF) mixed.

Claims (23)

一種基於極性化合物之混合物的液晶介質,其特徵在於其包含式I化合物,
Figure 109116296-A0305-02-0163-1
,及至少一個選自式BC、CR、PH-1、PH-2、BF-1、BF-2、BS-1及BS-2之化合物,
Figure 109116296-A0305-02-0163-2
Figure 109116296-A0305-02-0163-3
Figure 109116296-A0305-02-0163-4
Figure 109116296-A0305-02-0163-5
Figure 109116296-A0305-02-0163-6
Figure 109116296-A0305-02-0163-7
Figure 109116296-A0305-02-0163-8
Figure 109116296-A0305-02-0164-9
其中RB1、RB2、RCR1、RCR2、R1、R2各彼此獨立地表示H;具有至多15個C原子之烷基或烯基,其未經取代、經CN或CF3單取代或至少經鹵素單取代,其中,另外,此等基團中之一或多個CH2基團可以使得 O原子不直接彼此鍵聯之方式經-O-、-S-、
Figure 109116296-A0305-02-0164-10
、-C≡C-、-CF2O-、-OCF2-、-OC-O-或-O-CO-置換,c為0、1或2,且d為1或2。
A liquid crystal medium based on a mixture of polar compounds, characterized in that it contains a compound of formula I,
Figure 109116296-A0305-02-0163-1
, and at least one compound selected from the group consisting of formula BC, CR, PH-1, PH-2, BF-1, BF-2, BS-1 and BS-2,
Figure 109116296-A0305-02-0163-2
Figure 109116296-A0305-02-0163-3
Figure 109116296-A0305-02-0163-4
Figure 109116296-A0305-02-0163-5
Figure 109116296-A0305-02-0163-6
Figure 109116296-A0305-02-0163-7
Figure 109116296-A0305-02-0163-8
Figure 109116296-A0305-02-0164-9
wherein R B1 , R B2 , R CR1 , R CR2 , R 1 , and R 2 each independently represent H; an alkyl or alkenyl group with up to 15 C atoms, which is unsubstituted, monosubstituted by CN or CF 3 or at least monosubstituted by halogen, wherein, in addition, one or more of the CH 2 groups in these groups may be -O-, -S-,
Figure 109116296-A0305-02-0164-10
, -C≡C-, -CF 2 O-, -OCF 2 -, -OC-O- or -O-CO- substitution, c is 0, 1 or 2, and d is 1 or 2.
如請求項1之液晶介質,其中該至少一個選自式BC、CR、PH-1、PH-2、BF-1、BF-2、BS-1及BS-2之化合物係選自式BC-1至BC-7、CR-1至CR-5、BF-1a至BF-1d及BS-1a至BS-1d之化合物之群,
Figure 109116296-A0305-02-0165-11
Figure 109116296-A0305-02-0165-12
Figure 109116296-A0305-02-0165-13
Figure 109116296-A0305-02-0165-14
Figure 109116296-A0305-02-0165-15
Figure 109116296-A0305-02-0165-16
Figure 109116296-A0305-02-0165-17
Figure 109116296-A0305-02-0166-18
Figure 109116296-A0305-02-0166-19
Figure 109116296-A0305-02-0166-20
Figure 109116296-A0305-02-0166-21
Figure 109116296-A0305-02-0166-22
Figure 109116296-A0305-02-0166-23
Figure 109116296-A0305-02-0166-24
Figure 109116296-A0305-02-0167-25
Figure 109116296-A0305-02-0167-26
Figure 109116296-A0305-02-0167-27
Figure 109116296-A0305-02-0167-28
Figure 109116296-A0305-02-0167-29
Figure 109116296-A0305-02-0167-30
其中烷基及烷基*各彼此獨立地表示具有1至6個C原子之直鏈烷基,烯基及烯基*各彼此獨立地表示具有2至6個C原子之直鏈烯基,烷氧基及烷氧基*各彼此獨立地表示具有1至6個C原子之烷氧基,且烯氧基表示具有2至6個C原子之直鏈烯氧基。
The liquid crystal medium of claim 1, wherein the at least one compound selected from the group consisting of formula BC, CR, PH-1, PH-2, BF-1, BF-2, BS-1 and BS-2 is selected from the group consisting of formula BC- The group of compounds from 1 to BC-7, CR-1 to CR-5, BF-1a to BF-1d and BS-1a to BS-1d,
Figure 109116296-A0305-02-0165-11
Figure 109116296-A0305-02-0165-12
Figure 109116296-A0305-02-0165-13
Figure 109116296-A0305-02-0165-14
Figure 109116296-A0305-02-0165-15
Figure 109116296-A0305-02-0165-16
Figure 109116296-A0305-02-0165-17
Figure 109116296-A0305-02-0166-18
Figure 109116296-A0305-02-0166-19
Figure 109116296-A0305-02-0166-20
Figure 109116296-A0305-02-0166-21
Figure 109116296-A0305-02-0166-22
Figure 109116296-A0305-02-0166-23
Figure 109116296-A0305-02-0166-24
Figure 109116296-A0305-02-0167-25
Figure 109116296-A0305-02-0167-26
Figure 109116296-A0305-02-0167-27
Figure 109116296-A0305-02-0167-28
Figure 109116296-A0305-02-0167-29
Figure 109116296-A0305-02-0167-30
Wherein alkyl and alkyl* each independently represent a straight-chain alkyl group having 1 to 6 C atoms, alkenyl and alkenyl* each independently represent a straight-chain alkenyl group having 2 to 6 C atoms, alkyl Oxy and alkoxy* each independently represent an alkoxy group having 1 to 6 C atoms, and alkenoxy represents a linear alkenyloxy group having 2 to 6 C atoms.
如請求項1之液晶介質,其中該至少一個選自式BC、CR、PH- 1、PH-2、BF-1、BF-2、BS-1及BS-2之化合物之量為3至15重量%。 The liquid crystal medium of claim 1, wherein the at least one is selected from the group consisting of BC, CR, PH- 1. The amount of compounds of PH-2, BF-1, BF-2, BS-1 and BS-2 is 3 to 15% by weight. 如請求項2之液晶介質,其中該介質包含一種、兩種或三種式BC-2及BF-1a之化合物。 Such as the liquid crystal medium of claim 2, wherein the medium contains one, two or three compounds of formulas BC-2 and BF-1a. 如請求項1之液晶介質,其中其另外包含一或多種選自式IIA、IIB及IIC之化合物之群的化合物,
Figure 109116296-A0305-02-0168-31
Figure 109116296-A0305-02-0168-32
Figure 109116296-A0305-02-0168-33
其中R2A、R2B及R2C各彼此獨立地表示H;具有至多15個C原子之烷基或烯基,其未經取代、經CN或CF3單取代或至少經鹵素單取代,其中,另外,此等基團中之一或多個CH2基團可以使得O原子不直接彼此鍵聯之方式經-O-、-S-、
Figure 109116296-A0305-02-0168-34
、-C≡C-、-CF2O-、-OCF2-、-OC-O-或-O-CO-置換,L1-4各獨立地表示F或Cl,Z2及Z2'各獨立地表示單鍵、-CH2CH2-、-CH=CH-、-CF2O-、-OCF2-、-CH2O-、-OCH2-、-COO-、-OCO-、-C2F4-、-CF=CF-、-CH=CHCH2O-, p表示1或2,q表示0或1,且v表示1至6。
The liquid crystal medium of claim 1, wherein it additionally contains one or more compounds selected from the group of compounds of formulas IIA, IIB and IIC,
Figure 109116296-A0305-02-0168-31
Figure 109116296-A0305-02-0168-32
Figure 109116296-A0305-02-0168-33
wherein R 2A , R 2B and R 2C each independently represent H; an alkyl or alkenyl group having up to 15 C atoms, which is unsubstituted, monosubstituted with CN or CF 3 or at least monosubstituted with halogen, wherein, In addition, one or more of the CH 2 groups in these groups may be passed through -O-, -S-,
Figure 109116296-A0305-02-0168-34
, -C≡C-, -CF 2 O-, -OCF 2 -, -OC-O- or -O-CO- substitution, L 1-4 each independently represents F or Cl, Z 2 and Z 2' each independently Independently represents a single bond, -CH 2 CH 2 -, -CH=CH-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, - C 2 F 4 -, -CF=CF-, -CH=CHCH 2 O-, p represents 1 or 2, q represents 0 or 1, and v represents 1 to 6.
如請求項5之液晶介質,其中該式IIA、IIB及IIC之化合物係選自由式IIA-1至IIA-50、IIB-1至IIB-16及IIC-1之化合物所組成之群,
Figure 109116296-A0305-02-0169-35
Figure 109116296-A0305-02-0169-36
Figure 109116296-A0305-02-0169-37
Figure 109116296-A0305-02-0169-38
Figure 109116296-A0305-02-0170-39
Figure 109116296-A0305-02-0170-40
Figure 109116296-A0305-02-0170-41
Figure 109116296-A0305-02-0170-42
Figure 109116296-A0305-02-0170-43
Figure 109116296-A0305-02-0170-44
Figure 109116296-A0305-02-0170-45
Figure 109116296-A0305-02-0170-46
Figure 109116296-A0305-02-0170-47
Figure 109116296-A0305-02-0171-48
Figure 109116296-A0305-02-0171-49
Figure 109116296-A0305-02-0171-50
Figure 109116296-A0305-02-0171-51
Figure 109116296-A0305-02-0171-52
Figure 109116296-A0305-02-0171-53
Figure 109116296-A0305-02-0171-54
Figure 109116296-A0305-02-0171-55
Figure 109116296-A0305-02-0171-56
Figure 109116296-A0305-02-0172-59
Figure 109116296-A0305-02-0172-60
Figure 109116296-A0305-02-0172-61
Figure 109116296-A0305-02-0172-62
Figure 109116296-A0305-02-0172-63
Figure 109116296-A0305-02-0172-64
Figure 109116296-A0305-02-0172-65
Figure 109116296-A0305-02-0172-66
Figure 109116296-A0305-02-0172-67
Figure 109116296-A0305-02-0173-68
Figure 109116296-A0305-02-0173-69
Figure 109116296-A0305-02-0173-70
Figure 109116296-A0305-02-0173-71
Figure 109116296-A0305-02-0173-72
Figure 109116296-A0305-02-0173-73
Figure 109116296-A0305-02-0173-74
Figure 109116296-A0305-02-0173-75
Figure 109116296-A0305-02-0173-76
Figure 109116296-A0305-02-0174-77
Figure 109116296-A0305-02-0174-78
Figure 109116296-A0305-02-0174-79
Figure 109116296-A0305-02-0174-80
Figure 109116296-A0305-02-0174-81
Figure 109116296-A0305-02-0174-82
Figure 109116296-A0305-02-0174-83
Figure 109116296-A0305-02-0174-84
Figure 109116296-A0305-02-0174-85
Figure 109116296-A0305-02-0175-86
Figure 109116296-A0305-02-0175-87
Figure 109116296-A0305-02-0175-88
Figure 109116296-A0305-02-0175-89
Figure 109116296-A0305-02-0175-90
Figure 109116296-A0305-02-0175-91
Figure 109116296-A0305-02-0175-92
Figure 109116296-A0305-02-0175-93
Figure 109116296-A0305-02-0175-94
Figure 109116296-A0305-02-0176-95
Figure 109116296-A0305-02-0176-96
Figure 109116296-A0305-02-0176-97
Figure 109116296-A0305-02-0176-98
Figure 109116296-A0305-02-0176-99
Figure 109116296-A0305-02-0176-100
Figure 109116296-A0305-02-0176-101
Figure 109116296-A0305-02-0176-102
Figure 109116296-A0305-02-0176-103
其中烷基及烷基*各彼此獨立地表示具有1至6個C原子之直鏈烷基且烯基表示具有2至15個C原子之烯基。
Such as the liquid crystal medium of claim 5, wherein the compounds of formulas IIA, IIB and IIC are selected from the group consisting of compounds of formulas IIA-1 to IIA-50, IIB-1 to IIB-16 and IIC-1,
Figure 109116296-A0305-02-0169-35
Figure 109116296-A0305-02-0169-36
Figure 109116296-A0305-02-0169-37
Figure 109116296-A0305-02-0169-38
Figure 109116296-A0305-02-0170-39
Figure 109116296-A0305-02-0170-40
Figure 109116296-A0305-02-0170-41
Figure 109116296-A0305-02-0170-42
Figure 109116296-A0305-02-0170-43
Figure 109116296-A0305-02-0170-44
Figure 109116296-A0305-02-0170-45
Figure 109116296-A0305-02-0170-46
Figure 109116296-A0305-02-0170-47
Figure 109116296-A0305-02-0171-48
Figure 109116296-A0305-02-0171-49
Figure 109116296-A0305-02-0171-50
Figure 109116296-A0305-02-0171-51
Figure 109116296-A0305-02-0171-52
Figure 109116296-A0305-02-0171-53
Figure 109116296-A0305-02-0171-54
Figure 109116296-A0305-02-0171-55
Figure 109116296-A0305-02-0171-56
Figure 109116296-A0305-02-0172-59
Figure 109116296-A0305-02-0172-60
Figure 109116296-A0305-02-0172-61
Figure 109116296-A0305-02-0172-62
Figure 109116296-A0305-02-0172-63
Figure 109116296-A0305-02-0172-64
Figure 109116296-A0305-02-0172-65
Figure 109116296-A0305-02-0172-66
Figure 109116296-A0305-02-0172-67
Figure 109116296-A0305-02-0173-68
Figure 109116296-A0305-02-0173-69
Figure 109116296-A0305-02-0173-70
Figure 109116296-A0305-02-0173-71
Figure 109116296-A0305-02-0173-72
Figure 109116296-A0305-02-0173-73
Figure 109116296-A0305-02-0173-74
Figure 109116296-A0305-02-0173-75
Figure 109116296-A0305-02-0173-76
Figure 109116296-A0305-02-0174-77
Figure 109116296-A0305-02-0174-78
Figure 109116296-A0305-02-0174-79
Figure 109116296-A0305-02-0174-80
Figure 109116296-A0305-02-0174-81
Figure 109116296-A0305-02-0174-82
Figure 109116296-A0305-02-0174-83
Figure 109116296-A0305-02-0174-84
Figure 109116296-A0305-02-0174-85
Figure 109116296-A0305-02-0175-86
Figure 109116296-A0305-02-0175-87
Figure 109116296-A0305-02-0175-88
Figure 109116296-A0305-02-0175-89
Figure 109116296-A0305-02-0175-90
Figure 109116296-A0305-02-0175-91
Figure 109116296-A0305-02-0175-92
Figure 109116296-A0305-02-0175-93
Figure 109116296-A0305-02-0175-94
Figure 109116296-A0305-02-0176-95
Figure 109116296-A0305-02-0176-96
Figure 109116296-A0305-02-0176-97
Figure 109116296-A0305-02-0176-98
Figure 109116296-A0305-02-0176-99
Figure 109116296-A0305-02-0176-100
Figure 109116296-A0305-02-0176-101
Figure 109116296-A0305-02-0176-102
Figure 109116296-A0305-02-0176-103
wherein alkyl and alkyl* each independently represent a straight-chain alkyl group having 1 to 6 C atoms and alkenyl represents an alkenyl group having 2 to 15 C atoms.
如請求項1之液晶介質,其中該介質另外包含一或多種式III化合物,
Figure 109116296-A0305-02-0177-104
其中R31及R32各獨立地表示具有至多12個C原子之直鏈烷基、烷氧基烷基或烷氧基,
Figure 109116296-A0305-02-0177-105
表示
Figure 109116296-A0305-02-0177-106
Figure 109116296-A0305-02-0177-107
Figure 109116296-A0305-02-0177-108
Figure 109116296-A0305-02-0177-109
Figure 109116296-A0305-02-0177-110
Z3表示單鍵、-CH2CH2-、-CH=CH-、-CF2O-、-OCF2-、-CH2O-、-OCH2-、-COO-、-OCO-、-C2F4-、-C4H9-、-CF=CF-。
The liquid crystal medium of claim 1, wherein the medium additionally contains one or more compounds of formula III,
Figure 109116296-A0305-02-0177-104
wherein R 31 and R 32 each independently represent a straight-chain alkyl group, an alkoxyalkyl group or an alkoxy group having up to 12 C atoms,
Figure 109116296-A0305-02-0177-105
express
Figure 109116296-A0305-02-0177-106
,
Figure 109116296-A0305-02-0177-107
,
Figure 109116296-A0305-02-0177-108
,
Figure 109116296-A0305-02-0177-109
or
Figure 109116296-A0305-02-0177-110
Z 3 represents a single bond, -CH 2 CH 2 -, -CH=CH-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, - C 2 F 4 -, -C 4 H 9 -, -CF=CF-.
如請求項1之液晶介質,其中該介質另外包含一或多種式L-1至L-11之化合物,
Figure 109116296-A0305-02-0178-112
Figure 109116296-A0305-02-0178-113
Figure 109116296-A0305-02-0178-114
Figure 109116296-A0305-02-0178-115
Figure 109116296-A0305-02-0178-116
Figure 109116296-A0305-02-0178-117
Figure 109116296-A0305-02-0178-118
Figure 109116296-A0305-02-0178-119
Figure 109116296-A0305-02-0179-120
Figure 109116296-A0305-02-0179-121
Figure 109116296-A0305-02-0179-122
其中R、R1及R2各彼此獨立地具有請求項2中對於R2A所指示之含義,且烷基表示具有1至6個C原子之烷基,且s表示1或2。
The liquid crystal medium of claim 1, wherein the medium additionally contains one or more compounds of formulas L-1 to L-11,
Figure 109116296-A0305-02-0178-112
Figure 109116296-A0305-02-0178-113
Figure 109116296-A0305-02-0178-114
Figure 109116296-A0305-02-0178-115
Figure 109116296-A0305-02-0178-116
Figure 109116296-A0305-02-0178-117
Figure 109116296-A0305-02-0178-118
Figure 109116296-A0305-02-0178-119
Figure 109116296-A0305-02-0179-120
Figure 109116296-A0305-02-0179-121
Figure 109116296-A0305-02-0179-122
wherein R, R 1 and R 2 each independently have the meaning indicated for R 2A in claim 2, and alkyl represents an alkyl group having 1 to 6 C atoms, and s represents 1 or 2.
如請求項1之液晶介質,其中該介質另外包含一或多種式O-1至O-17之化合物,
Figure 109116296-A0305-02-0179-123
Figure 109116296-A0305-02-0179-124
Figure 109116296-A0305-02-0179-125
Figure 109116296-A0305-02-0179-126
Figure 109116296-A0305-02-0179-127
Figure 109116296-A0305-02-0180-128
Figure 109116296-A0305-02-0180-129
Figure 109116296-A0305-02-0180-130
Figure 109116296-A0305-02-0180-131
Figure 109116296-A0305-02-0180-132
Figure 109116296-A0305-02-0180-133
Figure 109116296-A0305-02-0180-134
Figure 109116296-A0305-02-0180-135
Figure 109116296-A0305-02-0180-136
Figure 109116296-A0305-02-0180-137
Figure 109116296-A0305-02-0180-138
Figure 109116296-A0305-02-0180-139
其中R1及R2各彼此獨立地具有請求項2中對於R2A所指示之含義,且該(該等)式O-17化合物與該式I化合物不相同。
The liquid crystal medium of claim 1, wherein the medium additionally contains one or more compounds of formulas O-1 to O-17,
Figure 109116296-A0305-02-0179-123
Figure 109116296-A0305-02-0179-124
Figure 109116296-A0305-02-0179-125
Figure 109116296-A0305-02-0179-126
Figure 109116296-A0305-02-0179-127
Figure 109116296-A0305-02-0180-128
Figure 109116296-A0305-02-0180-129
Figure 109116296-A0305-02-0180-130
Figure 109116296-A0305-02-0180-131
Figure 109116296-A0305-02-0180-132
Figure 109116296-A0305-02-0180-133
Figure 109116296-A0305-02-0180-134
Figure 109116296-A0305-02-0180-135
Figure 109116296-A0305-02-0180-136
Figure 109116296-A0305-02-0180-137
Figure 109116296-A0305-02-0180-138
Figure 109116296-A0305-02-0180-139
wherein R 1 and R 2 each independently have the meaning indicated for R 2A in claim 2, and the compound(s) of formula O-17 is not the same as the compound of formula I.
如請求項1之液晶介質,其中該介質另外包含一或多種式In之茚滿化合物,
Figure 109116296-A0305-02-0181-140
其中R11、R12、R13分別表示具有1至6或2至6個C原子之直鏈烷基、烷氧基、烷氧基烷基或烯基,R12及R13另外亦表示鹵素,
Figure 109116296-A0305-02-0181-141
表示
Figure 109116296-A0305-02-0181-142
i表示0、1或2。
The liquid crystal medium of claim 1, wherein the medium additionally contains one or more indane compounds of the formula In,
Figure 109116296-A0305-02-0181-140
Among them, R 11 , R 12 and R 13 respectively represent a straight-chain alkyl group, alkoxy group, alkoxyalkyl group or alkenyl group with 1 to 6 or 2 to 6 C atoms. R 12 and R 13 also represent halogen. ,
Figure 109116296-A0305-02-0181-141
express
Figure 109116296-A0305-02-0181-142
i represents 0, 1 or 2.
如請求項1至10中任一項之液晶介質,其中該式I化合物在該整體混合物中之比例為1至30重量%。 The liquid crystal medium of any one of claims 1 to 10, wherein the proportion of the compound of formula I in the overall mixture is 1 to 30% by weight. 如請求項1至10中任一項之液晶介質,其中其另外包含一或多種來自下式之化合物之群的化合物,
Figure 109116296-A0305-02-0181-143
Figure 109116296-A0305-02-0182-144
Figure 109116296-A0305-02-0182-145
Figure 109116296-A0305-02-0182-146
Figure 109116296-A0305-02-0182-147
Figure 109116296-A0305-02-0182-148
Figure 109116296-A0305-02-0182-149
Figure 109116296-A0305-02-0182-150
Figure 109116296-A0305-02-0182-151
The liquid crystal medium of any one of claims 1 to 10, wherein it additionally contains one or more compounds from the group of compounds of the following formula,
Figure 109116296-A0305-02-0181-143
Figure 109116296-A0305-02-0182-144
Figure 109116296-A0305-02-0182-145
Figure 109116296-A0305-02-0182-146
Figure 109116296-A0305-02-0182-147
Figure 109116296-A0305-02-0182-148
Figure 109116296-A0305-02-0182-149
Figure 109116296-A0305-02-0182-150
Figure 109116296-A0305-02-0182-151
如請求項1至10中任一項之液晶介質,其中其另外包含選自以下之群的化合物
Figure 109116296-A0305-02-0182-152
Figure 109116296-A0305-02-0182-153
Figure 109116296-A0305-02-0183-154
Figure 109116296-A0305-02-0183-155
Figure 109116296-A0305-02-0183-156
Figure 109116296-A0305-02-0183-157
The liquid crystal medium of any one of claims 1 to 10, wherein it additionally contains a compound selected from the group consisting of:
Figure 109116296-A0305-02-0182-152
Figure 109116296-A0305-02-0182-153
Figure 109116296-A0305-02-0183-154
Figure 109116296-A0305-02-0183-155
Figure 109116296-A0305-02-0183-156
Figure 109116296-A0305-02-0183-157
如請求項1至10中任一項之液晶介質,其中其另外包含一或多種選自由式B-1至B-4之化合物所組成之群的化合物
Figure 109116296-A0305-02-0183-158
Figure 109116296-A0305-02-0183-159
Figure 109116296-A0305-02-0183-160
Figure 109116296-A0305-02-0183-161
其中烷基及烷基*各彼此獨立地表示具有1至6個C原子之直鏈烷基,烯基及烯基*各彼此獨立地表示具有2至6個C原子之直鏈烯基,且烷氧基表示具有1至6個C原子之直鏈烷氧基。
The liquid crystal medium of any one of claims 1 to 10, wherein it additionally contains one or more compounds selected from the group consisting of compounds of formulas B-1 to B-4
Figure 109116296-A0305-02-0183-158
Figure 109116296-A0305-02-0183-159
Figure 109116296-A0305-02-0183-160
Figure 109116296-A0305-02-0183-161
wherein alkyl and alkyl* each independently represent a straight-chain alkyl group having 1 to 6 C atoms, and alkenyl and alkenyl* each independently represent a straight-chain alkenyl group having 2 to 6 C atoms, and Alkoxy represents a straight-chain alkoxy group having 1 to 6 C atoms.
如請求項1至10中任一項之液晶介質,其中其另外包含一或多種 選自由式B-1a、B-2a、B-2b及B-2c之化合物所組成之群的化合物
Figure 109116296-A0305-02-0184-162
Figure 109116296-A0305-02-0184-163
Figure 109116296-A0305-02-0184-164
Figure 109116296-A0305-02-0184-165
其中烷基*表示具有1至6個C原子之烷基。
The liquid crystal medium of any one of claims 1 to 10, wherein it additionally contains one or more compounds selected from the group consisting of compounds of formulas B-1a, B-2a, B-2b and B-2c
Figure 109116296-A0305-02-0184-162
Figure 109116296-A0305-02-0184-163
Figure 109116296-A0305-02-0184-164
Figure 109116296-A0305-02-0184-165
Where alkyl* represents an alkyl group having 1 to 6 C atoms.
如請求項1至10中任一項之液晶介質,其中該介質包含至少一種可聚合化合物。 The liquid crystal medium of any one of claims 1 to 10, wherein the medium contains at least one polymerizable compound. 如請求項16之液晶介質,其中該介質包含一或多種用以聚合之引發劑。 The liquid crystal medium of claim 16, wherein the medium contains one or more initiators for polymerization. 如請求項17之液晶介質,其中該引發劑之量為基於該液晶介質之0.001至2重量%。 The liquid crystal medium of claim 17, wherein the amount of the initiator is 0.001 to 2% by weight based on the liquid crystal medium. 如請求項1至10中任一項之液晶介質,其中該介質包含一或多種添加劑。 The liquid crystal medium of any one of claims 1 to 10, wherein the medium contains one or more additives. 如請求項19之液晶介質,其中該添加劑係選自自由基清除劑、 抗氧化劑及/或UV穩定劑之群。 The liquid crystal medium of claim 19, wherein the additive is selected from the group consisting of free radical scavengers, Antioxidants and/or UV stabilizers. 一種如請求項1至20中任一項之液晶介質之用途,其係用於電光顯示器中。 A use of a liquid crystal medium according to any one of claims 1 to 20, which is used in an electro-optical display. 一種具有主動矩陣定址之電光顯示器,其特徵在於其含有如請求項1至20中任一項之液晶介質作為介電質。 An electro-optical display with active matrix addressing, characterized in that it contains the liquid crystal medium according to any one of claims 1 to 20 as a dielectric. 如請求項22之電光顯示器,其中其為VA、PSA、PS-VA、PALC、IPS、PS-IPS、SS-VA、PM-VA、FFS或PS-FFS顯示器。 The electro-optical display of claim 22, wherein it is a VA, PSA, PS-VA, PALC, IPS, PS-IPS, SS-VA, PM-VA, FFS or PS-FFS display.
TW109116296A 2014-11-25 2015-11-24 Liquid-crystalline medium TWI828910B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102014017358.5 2014-11-25
DE102014017358 2014-11-25
US201562105578P 2015-01-20 2015-01-20
US62/105,578 2015-01-20

Publications (2)

Publication Number Publication Date
TW202104555A TW202104555A (en) 2021-02-01
TWI828910B true TWI828910B (en) 2024-01-11

Family

ID=75745003

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109116296A TWI828910B (en) 2014-11-25 2015-11-24 Liquid-crystalline medium

Country Status (1)

Country Link
TW (1) TWI828910B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102482577A (en) * 2009-09-08 2012-05-30 默克专利股份有限公司 Liquid-crystal display
CN103980910A (en) * 2008-12-22 2014-08-13 默克专利股份有限公司 Liquid-crystal medium

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103980910A (en) * 2008-12-22 2014-08-13 默克专利股份有限公司 Liquid-crystal medium
CN102482577A (en) * 2009-09-08 2012-05-30 默克专利股份有限公司 Liquid-crystal display

Also Published As

Publication number Publication date
TW202104555A (en) 2021-02-01

Similar Documents

Publication Publication Date Title
TWI756684B (en) Liquid-crystalline medium
TWI823218B (en) Liquid-crystalline medium
TWI805650B (en) Liquid-crystalline medium
TWI797057B (en) Liquid-crystalline medium, process of preparation thereof and use thereof
TWI708833B (en) Liquid-crystalline medium
TWI791417B (en) Liquid-crystalline medium
TW202323504A (en) Liquid-crystalline medium
TW201604266A (en) Liquid-crystalline medium
TW201529812A (en) Liquid-crystalline medium
TW202346547A (en) Liquid-crystalline medium
TWI828910B (en) Liquid-crystalline medium
KR102660653B1 (en) liquid crystal medium